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Abstract 
The  incidence  of  neoplasia  at  the  gastroesophageal  junction  has  increased 
markedly  over  the  past  20  years,  but  the  mutagen  responsible  for  this  remains 
unknown.    Human  saliva  contains  substantial  quantities  of  nitrite  and  is  the  main 
source  of  nitrite  entering  the  stomach.    It  is  derived  from  the  enterosalivary 
recirculation of dietary nitrate and its reduction by buccal bacteria.  Carcinogenic N-
nitrosocompounds may be formed from the nitrite in swallowed saliva by bacterially-
catalysed nitrosation in the achlorhydric stomach or acid-catalysed nitrosation in the 
healthy acid secreting stomach.  Protection against luminal acid-catalysed nitrosation is 
provided by the ascorbic acid content of human gastric juice which reduces nitrite to 
nitric oxide (NO).  A high luminal concentration of NO generated from salivary nitrite 
has been shown at the gastroesophageal junction. 
 
A bench top model has been developed to explore the chemistry occurring in an 
aqueous  phase,  representing  the  lumen  at  the  gastroesophageal  junction,  after  the 
addition of nitrite.  Within this model an adjacent lipid phase has been created.  The 
lipid phase represents the adjacent mucosa to the lumen or the dietary fat shown to sit 
within the fundus of the stomach.  In this two-phase model, addition of physiological 
concentrations of nitrite to an acidic aqueous phase in the absence of ascorbic acid 
generated nitrosative stress within the aqueous phase.  The addition of physiological 
concentrations of ascorbic acid to the aqueous phase prevents nitrosative stress within 
the aqueous phase but in so doing generates nitrosative stress within the lipid phase.  
This can be explained by the ascorbic acid converting the salivary nitrite to NO which vii 
 
diffuses into the lipid phase and there reacts with O2 to form the nitrosating species 
N2O3. 
The  bench  top  model  has  been  developed  further  to  include  the  lipid 
antioxidants, ʱ-tocopherol, β-carotene and BHT.  All three of these antioxidants are 
effective in inhibiting nitrosative stress within the lipid phase.  The concentration of ʱ-
tocopherol  required  to  inhibit  nitrosation  is  less  than  would  be  expected  from  the 
reaction equation.  A possible explanation for this is that ascorbic acid recycles the 
active  antioxidant  ʱ-tocopherol  from  its  reduced  form.    Further  studies  to  support 
recycling of ʱ-tocopherol by ascorbic acid are presented within this thesis. 
 
The design of a model used in vivo to assess for nitrosative stress is discussed.  
The model consisted of a hydrophobic silastic tubing containing a secondary amine at 
a neutral pH.  The hydrophobic membrane that the tubing is composed of allowed the 
passage of gaseous NO.  Human studies in healthy volunteers were performed using 
the silastic tubing.  The data presented shows that after a nitrate rich drink there is 
significantly more nitrosative stress within the upper gastrointestinal tract and this is 
particularly the case in the first part of the stomach where salivary nitrite meets acidic 
gastric juice containing ascorbic acid. 
 
Finally,  the  studies  explore  directly  measuring  nitrosative  stress  in  biopsy 
samples from humans and rats.  As nitrite has been shown previously to be a marker of 
nitrosative stress in bench top models biopsy samples were assessed for nitrite and 
nitrate concentrations.  Methods for assessing nitrite and nitrate concentrations within viii 
 
biopsy samples from the upper gastrointestinal tract are discussed, as nitrite and nitrate 
have not been analysed from this region previously.  Thereafter, upper gastrointestinal 
biopsy samples from healthy human subjects were analysed after a control drink and a 
drink rich in nitrate.  The studies presented show that biopsy nitrate and nitrite was 
higher in samples taken from the proximal stomach as compared to the oesophagus and 
distal stomach.  This suggests that there is more nitrosative stress in the biopsies from 
the same area as where NO is generated after a nitrate meal. 
 
Together the data presented supports a novel mechanism for N-nitrosation in 
the upper gastrointestinal tract of a healthy subject.  The N-nitrosation is maximal 
where  swallowed  salivary  nitrite  from  dietary  nitrate  meets  acidic  gastric  juice 
containing the aqueous antioxidant ascorbic acid. ix 
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Chapter 1 – Introduction 
 
1.1  Overview of adenocarcinoma of the gastroesophageal junction and cardia 
of the stomach 
 
The first report of an oesophageal adenocarcinoma was over a century ago and 
is credited
 to White in 1898. A review of the literature in 1900 revealed
 only six 
cases  (1).    Initially  it  was  thought  that  this  cancer  was  an  extension  of  gastric 
tumours into the lower oesophagus.  It was not until the 1950s that the existence of a 
primary  adenocarcinoma  of  the  oesophagus  was  established.    While  once  an 
uncommon tumour, it is now one of the cancers with the fastest increasing incidence 
in the developing world.  In the US, the rate of increase in adenocarcinoma of the 
gastroesophageal junction and cardia of the stomach has overtaken the next closest 
cancer,  melanoma,  by  nearly  three  times  (2-4).  Using  the  European  computer 
database Eurocim, it was found that, when the period 1968-95 was examined, there 
was an increase in incidence of adenocarcinoma of the oesophagus and gastric cardia 
throughout most of Europe (5). The interest in cancer of the oesophagus and gastric 
cardia is such that the recent fourth meeting in the series of international ‘From Gene 
to Cure’ congress in 2002 was dedicated to the topic.  Scotland, in particular, has a 
high  and  increasing  incidence  of  adenocarcinoma  at  and  around  the 
gastroesophageal junction.  The incidence here has increased two to three fold in the 
last three decades.  The incidence of cancer in Scotland, from all anatomical sites 
combined, has not changed much over the time period 1975-99.  However, when 2 
 
broken down into regions of the body, there are some striking differences.  Areas of 
the body which are exposed to high luminal nitrite have shown significant increases 
in the incidence of cancer between the years 1975-99.  These areas include the oral 
cavity  (+151%),  oesophageal  adenocarcinoma  (+195%),  oesophageal  squamous 
carcinoma  (+60%)  and  the  cardia  region  of  the  stomach  which  has  the  highest 
increase in incidence over this time period with a percentage increase of 230% (6).   
 
In  contrast  to  the  increasing  incidence  of  cardia  gastric  cancer,  there  is  a 
progressive fall in incidence of distal  gastric cancer (7).  These opposing trends 
would suggest that there is a different aetiology behind these cancers.  In keeping 
with this, non cardia cancer is associated with Helicobacter pylori induced atrophic 
gastritis  and  hypochlohydria  (8,9),  whereas,  gastric  cardia  and  gastroesophageal 
junction cancers occur in individuals with healthy acid secreting stomachs, and are 
not associated with Helicobacter pylori (8,10).   The decreasing incidence of non 
cardia gastric cancer may be explained by the decreasing incidence of Helicobacter 
pylori  and  associated  atrophic  gastritis.    However,  the  cause  of  the  increasing 
incidence of gastroesophageal junction and gastric cardia adenocarcinoma remains 
unclear. Patients diagnosed with oesophageal cancer have a poor prognosis, with 5 
year survival ranging between 5% and 20% in patients amenable to surgery.  An 
understanding of the causes of this cancer and its progression is therefore important, 
to try and decrease the incidence of this disease and also to help direct therapeutic 
interventions. 
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1.2  Epidemiology of Gastroesophageal Junction Adenocarcinoma 
 
The incidence of oesophageal adenocarcinoma is usually higher in men than 
women and increases  over the  age of 35  years, although the rate of  rise differs 
markedly between different regions, probably in association with differences in risk 
factor patterns.  Long-standing gastroesophageal reflux, Caucasian race and obesity 
are well recognised associations with this cancer.  While tobacco smoke has been 
shown in some studies to be a risk factor the evidence of this is not universal and 
some studies have shown no risk.  This is in contrast to non cardia gastric cancer 
where  there  is  a  strong  association  with  cigarette  smoking.    Long-standing 
gastroesophageal reflux disease may induce Barrett’s oesophagus, which is a pre-
malignant condition where the squamous cells of the lower oesophagus are replaced 
by columnar epithelial metaplasia. The rate of conversion from Barrett’s oesophagus 
to  oesophageal  adenocarcinoma  is  0.5-1%  per  year.    There  may  be  a  protective 
effect from infection of the stomach with Helicobacter pylori and it is known that 
Helicobacter pylori is itself associated with achlorhydria.  There was a nested case 
control study from Norway based on over one hundred thousand individuals where it 
was shown that Helicobacter pylori was associated with a 5 fold reduction in risk of 
cardia cancer and a five fold increase in risk of non cardia cancer (11,12).  Similar, 
although less dramatic, results have been shown elsewhere
 (13) and meta-analysis of 
this data shows a negative association between Helicobacter pylori infection and 
cardia gastric cancer (14). 
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The pattern of increase would make it unlikely that the increasing incidence in 
oesophageal adenocarcinoma is related to genetic factors and there does not seem to 
be any link with heredity.  This would therefore suggest that acquired factors are 
more likely to be involved. The demonstration of a ‘birth cohort effect’, with higher 
incidence in younger cohorts, would support the idea that exposure to environmental 
factors in early life is an important determinant of risk (15). A potential source of the 
acquired  risk  factors  would  be  gastroesophageal  reflux  disease.    Perhaps 
surprisingly, there is not reliable data to suggest a correlation between GORD and 
oesophageal  adenocarcinoma.  It  is  also  of  note  that  long  term  acid  suppressive 
therapy does not remove the risk of malignant complications of the disease (16,17).  
Acid reflux exposure has however been shown to cause non-specific DNA damage 
(18-20). There has been one large case control study that has demonstrated a positive 
association between use of lower oesophageal sphincter relaxing medication and the 
risk of oesophageal adenocarcinoma (21).  It has been postulated that the increased 
abdominal pressure caused by central obesity, a sedentary position and wearing of 
tight  belts  may  be  a  factor  for  gastro-oesophageal  reflux  (22).    The  pattern  of 
incidence  of  adenocarcinoma,  the  rapidity  of  its  increase  and  the  marked  male 
preponderance  are  inconsistent  with  the  increased  body  mass  index  seen  in  the 
western world being related to GORD and subsequent adenocarcinoma.   
 
As  well  as  the  epidemiology  discussed  above,  there  have  also  been  some 
interesting epidemiological findings which could suggest a possible implication of 
dietary nitrate in the increasing incidence of upper gastrointestinal cancer.  After the 5 
 
Second World War, until the mid 1980s, there was an exponential rise in nitrogen 
fertiliser usage in the UK.  This same picture was seen in the USA (23).  In the UK 
there has been a gradual decline in the nitrate rich fertilisers used in predominately 
arable farming.  Since 1984 there has been a fall of approximately 30% in nitrate 
fertiliser use (24).  It is known that, for many epidemiological factors implicated in 
cancer  development  there  is  a  lag  period  between  the  cancerous  insult  and  the 
resulting cancer, an example being cigarette smoking and bronchial carcinoma.  This 
is  found  in  comparing  the  rise  in  adenocarcinoma  at  and  around  the 
gastroesophageal junction and nitrogen fertiliser usage. There have been surprisingly 
few  studies  looking  at  the  epidemiology  of  fruit  and  vegetable  intake  and 
cardia/gastroesophageal  junction  adenocarcinoma.    Most  of the  studies  that  have 
been performed have classified upper gastrointestinal cancers into oesophageal and 
gastric cancers.  As we suspect that there may be at least two different mechanisms 
to gastric cancer, with one involving the healthy acid secreting subject, and the other 
the hypochlorhydric Helicobacter pylori colonised stomach, it is difficult to draw 
useful relevant epidemiological analysis from most of these studies looking at non 
cardia cancer.  There was, however, a study from the Karolinska Institute in Sweden 
in 2001, where they evaluated fruit and vegetable consumption in the prevention of 
oesophageal and cardia cancers.  Interestingly, in the authors’ conclusions from this 
paper, they showed a 40% lower risk of oesophageal squamous cell carcinoma but 
no risk reduction for gastric cardia adenocarcinoma, in individuals in the highest 
fruit and vegetable exposure quartile. They suggest that the lack of association with 
gastric adenocarcinoma may be due to etiological differences between these cancers 6 
 
(25).   Looking closely  at  the data from  this  study shows that there was  a trend 
toward those with higher fruit and vegetable intake having a higher incidence of 
adenocarcinoma of the gastric cardia, although this was not statistically significant 
(p=0.92)
  (25).    This  raises  the  possibility  that,  despite  the  increased  antioxidant 
provided  by  fruit  and  vegetables,  there  is  still  a  potentially  harmful  effect  from 
dietary nitrate that will be present within these farmed products.   
 
The  possibility,  that  a  luminal,  locally  acting  carcinogen  is  involved,  is 
highlighted  by  a  study  in  Iran,  looking  at  the  anatomical  site  of  gastric 
adenocarcinoma (26).  This group found that within the Ardabil region of Iran, an 
area with a very high incidence of gastric cancer, the great majority of the cancers 
were arising in the right side of the cardia.  It has previously been shown that, on 
entering  the  stomach,  non  solid  material  proceeds  down  the  lesser  curvature, 
following the ‘Magenstrasse’ formed by the longitudinal mucosal folds.  The right 
side of the cardia will therefore have a particularly high exposure to carcinogens 
from the lumen.  The observation that, within an area where they have the highest 
incidence  of  gastric  cancers  in  the  world,  there  are  a  significant  number  of  the 
tumours  located  in  the  same  anatomical  region  where  non  solid  material  passes 
through the stomach, makes it highly likely there is a luminally acting carcinogen. 
 
   7 
 
1.3  Dietary Nitrate and Nitrite 
 
The dominating dietary source of nitrate is the ingestion of vegetables (27) and 
this in part relates to the use of nitrogen rich fertilisers.  Green leafy vegetables such 
as spinach and lettuce, but also beetroot, cauliflower and celery, are especially rich 
in nitrate, as are strawberries, grapes, and a few other fruits (28).  Total intake of 
nitrate is subject to seasonal variations, fertiliser use and cooking procedures, and 
varies greatly between individuals and regions.  Drinking water also contains nitrate 
and nitrite but the concentrations of these are strictly regulated in Europe and the 
USA  in  part  due  to  fears  over  N-nitrosocompounds  and  also  the  formation  of 
methaemoglobin in infants.  Nitrite in the form sodium nitrite is used as a fixative 
and preservative during the processing of meat, cheese and fish (29).  It is widely 
used  to  preserve  lunchmeat,  ham,  sausages,  hot  dogs  and  bacon  (30).    The 
antimicrobial activity of sodium nitrite is important in controlling the bacterium that 
causes botulism (31).  It is thought that there are more in the way of nitrates in our 
diet than nitrites, in part due to farming methods and due to regulations that are in 
place regarding nitrite. 
 8 
 
1.4  Barrett’s oesophagus 
 
Barrett’s oesophagus is the conversion of oesophageal squamous epithelium to 
columnar-lined  epithelium  as  first  described  by  Norman  Barrett  from  St  Marks 
hospital in London in the 1950s.  Due to concerns regarding the incidence of both 
Barrett’s oesophagus and oesophageal adenocarcinoma, The UK National Barrett’s 
Oesophagus Registry (UKBOR) was set up in 1996 (32,33).  Barrett’s oesophagus 
can  be  considered  a  pre-malignant  condition.    Between  5-10%  of  patients  with 
Barrett’s oesophagus will develop adenocarcinoma, the annual risk in surveillance 
programmes being 0.5%-1%, which is 30-125 times that of the general population 
(3,34,35).  Not everyone with Barrett’s oesophagus has a similar risk of developing 
adenocarcinoma and much work has been done to identify risk factors that increase 
the risk of adenocarcinoma conversion from Barrett’s oesophagus (Table 1.1).   
 
Overall it is known that injury to the squamous oesophagus by bile reflux or 
acid  causes  chronic  inflammation,  which  results  in  the  evolution  of  Barrett’s 
oesophagus. The step which causes chronic inflammation to progress to Barrett’s 
oesophagus is as yet unknown.  The transition from metaplasia to adenocarcinoma 
proceeds via low grade and high grade dysplasia with increasing aneuploidy (53).  
There  are  many  cell  signalling  pathways  that  have  strong  evidence  to  suggest 
involvement  in  oesophageal  carcinogenesis:  c-myc,  TNF,  FasL,  MAP  kinase 
activation,  p53  and  p27  cell  cycle  check  point  control,  cytokine  signalling 
(COX/prostaglandins, NFκB) and gastrin, to name a few.  Cyclooxygenase (COX)-2 9 
 
is reportedly involved in chronic inflammation and epithelial cell growth.  It appears 
to be constitutively expressed in the oesophagus and the level of COX-2 expression 
seems  to  increase  with  progression  from  Barrett’s  oesophagus  to  oesophageal 
adenocarcinoma.  In a study performed by the Triadafilopoulos group they have 
shown that when Barrett’s oesophagus explants are exposed to acid or bile there is a 
significant increase in COX-2 expression and stimulated proliferation (54,55).   
 
In order for an individual to develop Barrett’s oesophagus, and in some cases 
adenocarcinoma, environmental exposures probably need to interact with genetically 
determined characteristics that define personal susceptibility (56).  It is unlikely that 
a single gene mutation is to blame, as most cases occur in the absence of a family 
history.  This, therefore, means that inherited genetic factors are likely to be normal 
variants or polymorphisms in multiple genes, such as has been seen in DNA repair 
mechanisms, cytokine responses and chemical detoxification (57-59). 
 
The  metaplastic  conversion  to  columnar-lined  epithelium  from  oesophageal 
squamous  epithelium  could  arise  from  two  different  categories  of  cell.      One 
possibility  is  transdifferentiation,  where  there  is  the  direct  conversion  of 
differentiated cells in the absence of cell proliferation (60).  The other possibility is 
where metaplasia can develop from the conversion of a pluripotent cell to columnar 
epithelium, either tissue specific stem cells (61) or bone marrow derived stem cells 
(62), although there is no direct evidence of the latter in Barrett’s oesophagus as yet.  
There  are  likely  to  be  many  determinants  of  a  cell’s  fate.    The  triggering 10 
 
mechanisms  whereby  specific  genes  are  activated  or  silenced,  leading  to  the 
development of Barrett’s metaplasia are not yet understood.  Given that GORD is 
implicated in the pathogenesis of Barrett’s oesophagus, it is interesting to know how 
this may affect gene expression.  Reflux contents are a complex mixture of variable 
pH fluid, bile salts and dietary components. The combination of any or all of these 
may be important as regards genotoxicity.  It is with respect to this refluxate that 
parts of this thesis are related. 
 
The COX-2 enzyme has a role in inducing angiogenesis (63), as well as effects 
on immune surveillance, tissue growth and cell adhesion.  As already discussed, acid 
and bile have been shown to increase COX-2 expression (54,55).  Laboratory and 
epidemiological  data suggest  that aspirin  and  NSAIDs may be chemopreventive, 
through  inhibitory  effects  on  COX-2  (64-66).  It  has  been  suggested,  by  a 
prospective  study,  that  the  incidence  of  oesophageal  cancer  and  aneuploidy  is 
significantly lower in those people who took aspirin or NSAIDs (67).  Based on this 
COX-2 evidence and evidence suggesting that acid reflux is important in Barrett’s 
oesophagus, the 10 year AspECT chemoprevention trial has been set up to look at 
the role of high-dose versus low dose esomeprazole, with low dose or no aspirin in 
affecting  the  overall  mortality  of  patients  with  Barrett’s  oesophagus.    Although 
lacking a placebo limb, this trial offers a look at the effect of anti-secretory therapy 
in relation to oesophageal adenocarcinoma in Phase III studies.  This high profile 
study highlights the expected importance of the luminal environment, as well as 
signalling at a cellular level, in Barrett’s oesophagus.  11 
 
Table 1.1:  Risk factors for developing adenocarcinoma from Barrett’s oesophagus 
 
Risk Factor Category  Risk Factor 
Demographic  Male preponderance (M:F 4:1)
 (36) 
Obesity (37,38)
 
Pathophysiological  Hiatus Hernia length (39,40)
 
Increased acid exposure (40)
 
Decreased lower oesophageal sphincter pressure (40)
 
Duodeno-gastric reflux (41)
 
Environmental  Drugs (lowering lower oesophageal sphincter pressure) 
(38,42)
 
Low fruit intake (37)
 
Dietary nitrate? (43,44,45)
 
Histopathological  Length of Barrett’s >6cm (39,40,46)
 
Presence of dysplasia
  (47,50)
 
Ulceration in high grade dysplasia (48,47,49,50,51)
 
Molecular Genetics (52)  Increased Proliferation  Increased Invasive potential 
TGFʱ, EGF, TGFβ  EGFR, C-erb B2, p27 
COX-2, TNFʱ, iNOS  PKC 
Gastrin, Bile salts, Acid  c-myc, β catenin 
Ras, Fos, Jun, c-myc  CCK2, COX2, p38
MAPK, p44
ERK 
CyclinD1, E, B1,  p16  p21 
P53, Bcl-2   
APC, FGF1&2, E-cadherin   12 
 
1.5  Correa Hypothesis for non cardia gastric cancer  
 
The  Correa  hypothesis  was  first  proposed  as  early  as  1975  (68).    This 
hypothesis postulated that intestinal type gastric cancer is the end result of a series of 
mutations and cell transformations begun in early life, possibly as early as the first 
decade.  Initially, it was believed that factors such as a high salt diet may be the 
trigger to superficial gastritis. There is then a change from superficial gastritis to 
atrophic gastritis.  More is known about some of these early steps in this model since 
the identification of Helicobacter pylori infection.  It is known that this infectious 
agent is associated with increased gastric pH and achlorhydria.  Once the pH of the 
stomach  is  above  pH  of  4  it  can  be  colonised  by  denitrifying  bacteria.    This, 
thereafter, allows the bacterial generation of N-nitrosocompounds, which are known 
to  be  carcinogenic  by  causing  DNA  damage.    Since  1994  the  infectious  agent 
Helicobacter pylori has been regarded as a class I human carcinogen by the IARC 
(69).  More recently polymorphisms, in both the microbial agent and host, have 
shown the influence of genetic susceptibility to the development of gastric cancer 
(70).    
 
However, this hypothesis only explains the potential stages of development in 
non cardia gastric cancer and this cancer has been shown to be both decreasing in 
incidence and related to individuals who are Helicobacter pylori infected.  The focus 
of  interest  in  the  upper  gastrointestinal  tract  has  now  shifted  to  look  at 
gastroesophageal  junction  adenocarcinoma  and  proximal  gastric  cardia  tumours.  13 
 
The Correa hypothesis still provides us with insights into the construction of a model 
for other cancers of the upper gastrointestinal tract, in particular, the potential of N-
nitrosocompounds  to  be  implicated  in  upper  gastrointestinal  tract  tumours.    The 
Correa hypothesis is still directly relevant to non cardia gastric tumours. 
 
1.6  N-nitrosocompounds 
 
1.6.1 Introduction 
 
N-nitrosation  is  one  of  the  oldest  organic  chemical  reactions  known.    N-
nitrosamines  were  first  described  in  the  middle  of  the  nineteenth  century.    N-
nitrosation is the replacement of hydrogen, attached to nitrogen, by a nitrosogroup as 
shown in the following reaction (71).  
 
                                 Y                                                    Y 
     X  NO          +          N   H                          H-X   +          N  NO 
                                 Z                                                     Z 
 
 
There are groups known as nitrosating agents which form nitrosogroups.  The 
prime candidate for the formation of nitrosating agents in vivo, particularly in the 
acidic environment  of the stomach, is  nitrous acid  (HONO =  NHO2) (pKa 3.3).  
Nitrous acid is formed from the reaction of nitrite ion (NO2
-) with protons (H
+ or 14 
 
H3O
+).    This  reaction  has  been  considered  to  be  the  prime  candidate  for  the 
formation of nitrosating agents in the acidic environment of the stomach for some 
time.  There are a number of potentially N-nitrosatable substrates in the diet (72) as 
well as in refluxate, particularly of bile contents.  Secondary amines and amides are 
compounds capable of being nitrosated.     
 
The  first  validated  confirmation  of  the  environmental  occurrence  of  N-
nitrosamines was provided when traces of N-nitrosodimethylamine were found in 
nitrite preserved herring, in sheep fodder, following an outbreak of toxic hepatosis 
(73).  N-nitrosocompounds have been found to produce tumours in many animal 
species.  Studies from more than 130 N-nitrosocompounds, obtained from foodstuffs 
(74), from the environment (75), and from the interaction between drugs and nitrite 
(76), indicate that about 80% of them are carcinogenic in animals.  Although this 
suggests that N-nitrosocompounds may be carcinogenic in humans, there has yet to 
be an established causal relationship between exposure to N-nitrosocompounds and 
human cancer.  In the IARC list of agents causing cancer in humans, there are no N-
nitrosocompounds mentioned.  This is not to say that N-nitrosocompounds are not 
carcinogenic.  It can be difficult to demonstrate a direct cause effect relationship 
when there is no unexposed control group and when the available epidemiological 
instruments  lack the sensitivity to  show a relationship  between low levels  of  N-
nitrosocompounds  and  individual  cancers.  The  IARC  classifies  N-
nitrosodimethylamine,  N-nitrosodiethylamine,  N-methyl-N-nitrosurea  and  N-ethyl-15 
 
N-nitrosourea as probably carcinogenic in humans (Group 2A) and have listed 15 
other N-nitrosocompounds as being possibly carcinogenic in humans (Group 2B).   
 
Epidemiological studies across several countries have shown evidence relating 
elevated  intake  of  environmental  nitrate  being  associated  with  stomach  cancer.  
Sander and Buerkle first demonstrated that the reaction between ingested secondary 
amine and nitrite could occur in vivo and could produce carcinogenic nitrosamines in 
laboratory  animals  (77).  An  effective  and simple method for demonstrating the 
endogenous formation of N-nitrosoproline (NPRO) in humans was later designed 
(78) and was widely used to assess for the importance of nitrosation in vivo.  In a 
typical example of this technique, sequential oral doses of nitrate and proline were 
administered  to  a  subject  and  the  resulting  NPRO  measured  in  a  24  hour  urine 
collection.    This  method  is  effective  because  NPRO  is  not  metabolised,  is  not 
carcinogenic and can be quantitatively measured in urine (79).  Patients with an 
achlorhydric  stomach  have  suitable  conditions  for  the  intragastric  formation  of 
nitrosamines  because  of  the  presence  of  denitrifying  bacteria  and  subsequent 
nitrosation of amino precursors.  In a field study of Polish inhabitants, from areas of 
low (urban) versus high (rural) risk for gastric cancer, the urinary excretion of N-
nitrosamino acids and nitrate was significantly higher in inhabitants of high risk 
areas than in inhabitants of low risk (80).  A similar study was performed in Japan 
(81), where three different 24 hour samples of urine were collected, from each of the 
inhabitants  of  a  high  risk  area  (Akita)  and  a  low  risk  area  (Iwate).    NPRO 
concentrations  were  measured  before  and  after  the  ingestion  of  the  nitrosatable 16 
 
amine  proline.    After  the  intake  of  proline,  the  NPRO  concentration  increased 
significantly only in the subjects who were from the high risk area.  The increase 
over urinary background NPRO in high versus low risk areas was 4 versus 1.4 fold.   
In both the Japanese and Polish studies ascorbic acid intake inhibited the increase in 
urinary N-nitrosocompounds.  In a study in Costa Rica, in an area of high risk of 
gastric cancer, children have a significantly higher urinary NPRO level after proline 
intake compared with results for children in a low risk area
 (82).  In a separate study 
in a high risk group for gastric cancer, the results, when taken as a whole, suggest 
that  gastric  carcinogenesis,  in  high  risk  areas,  is  more  likely  to  be  related  to 
intragastric N-nitrosocompounds formed by acid-catalysed nitrosation, whereas, in 
low risk areas  it is more likely to  be related to  intragastric N-nitrosocompounds 
formed by biologically catalysed intragastric nitrosation (83).   
 
Oesophageal cancer is a prevalent disease in northern China and earlier studies 
suggested  that  environmental  factors  such  as  N-nitrosocompounds  and  their 
precursors may be important (84).  After this time a study was performed to look at 
urinary NPRO concentrations before and after oral proline intake, comparing high 
and  low  risk  populations  for  oesophageal  cancer.    Ingestion  of  proline  led  to 
increased urinary NPRO in inhabitants from both areas but the concentrations were 
twice as high in the high risk area (85).  This suggests that endogenous nitrosation 
may occur to a larger extent when appropriate amine precursors are present from 
ingestion of foodstuffs and also that the nitrosation seems to occur more in those 
who are living in the high risk group.  There have been further studies in China 17 
 
indicating  that  there  was  a  significant  mortality  rate  associated  with  urinary 
excretion of NPRO and N-nitrosoarcosine (86).  There are also results that implicate 
N-nitrosocompounds  with  colorectal  cancer  (87),  brain  tumours  (88), 
nasopharyngeal (89), pancreatic (90) and bladder cancers (91). 
 
There has been considerable interest in the role of N-nitrosocompounds and 
upper gastro-intestinal cancer for many years, in part based on the Correa hypothesis 
for  gastric  cancer.  The  thought  being  that,  at  a  pH  greater  than  4,  there  is  the 
potential for denitrifying bacteria to colonise the stomach and therefore generate N-
nitrosocompounds.  There has also been interest in N-nitrosocompounds within the 
diet, where they would potentially exert a carcinogenic effect on the environment in 
which they are first situated for a prolonged period of time. Little work was done on 
the role of nitrosamines in the upper gastrointestinal tract after the identification of 
Helicobacter  pylori  and  the  recognition  of  the  microbe’s  role  in  gastric  cancer.  
However,  we  now  propose  a  model  by  which  N-nitrosocompounds  may  still  be 
implicated  in  cancer  of  the  upper  gastrointestinal  tract  at  and  around  the 
gastroesophageal junction but in those who are Helicobacter pylori negative.  This 
mechanism is discussed in more length later in the introduction. 
 
1.6.2  N-nitrosamines  
 
N-nitrosamines  are  the  N-nitrosocompounds  formed  by  the  nitrosation  of 
amines.    Amines  can  be  divided  into  primary,  secondary  and  tertiary  as  shown 
below. 18 
 
 
 
 
R’    NH2                               R1’    N     H                             R1’    N     R3’ 
 
 
Amines are nucleophiles in that the lone electron-pair on the nitrogen atom in 
amines makes the N-atom a nucleophilic centre and is therefore an electron-pair 
donor.  The  kinetics  of  secondary  amine  nitrosation  are  such  that  the  rate  of 
formation of secondary amines is proportional to the stoichiometric concentration of 
the amine and the square of the nitrite concentration.  It is only the unprotonated 
form of the amine that reacts, as is shown by the fact that the overall rate of reaction 
is dependent on the pH. 
 
Nitrosamines have been known for a number of years to be carcinogenic and 
because of this were used for the specific purpose of generating animal models of 
certain  cancers.   Barnes and Magee  first  showed, in  1954, the hepatotoxicity of 
nitrosamines  in  the  rubber  industry  before  going  on  to  note  that 
nitrosodimethylamine was a potent carcinogen in rodents (92).  It was not until 1967 
that the same two researchers suggested that if you choose a suitable nitrosamine 
and test animal, cancer could be induced at any site in the body (93).  At that time, 
there was great interest in the formation of nitrosamines as possible carcinogenic 
agents but, as research into this area was proving difficult, there was a shift away 
R2’   R2’ 
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from studying this important group of compounds.  It has only been more recently 
that there has been renewed interest in these carcinogenic compounds.   
 
N-Nitrosamines are carcinogenic in that they act on DNA as alkylating agents.  
N-nitrosamines,  per  se,  are  stable  under  physiological  conditions  and  require 
metabolic activation by cytochrome P450-dependent hydroxylation, at the carbon 
adjacent to the N-nitroso group, to form an ʱ-hydroxynitrosamine.  This can then 
form an alkyldiazohydroxide by spontaneous elimination of an aldehyde (R
-CHO).    
From  the  alkyldiazohydroxide  an  electrophilic  alkyl  diazonium  ion,  a  strong 
carcinogen, is produced, which can react at nucleophilic sites of various cellular 
constituents.    The  alkylation  of  DNA  is  generally  considered  to  be  the  critical 
cellular target for carcinogens in the initiation of cancer (73). Alkylation of DNA by 
dialkylnitrosamines results in a range of modified bases.  Not all base modifications 
are  biologically  important.    The  most  abundant  modified  base  produced  by 
dialkylnitrosamines is alkylation of the seventh position of guanine and this shows 
no correlation with carcinogenic activity.  A significant proportion of alkylated DNA 
products are repaired.  The formation and persistence of O
6-alkylguanine (94) and 
O
4-alkylthymine (95) are considered to be important base modifications that result in 
miscoding, in RNA or DNA synthesis. 
 
There are several inhibitors of nitrosation.  The most effective of these and the 
one most relevant to our understanding of adenocarcinoma of the gastroesophageal 
junction is the powerful reducing agent ascorbic acid.  Ascorbic acid is found in 20 
 
gastric juice at high concentrations (96).  These high concentrations can be assumed 
to be required as a luminal antioxidant.  It has previously been shown that this will 
potentially prevent the luminal generation of N-nitrosocompounds.  In acting as a 
reducing agent ascorbic acid requires O2 and forms NO.  O2 has been shown to be 
rapidly consumed in the presence of NO generation from nitrite by ascorbic acid in 
an acidic environment.   Other inhibitors of nitrosation are phenols and in a number 
of in vitro systems biologically occurring thiols (cysteine and glutathione) inhibit 
nitrosamine synthesis (97).  Nitrosamine formation is catalysed by thiocyanate.  At 
acidic pH with nitrite present and in the presence of high thiocyanate concentrations, 
the intermediate product NOSCN is a powerful and the most important nitrosating 
agent (98,99).   
 
1.6.3 N-nitrosomorpholine, N-nitrosopiperidine and N-nitrosodimethylamine 
 
There have been three nitrosamines that have been looked at closely in this 
thesis, in in vitro experiments simulating the gastroesophageal junction.  The first of 
these is  N-nitrosomorpholine (NMOR).   It  is  formed from  the nitrosation of the 
secondary  basic  amine  morpholine.    Morpholine’s  (Tetrahydro-1,4-oxazine) 
structure is shown in figure 1.1.  It has a relatively low pKa, for an amine, of 8.3.  
Another secondary amine measured in the following experiments is piperidine (pKa 
11.1),  which  forms  N-nitrosopiperidine  (NPIP)  when  nitrosated.    The  most 
commonly  found  nitrosamine  in  the  body  is  the  volatile  nitrosamine  N-
nitrosodimethylamine (NDMA) and this was also examined in the following studies.  
NDMA is formed by nitrosation of the secondary amine dimethylamine (pKa 10.3). 21 
 
 
 
                                                              
 
 
                      
 
 
 
 
Figure 1.1:  The chemical structures for the secondary amine morpholine (left) and 
the N-nitrosated version of morpholine, N-nitrosomorpholine (right) are 
shown.  
 
 
     
   
Morpholine 
 
C4H9NO 
N-nitrosomorpholine 
 
C4H8N2O2 
 
O 
H 
N 
O 
N 
N   O 22 
 
1.7  NO 
 
1.7.1 Introduction to NO 
 
NO is  a small  chemically simple and highly toxic gas,  which has  attracted 
much interest over the past two decades.  In 1992, it was the Molecule of the Year.  
Nearly every cell is capable of synthesising it by one of three NO synthase isoforms.  
It is also formed without enzymatic function in the body such as in the cardia of the 
stomach and through interaction with drugs with nitrogen related compounds.  The 
effects of NO depend on the site where it is formed, the amount formed and the local 
environment in which it is present. 
 
It was shown, in the 1970s, by Tannenbaum et al that nitrate was formed in 
humans (100) and this was later confirmed to be the final product of NO metabolism 
(101).  As well as generation of NO from nitrite, as outlined above, in gastric juice, 
NO  can  be  synthesised  from  L-arginine  through  the  L-Arg-NO  pathway  by  NO 
synthase with NADPH (102) and O2 (103) as cosubstrates. NO consists of seven 
electrons from the nitrogen atom and eight electrons from the O2 atom.  Therefore 
NO
 has the paramagnetism of a molecule with one unpaired electron and is highly 
reactive in the gas phase with O2, to form nitrosating agents such as N2O3.   
 
The  chemical  biology  of  NO  has  been  defined  as,  ‘the  pertinent  chemical 
reactions  which  occur  in  biological  systems’  (104).    These  reactions  can  be 23 
 
categorised  into  direct  and  indirect  effects.    The  reactions  where  NO  interacts 
directly with biological molecules can be considered to be direct effects.  NO is also 
known  to  form  RNOS  and  the  chemical  reactions  of  RNOS  with  biological 
molecules are known as indirect effects.  Direct effects are generally seen at lower 
levels  of  NO  (<1µM), such as  those seen through constitutively  generated nitric 
oxide, whereas indirect effects are generally seen at higher concentrations (>1µM) 
(105).  Indirect effects can be further broken down into nitrosative, oxidative and 
nitrative chemistry (105). 
 
NO is known to directly interact with metalloproteins such as haem containing 
enzymes  but  does  not  react  directly  with  molecules  containing  thiol  or  amines.  
However, under aerobic conditions, NO can react with O2 or superoxide to form 
reactive nitrogen oxide species such as peroxynitrite.  One of the modes of chemistry 
of these nitrosating agents is to nitrosate amines and thiols to form N-nitrosamines 
and S-nitrosothiols (106).  This is known as nitrosative stress.  Peroxynitrite, under 
certain circumstances, can exert oxidative stress as well as nitrative stress (such as 
the formation of nitrotyrosine from ONOO
-).  At a neutral pH, ONOO
-  HOONO 
and this is a reactive intermediate, which can oxidise various biological substrates or 
simply  isomerise  to  nitrate  (107).  Although  able  to  exert  oxidative  stress,  the 
oxidation mediated by peroxynitrite is influenced by the relative amounts of NO and 
superoxide  formed  (108,109).    In  the  presence  of  excess  NO  or  superoxide, 
peroxynitrite is converted to nitrogen dioxide (1) (109) and this can rapidly react 
with NO to form the nitrosating species N2O3 (2). 24 
 
 
H  +  ONOO
-  +  NO    H  + NO2   +  NO2
-            (1) 
 
                                         NO2 + NO    N2O3                                                  (2) 
 
Thus  the  concentrations  and  relative  amounts  of  NO  and  superoxide  will 
impact on the chemistry of peroxynitrite in vivo.  
 
NO  reacts  with  O2  to  produce  NO2,  which  exists  in  equilibrium  with  the 
nitrosating  agents  N2O3  and  N2O4  (110).    Both  N2O3  and  N2O4  are  capable  of 
reacting with water to form NO2
- and NO3
-.  Nitrite is oxidised to nitrate in the 
presence of haemoglobin and is the urinary excretion product of nitric oxide.  The 
reaction  of  NO  with  O2  in  both  gaseous  and  aqueous  phases  is  a  complicated 
process.    The  reaction  rate  is  first  order  in  O2  and  second  order  in  NO  (111).  
Because  of  the  second  order  NO  dependency,  the  half-life  of  NO
  is  inversely 
proportional  to  its  concentration  (111).    The  formation  of  N2O3  and  N2O4  are 
favoured in solution compared to the gaseous phase.  The intracellular half-life of 
NO may be affected by reaction with compounds such as haem-Fe
2+.  As well as 
reacting with molecular O2, NO also reacts rapidly with superoxide (O2
-) to form 
peroxynitrite (ONOO
-).  The half life of NO in biological systems is estimated to be 
4-50 seconds (112).  In a similar fashion to O2, NO can migrate in and out of cells in 
part because it is a highly lipophilic molecule (113).  This means that there should be 25 
 
time  for  NO  to  travel  several  cell  diameters  to  reach  target  sites  before  being 
consumed by molecular O2.   
 
It is also known that biological carriers, such as S-nitroso thiols exist in vivo 
and these allow NO to move via the circulation to tissues distant from the origin of 
the NO. 
 
One of the direct effects of NO is the reaction with metal complexes (114).  NO 
reacts with some transition metals to form stable metal nitrosyl complexes, such as 
Fe-NO complexes.  One of the most facile NO reactions with metalloproteins is that 
of NO reacting with proteins containing haem moieties.  The most relevant reactions 
in biological systems include those with haem proteins such as guanylate cyclase, 
cytochrome  P450  and  NO  synthase.  The  reaction  between  NO  and  guanylate 
cyclase produces  an  Fe-nitrosyl  complex that becomes  activated to  form  cGMP.  
The concentration of NO required to activate guanylate cyclase is relatively low, 
with  an  EC50  of  100nM  (115).    cGMP  is  a  key  messenger  mediating  numerous 
regulation functions (116).  A significant number of biological effects of NO are 
mediated through guanylate cyclase.  Another haem/NO interaction is of NO with 
cytochrome P450.  Cytochrome P450 activity is inhibited by NO in both a reversible 
and irreversible manner.  Reversible inhibition occurs when NO binds to haem to 
prevent O2 binding.  Irreversible inhibition is mediated through RNOS formed from 
NO. As cytochrome P450 is involved in the synthesis and catabolism of numerous 
biomolecules, inhibition can result in important pathophysiological sequelae.  NO 26 
 
synthase  can  also  be  inhibited  by  NO  in  a  similar  fashion  to  that  in  which 
cytochrome  P450  is  inhibited.    NO  has  also  been  shown  to  react  directly  with 
various metal-oxygen complexes.  An important direct effect of NO is the reaction 
with oxyhaemoglobin to form methaemoglobin and nitrate (117) as shown in the 
reaction (3): 
 
         Hb(Fe-O2)   +   NO    metHb(Fe(III))    +    NO3         (3) 
 
This reaction is the primary mechanism by which movement and concentration 
of NO are controlled in vivo.  Due to the high concentration of oxyhaemoglobin and 
its rapid reaction with NO, this is one of the primary metabolic fates of NO (118). 
 
1.7.2 Carcinogenesis of Nitric Oxide 
 
The  major  nitrosating  agents  produced  from  nitrite  under  aqueous  acidic 
conditions are N2O3, NO
+ and H2NO2
+, none of which reacts with protonated amines 
(119).  Only unprotonated amine can be nitrosated.  Nitrosation by N2O3 and N2O4 at 
neutral pH is rapid because of the relatively high concentration of free amine.  As 
has  been  discussed  previously  N-nitrosocompounds  are  themselves  carcinogenic.  
Thus NO can exert a carcinogenic effect through N-nitrosocompounds by reacting 
with O2 to form the nitrosating compound N2O3 (120). 
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Another mechanism through which NO may be carcinogenic is through DNA 
damage mediated by RNOS such as N2O3 and peroxynitrite.  Nitrosation of primary 
amines results in deamination.  Acidic nitrite can deaminate purines, pyrimidines 
and various forms of RNA and DNA, through a pathway in which protonation of 
nitrite leads to formation of N2O3.  N2O3 reacts with unprotonated amino groups of 
DNA  in  the  presence  of  water  (121).    In  the  early  1990s  NO  was  reported  to 
accelerate base deamination in vitro (122) and cause deamination-induced genetic 
changes  in  living  cells,  but  only  in  the  presence  of  O2  (123).  Changes  in  DNA 
resulting from deamination are consistent with the types of mutations seen in many 
cancers.  Deamination of cytosine will result in uracil formation.  Removal of uracil 
by  uracilglycolase  without  restoration  of  cytosine  would  leave  an  abasic  site,  a 
lesion often misrepaired by insertion of adenine opposite the site during replication.  
If the cytosine is methylated, the deamination of methylcytosine would result in the 
formation of thymine in the DNA chain.  This change is especially important for 
mammalian  DNA  where  methylation  patterns  are  critical  to  gene  regulation  and 
differentiation. Nguyen et al took mammalian cells of TK6 human lymphoblastoid 
cells in vitro and added high concentrations of NO gas to the medium.  There were 
39 and 47 fold increases in xanthine and hypoxanthine bases formed within these 
cells.    These  bases  are  the  product  of  deamination  of  guanine  and  adenine, 
respectively (122).  There have been other in vitro experiments performed showing 
mutagenicity of NO (124,125).  One of the criticisms of these experiments, at the 
time, was of the high concentrations of NO used in the experiments and that these 
did not represent physiological conditions.  While this may be the case for the many 28 
 
areas of the human body, it has been observed that the concentrations of NO at the 
gastroesophageal junction are the highest found in the body (43).  There have also 
been studies, such as that by Delaney et al in 1993, where they reported stimulated 
NO formation in rat Islets of Langerhans cells, which was shown to cause DNA 
damage, as measured by the ‘comet’ assay (126). 
 
As well as exerting nitrosative stress through N-nitrosocompound formation, 
there  may  be  the  potential  for  oxidative  stress  from  nitric  oxide.    The  potent 
oxidative  species  peroxynitrite  (ONOO
-)  and  hydroxyl  radical  (HO
.)  are  formed 
from NO after its reaction with superoxide as shown in equations (4) - (6) below: 
 
                         NO
       +       O2
-          ONOO
-                         (4) 
 
                        ONOO
-      +     H
+           ONOOH                    (5) 
 
                        ONOOH             OH
.    +    NO2
.                     (6) 
 
Peroxynitrite has strong oxidising properties towards biomolecules including 
thiols, deoxyribose and membrane phospholipids (127).  The hydroxyl radical reacts 
with DNA, leading to several types of DNA damage, including strand breaks, cross 
links, abasic sites and modified bases (128).  8-Hydroxyguanine, one of the products 
of  base  oxidation,  can  be  used  as  a  marker  of  oxidative  DNA  damage  (128). 
Although it should be pointed out that the amount of peroxynitrite which reacts with 29 
 
the biological target is minimal if the NO flux is in excess.  In fact, in some studies, 
it has been shown that NO has abated XO and peroxide mediated damage to DNA 
(129).   
 
RNOS  have  a  particularly  high  affinity  for  amino  acids  containing  thiol 
residues (130).  This suggests that enzymes which have thiol residues critical to their 
function  may  be  inhibited.    It  is  thought  that  very  often  this  effect  is  caused 
indirectly  by  NO  through  the  RNOS  N2O3.    Through  this  mechanism  NO  can 
inactivate  DNA  repair  enzymes  such  as  O
6-alkyltransferase  (131).  Another 
mechanism through which NO can affect DNA repair mechanisms is by affecting 
DNA interacting proteins that contain a zinc finger motif.  Zinc finger motifs contain 
either two or four cysteine residues.  It has been suggested that N2O3 nitrosates the 
thiol  residue,  resulting  in  the  ejection  of  the  zinc,  allowing  degradation  of  the 
structural integrity of the protein.  This has been shown for the DNA repair enzymes 
formaminodopyrimidine  DNA-glycolase  (Fpg  protein)  which  repairs  alkylation 
damage  due  to  guanine  (132).    In  this  way  the  Fpg  protein  was  shown  to  be 
inactivated in the presence of aerobic NO (133). Whether this leads to any damage 
will depend on whether luminally generated NO reaches the adjacent cells. 
 
1.8  Ascorbic acid  
 
Ascorbic acid is a potent aqueous antioxidant.  It has been recognised that the 
healthy  stomach  actively  secretes  ascorbic  acid  and  its  concentration  in  fasting 
gastric  juice  is  several  times  that  in  plasma  (96,134-136).    It  is  a  hydrophilic 30 
 
molecule.  In its reduced form it is present as ascorbic acid and in its oxidised form it 
is present as dehydroascorbic acid.   
 
Ascorbic acid inhibits the formation of N-nitrosocompounds by competing for 
the  nitrosating  agents  formed  from  nitrite.    When  ascorbic  acid  reacts  with  a 
nitrosating agent, such as N2O3, it is oxidised to dehydroascorbic acid.  For each 
mole of ascorbic acid oxidised, two moles of NO are formed (137).  This reaction is 
rapid and there is therefore the potential for effective removal of nitrosating agents.  
However,  in  the  presence  of  O2,  NO  may  be  reconverted  to  nitrosating  species, 
thereby negating the inhibitory effect.  Net removal of nitrite equivalents occurs only 
upon oxidation of N2O4 to nitrate (NO3
-), or by physical processes such as the in vivo 
absorption of nitrite across the gastric mucosa, or in vitro by the loss of volatile 
species such as NO.  The reaction of ascorbic acid with nitrite in an acidic media can 
be shown by the equation (7): 
 
                   ASC + NOX  DHA + 2NO + H
+ + X
- + H20             (7) 
 
Where NOX = N2O3, NO
+, NOSCN or NOCl 
 
In the presence of thiocyanate and chloride both exert catalytic activity.  This 
can  be  attributed  to  formation  of  their  nitrosyl  species  and  their  reaction  with 
ascorbic  acid  (138-140).    Thiocyanate  is  a  much  better  catalyst  and  this  can  be 
attributed to differences in the equilibrium constants of reactions (138,140).  The 31 
 
reaction shown above (7) accounts for all the loss of ascorbic acid, but none of the 
loss of total nitrite.  The nitrite is lost by oxidation to nitrate and transfer of NO and 
NO2 to the gas phase.  Given that when ascorbic acid reacts with nitrosating species 
the major product formed is NO, then the loss of nitrite from this system is mainly 
through transfer of NO in the gas phase.  Thus, while ascorbic acid does not remove 
total  nitrite  directly,  it  increases  the  rate  of  the  removal  process.  The  effective 
stoichiometry  of  the  reaction  between  ascorbic  acid  and  nitrite  depends  on  the 
competition between the recycle of NO back into nitrosating species and the removal 
of NO via mass transfer (139).  The rate determining step in the recycling of NO is 
the reaction with O2 producing dinitrogen tetroxide, as shown in equation (8) 
 
                2NO + O2  N2O4                                 (8) 
 
The  recycling  process  is  therefore  second  order  as  regard  NO  while  mass 
transfer  is  essentially  first  order.    This  means  that  as  the  NO  concentration  is 
increased, the recycling reaction will increase faster than physical removal.  Acidity, 
thiocyanate and chloride are known to increase the rate of reaction between ascorbic 
acid  and  nitrite,  and  therefore,  this  tends  to  favour  recycling  and  increases  the 
effective stoichiometric ratio of ascorbic acid consumption to nitrite removal. The 
reaction between NO and O2 is first order with regard to the O2 concentration.  This 
means that decreasing the O2 concentration will decrease the rate of recycling, and 
ascorbic  acid  will  be  more  effective  in  inhibiting  nitrosation.    The  equilibrium 
concentration of dissolved O2 is an inverse function of temperature, meaning that O2 32 
 
concentration is reduced as the temperature is increased.  However, increasing the 
temperature increases the rate of formation of NO from nitrosating species in the 
presence  of  ascorbic  acid.    So,  temperature  changes  can  shift  the  effective 
stoichemistry between ascorbic acid and nitrite in either direction depending on the 
conditions (139). 
 
The inhibition of bacterially mediated nitrosation of morpholine by ascorbic 
acid at neutral pH in vitro was noted as early as 1989 (141).  In an in vivo study, 
using healthy male volunteer’s, inhibition of endogenous NPRO from exogenous 
precursors requires more than the 2:1 molar ratio of ascorbic acid to nitrite that has 
been demonstrated in vitro.  A ten times molar excess of ascorbic acid over the 
available  nitrite  concentration  in  the  stomach  was  required  to  achieve  complete 
inhibition of endogenous nitrosation of proline in this study (142). 
 
In  the  human  stomach,  chemical  interaction  occurs  between  the  nitrite  and 
thiocyanate delivered in the saliva and the ascorbic acid secreted into acidic gastric 
juice.  Acidified nitrite forms N2O3 or reacts with the thiocyanate anion to form 
NOSCN, both of which can be reduced to NO by ascorbic acid.  The ascorbic acid is 
itself oxidised to dehydroascorbic acid.  The NO formed in this way can react with 
dissolved O2 to reform nitrous acid.  This reformed nitrite can further react with any 
remaining ascorbic acid.  This recycling of nitrite will continue until either all the 
ascorbic acid is converted to DHA or the O2 is depleted.  Following ingestion of 
nitrate and subsequent increase in delivery of nitrite to the proximal stomach, there 33 
 
was  a  four  fold  fall  in  gastric  juice  concentration  of  ascorbic  acid,  due  to  its 
conversion to dehydroascorbic acid, as there was accumulation of nitrite within the 
gastric juice (143).  The consumption of ascorbic acid in an acidic environment after 
the addition of nitrite has been shown to be greater in the presence of dissolved O2 
(144).  The increased consumption of ascorbic acid by nitrous acid in the presence of 
O2 is thought to be due to recycling of NO generated (144).   
 
1.9  Lipid antioxidants 
 
 
1.9.1 Overview 
 
In  biological  systems  there  are  lipid  antioxidants  as  well  as  aqueous 
antioxidants.    Lipid  antioxidants  are,  in  part,  present  to  prevent  lipid  membrane 
peroxidation.  Three  major  chain  breaking  lipid  antioxidants  are  ʱ-tocopherol,  β-
carotene  and  butylated  hydroxytoluene  (BHT).    Αlpha-tocopherol  is  the  major 
vitamin E compound found in the lipid fraction of living organisms.  It is thought to 
be one of the most powerful naturally occurring lipid antioxidants known (145).  β-
carotene  is  another  naturally  occurring  antioxidant  that  has  been  found  in  many 
biological systems (146).  BHT is a synthetic phenolic lipid antioxidant that is used 
in food preservatives (147). 
 
1.9.2 Vitamin E  
 
1.9.2.1 Introduction to vitamin E 
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Eighty five years ago vitamin E was discovered as a micronutrient essential for 
reproduction in female rats (148).  Despite many studies the essential functions in 
humans are still not fully understood.  Deficiencies in vitamin E primarily cause 
neurological  dysfunctions.    Vitamin  E  is  an  antioxidant  and  because  of  this  is 
thought to be important in diseases where oxidative stress occurs such as cancers, 
chronic inflammatory conditions and cardiovascular disease. Vitamin E refers to one 
or  more  of  the  structurally  related  phenolic  compounds  called  tocopherols  and 
tocotrienols.   These compounds are hydrophobic, peroxyl  radical  trapping, chain 
breaking antioxidants, found in the lipid fraction of living organisms.  The principle 
function of vitamin E is thought to be the protection of the lipid material of an 
organism from the undesirable effects of uncontrolled, spontaneous autooxidation.  
The most abundant tocopherol found in animal tissue is called ʱ-tocopherol.  The 
relative and absolute effectiveness of chain breaking antioxidants depends primarily 
on  their  reactivity  towards  peroxyl  radicals.    The  most  effective  tocopherol  to 
undergo this reaction is ʱ-tocopherol.  This has been shown by kinetic studies (149).  
These kinetic studies suggest that this faster rate of reaction can be explained by the 
stereoelectronic make up of ʱ-tocopherol, whereby the p-types lone pair can overlap 
with the orbital containing the unpaired electron and so stabilise the phenoxyl radical 
(149).  
 
The major mechanism of action of ʱ-tocopherol is thought to be the scavenging 
of lipid peroxyl radicals (LOO
.) generated during lipid peroxidation, resulting in 
inhibition  of  the  free  radical  chain  reaction  (150).    It  has  been  shown  that 35 
 
peroxynitrite  can  oxidise  ʱ-tocopherol  predominately  by  either  a  two-electron 
pathway  generating  ʱ-tocopherone  cation  or  via  a  minor  one  electron  pathway 
forming ʱ-tocopheroxyl radical (150).  Studies performed in the late 1990s showed 
that  NO  reacting  with  peroxynitrite  in  the  lipid  bilayer  was  preventing  lipid 
peroxidation (151,152).  Prior to this there had been suggestions that NO reacted 
directly  with  ʱ-tocopherol  to  generate  ʱ-tocopheroxyl  radical  (153-155).    This 
reaction was examined further by Nagata et al, who examined the reaction between 
NO and both ʱ-tocopherol and the ʱ-tocopherol analogue 2,2,5,7,8-Pentamethyl-6-
chromanol (PMC), in the presence and absence of O2.  At all different ratios of NO 
to O2, there was a reduction product of ʱ-tocopherol and this included when NO 
reacted  with  PMC  or  ʱ-tocopherol  even  in  the  absence  of  O2  (156).  There  is 
conflicting evidence in regard to this study (157) and further investigation into the 
reaction between NO and ʱ-tocopherol concluded that NO does not react with ʱ-
tocopherol directly (158).  This work suggested that previous experiments showing a 
direct reaction between NO and ʱ-tocopherol were in fact due to the experiments 
containing NO gas that may have been contaminated with a little O2.  However, 
oxidation products of NO in the form of N2O3 and related species will oxidise ʱ-
tocopherol to both ʱ-tocopheroxyl  radical and  ʱ-tocopheryl quinone (158).  In a 
paper by Hogg et al, it is suggested that under biological conditions, if ʱ-tocopherol 
oxidation is due to oxidised metabolites of  NO, then the relevance to  biological 
systems is questionable, as the reaction of NO with O2 to form N2O3 is extremely 
slow (159).  While this may be true of the concentrations of NO formed from NO 36 
 
synthase within human cells, at the concentrations of NO that have been found at the 
gastroesophageal junction this would be relevant chemistry. 
 
1.9.2.2 In vivo effects of α-tocopherol 
 
Administration  of  antioxidants  including
  ʱ-tocopherol  has  been  found  to 
prevent oxidative stress in the
 retina and heart of diabetic rats and to partially inhibit
 
the  development  of  retinopathy  in  these  rats,  where  chronic  elevation  of  NO  is 
thought to be important (160). In erectile dysfunction there are changes in corpus 
cavernosal vascular smooth muscle cells cells that are induced by glucose changes in 
protein C and NO expression and activity within the cell.  Α-tocopherol has also 
been shown to prevent these glucose-induced changes in protein kinase C and NO 
(161).  In pancreatic islet cells that were preincubated with ʱ-tocopherol there was 
significant  improvement  in  the  cells’  resistance  to  toxic  doses  of  NO.    This  is 
significant as, in vitro, NO has been identified as the most potent islet toxic product 
of inflammatory macrophages (162).  While it was suggested by Burkart et al (162), 
that the inhibition of toxic effects on the cells was likely to be due to direct effects of 
ʱ-tocopherol on NO, it is more likely that the inhibitory effect was of ʱ-tocopherol 
on nitrosating species.  Mergens et al, was the first to show that ʱ-tocopherol, in its 
reduced form, was protective against amine induced hepatotoxicity and in the same 
paper showed destruction of nitrite in an in vitro model of gastric juice (163).  In 
Mergens et al studies, ʱ-tocopherol was found to react with nitrosating agents both 37 
 
in lipophilic and aqueous environments and they also described greater nitrosamine 
inhibition when ʱ-tocopherol and ascorbic acid were used together (163). 
 
1.9.2.3 The vitamin E/vitamin C interaction and possible recycling 
 
Synergistic inhibition between vitamin C and vitamin E was first suggested in 
1941  when  it  was  found  that  although  ascorbic  acid  alone  was  a  very  poor 
antioxidant for lard and oil, it enhanced the antioxidant activity of tocopherols (164).  
It  was  not  until  1968  that  Tappel  suggested  that  vitamin  C  might  reduce  the 
tocopheroxyl radical formed from tocopherol during the scavenging of free radicals 
in vivo, permitting a single molecule of vitamin E to scavenge many radicals (165).   
 
Further  work  has  been  performed  to  evaluate  the  synergy  of  ascorbate  and 
tocopherols and to look at the possibility of recycling of tocopherol by ascorbate.  In 
electron spin  resonance studies  regeneration of vitamin E from  the chromanoxyl 
radical by GSH and vitamin C was detected (166,167).  In experiments investigating 
the effect of vitamin E and vitamin C on methyl linoleate peroxidation, vitamin E 
was kept in the reduced state as long as there was vitamin C present (168).  The 
synergistic  effects  of  vitamin  C  and  E  were  evaluated  in  preventing  lipid 
peroxidation  of  NADPH/iron-ADP-supplemeneted  rat  microsomal  fractions.    In 
these experiments, it was found that any protective effect was due to ascorbic acid 
reducing  vitamin  E,  which  was  then  active  and  could  act  as  a  chain  breaking 
antioxidant (169).  It should be noted that these studies do not distinguish prevention 38 
 
of ʱ-tocopherol oxidation from regeneration of ʱ-tocopherol.  Therefore, they do not 
provide unambiguous evidence for tocopheroxyl radical repair.  In similar studies 
using lipid peroxidation in liposomes, there has been the suggestion of recycling of 
vitamin E by ascorbic acid, since the ascorbate consumption in liposomes with ʱ-
tocopherol  was  much  more  rapid  than  would  be  expected  from  regeneration  of 
tocopheroxyl radicals, based on the rate of tocopherol depletion in the absence of 
ascorbate (170,171).   There was  direct  evidence of recycling  in  human  LDL  by 
Kagan et al.  They created vitamin E radicals in LDL by ultraviolet rays and found 
reduction of these radicals by water soluble antioxidants such as ascorbic acid.  It is 
thought that this increases the antioxidant effect of LDL (172).  It was found that 
when ʱ-tocopherol was oxidised to ʱ-tocopheroxyl radical by NO in an anaerobic, in 
vitro  experiment,  ascorbic  acid  was  depleted  and  ʱ-tocopherol  was  regenerated.  
Gorbunov et al suggested that recycling of vitamin E may be necessary for effective 
protection against NO-induced damage (153).  It has been proposed that effective 
hydrogen transfer between ascorbic acid and ʱ-tocopherol can take place because the 
polar  phenoxy  head  group  of  ʱ-tocopherol  is  located  near  the  polar  lipid-water 
interface (173). 
 
The first explicit, in vivo, test of ascorbate ʱ-tocopherol recycling suggested 
conflicting results with the in vitro studies discussed (174).  This study measured the 
turnover  kinetics  of  ʱ-tocopherol  in  several  tissues  from  guinea  pigs  fed  diets 
containing  different  levels  of  ascorbate.    Because  guinea  pigs  cannot  synthesise 
ascorbate,  rates  of  ʱ-tocopherol  turnover  were  expected  to  vary  inversely  with 39 
 
ascorbate status.  In fact, in these studies, the ʱ-tocopherol turnover kinetics were 
unaffected by ascorbate status  in all tissues examined and it was concluded that 
ascorbate-dependent recycling of ʱ-tocopherol was of negligible importance, in vivo, 
in guinea pigs that were not oxidatively stressed.  However subsequent studies have 
failed to confirm the absence of an in vivo recycling mechanism.  Rat hepatocytes 
incubated  with  various  doses  of  ascorbic  acid  were  compared  to  cells  that  were 
incubated  in  the  absence  of  ascorbic  acid.    Measurements  of  ʱ-tocopherol,  ʱ-
tocopherolquinone,  ascorbic  acid  and  dehydroascorbic  acid  were  made.    In  the 
absence  of  ascorbic  acid,  ʱ-tocopherol  was  undetected  at  the  completion  of  the 
experiment, while levels of ʱ-tocopherolquinone were high, whereas in  those rat 
hepatocytes incubated with ascorbic acid there were varying concentrations of ʱ-
tocopherol and little ʱ-tocopherolquinone (175).  It has also been suggested that 
ascorbate  within  intact  human  erythrocytes  protects  ʱ-tocopherol  in  the  cell 
membrane by a direct recycling mechanism.  This was the first study to evaluate 
recycling occurring across a cell membrane (176).  A proposed mechanism for this 
recycling of ʱ-tocopherol by ascorbate is shown in Figure 1.2. 
 
There has been some controversy in this field regarding the synergy between 
the  two  vitamins  and  part  of  the  function  of  our  study  was  to  investigate  this 
phenonomen  further,  in  a  model  of  nitrosative  stress  at  the  gastroesophageal 
junction. 
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Figure 1.2:  Representation of the proposed chemistry coccuring when ʱ-tocopherol 
is  regenerated  from  the  tocopheroxyl  radical  by  ascorbate.    Alpha-
tocopherol  is  shown  to  reduce  the  peroxyl  radical  (LOO
.)  to  its 
antioxidant  derived  peroxyl  radical  (LOOH)  and  in  so  doing 
tocopheroxyl radical has been formed.  The tocopheroxyl radical is then 
reduced by ascorbate back to the antioxidant ʱ-tocopherol (adapted from 
Liebler (170)). 
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1.10 Duodenal  refluxate,  bile  acids  and  carcinogenesis  in  the  upper 
gastrointestinal tract 
 
Many patients with Barrett’s oesophagus have been found to have, not only 
gastric acid exposure, but also duodenal juice exposure of the oesophagus.   The 
prevalence  of  increased  bilirubin  exposure  significantly  increases  between  the 
groups  of  patients  with  no  mucosal  injury  (30%),  oesophagitis  (62%)  and  long 
segment  Barrett’s  oesophagus  (85%)  (41,177-181).  Several  investigators  have 
shown that duodeno-gastroesophageal reflux per se can induce Barrett’s oesophagus 
to form oesophageal adenocarcinoma in rats (182-186).  
 
There is information on the toxicity of bile acids on the oesophageal mucosa 
(187),  gastric  mucosa  (188-190),  colonic  mucosa  (191,192)  and  hepatocytes 
(193,194).    However,  the  mechanism  of  action  for  bile  refluxate  causing 
oesophageal damage is not clear.  It has previously been shown that bile, in itself, is 
not mutagenic, in the Ames test (195).  There is the suggestion that at more alkaline 
pH, in their unionised form, bile acids can cross mucosal cell membranes and enter 
the cell, where they are noxious to the cell mitochondria.  Also, due to its pKa, 
taurine is unionised at a low pH and will therefore be able to enter cells across their 
membranes.  There have been reports of toxic synergism between taurine conjugates 
and acid in mucosal damage of the oesophagus (187).  The accumulation of bile 
acids in the oesophageal mucosa has been a proposed method of toxicity for many 
years, after they were shown to accumulate in rat oesophageal mucosa (196).  To 
elucidate  the  carcinogenic  effects  of  duodenal  contents,  many  researchers  have 42 
 
addressed the bile acids and pancreatic juice (197-199).  It is known that conjugated 
bile  acids,  in  the  form  of  amides,  are  a  target  for  nitrosative  stress,  leading  to 
nitrosated compounds that are carcinogenic.  The bile acids are the major source of 
nitrosatable amides in the body (200).  Glycocholic acid, shown to make up 60% of 
the total bile acid composition of reflux into the oesophagus of patients with GORD 
(201),  can  be  nitrosated  under  simulated  gastric  conditions  to  form  N-
nitrosoglycocholic  acid,  which  is  known  to  be  highly  mutagenic  to  bacteria  and 
mammalian cells (200,202).  N-nitroso bile salts such as N-nitrosoglycocholic acids 
and N-nitroso-taurocholic acids were also shown to be mutagenic and carcinogenic 
in rat stomachs as early as 1985 (197).  Such bile salts have been implicated in 
gastric cancer as well as gastric stump carcinogenesis post gastrectomy (185).  More 
recently,  it  has  been  demonstrated  that  bile  acids  can  induce  DNA  breaks  and 
oxidative damage in oesophageal cell lines and tissue (203-205) and importantly, 
duodenoesophageal reflux has been shown to be potentially mutagenic in rat models 
of Barrett’s oesophagus (206). 
 
In  a  rat  model  of  oesophageal  adenocarcinoma,  induced  by  gastroduodenal 
reflux,  it  was  found  that  the  nitrite  scavenger  thioproline  (207)  was  effective  in 
inhibiting the development of oesophageal adenocarcinoma (208).  In this rat model, 
there  is  reflux  of  duodenal  contents  but  the  stomach  retains  its  normal  function 
(209).  This model simulates the situation of patients with duodeno-gastroesophageal 
reflux,  including  reflux  of  both  duodenal  contents  and  gastric  juice  into  the 
oesophagus.  In this study, thioproline inhibited the development of oesophageal 43 
 
adenocarcinoma and iNOS protein was over expressed in Barrett’s oesophagus of 
both  the  control  and  thioproline  group.    Thioproline  could  not  suppress  the 
overexpression  of  iNOS.    The  suggested  mechanism  of  thioproline  inhibiting 
oesophageal  adenocarcinoma  was  summarised  as  follows  by  Kumagai  et  al: 
‘thioproline inhibits production of nitroso compounds by nitrite-reducing bacteria 
but  also  reactive  nitrogen  species  such  as  NO,  peroxynitrite  and  N-
nitrosocompounds derived from reflux of duodenal contents’.  This study therefore 
suggests  that  oesophageal  adenocarcinoma  is  associated  with  reactive  nitrogen 
species (such as NO, peroxynitrite and N-nitrosocompounds) derived from bile salts 
in the oesophagus (208). 
 
It  has  been  established  that  bile  salts  are  implicated  in  colon  cancer.  
Epidemiological  studies  have shown that  high levels  of secondary bile acids  are 
found in the faeces of patients with colon carcinoma (210).  It is also known that 
patients with Barrett’s esophagus have a significantly higher incidence of colonic 
polyps and adenomas (211).  It is therefore attractive to hypothesise that, as a high 
fat  diet  promotes  the  flow  of  bile,  the  excessive  amount  of  bile  acids  in  the 
alimentary tract may be a contributing factor which enhances carcinogenesis, not 
only  in  the  colon,  but  also  in  the  upper  gastrointestinal  tract,  through  reflux  of 
gastro-duodenal content.  
 
It is interesting to note that one of the few other cancers to have an increase in 
its incidence over the last couple of decades is cholangiocarcinoma.  Studies have 44 
 
shown  that  NO  generated  in  response  to  inflammation  may  initiate  malignant 
transformation  of  biliary  epithelia  and/or  promote  progression  of  established 
cholangicarcinoma (212).  NO inactivation of DNA repair enzymes may provide a 
link  between
  inflammation  and  the  initiation,  promotion,  and/or  progression
  of 
cholangiocarcinoma.
  This  tumour  also  provides  an  insight  into  the  potential 
mechanisms  underlying  NO  induced  malignancy,  in  a  cancer  also  increasing  in 
incidence.    It  is  attractive  to  suggest  that,  perhaps,  in  this  tumour  there  is  also 
indirect carcinogenesis through nitrosation of bile acids. 
 
It can be seen that the nitrosation of bile acids is an important carcinogenic 
mechanism and an environment rich in bile acid amides and nitrosative stress would 
potentially be a site of increased cancer risk.  In this thesis we explore nitrosative 
stress in the upper gastrointestinal tract where there is the potential for bile acid 
refluxate. 
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1.11 Enterosalivary  recirculation  and  NO  generation  at  and  around  the GO 
junction 
 
There are two mechanisms through which there can be nitrate circulating in the 
bloodstream.  The first of these involves dietary nitrate.  The increased nitrogen 
fertiliser  use  since  the  Second  World  War  has  resulted  in  an  increase  in  nitrate 
concentrations in the diet (213). Nitrate is swallowed in the diet and then a large 
percentage of this is absorbed across the small intestine into the bloodstream (214).  
There is also a smaller contribution to the overall circulating nitrate concentration 
from  endogenously  produced  nitrate,  as  the  end  product  of  enzymatically 
synthesised  NO.    Approximately  25%  of  the  total  nitrate  in  the  bloodstream  is 
actively taken up by the salivary glands and secreted into the mouth (214).  The 
resulting concentration of nitrate in saliva is 10-20 times higher than that in the 
circulating blood (215).  A significant proportion of salivary nitrate is then rapidly 
reduced to nitrite in the mouth by the action of nitrate reductase bacteria, colonised 
densely  on  the  dorsum  of  the  tongue  (216,217)  (Figure  1.3).    Due  to  this 
enterosalivary recirculation of nitrate and subsequent conversion of nitrate to nitrite, 
human saliva contains very high concentrations of nitrite.  Under fasting conditions 
the nitrite concentration of saliva is 10-1000µmol/l (143,215) and this rises 2-5 fold 
for  several  hours  after  the  ingestion  of  nitrate  containing  foods  (143).    This  is 
thought to be potentially beneficial to humans, as the nitrite formed on the tongue 
may then be acidified through encounter with the acid environment around the teeth 
and  periodontal  tissues,  provided  by  the  dental  plaque  microflora  (218).    The 46 
 
acidification of nitrite produces nitrogen oxides as well as nitrous acid.  The nitrous 
acid  will  spontaneously  decompose  to  NO  and  nitrogen  dioxide.    NO  has  been 
shown to be produced here (219).  This NO produced has an inhibitory effect on 
periodontal bacteria (220). 
 
Previous studies, using validated microdialysis probes, have provided useful 
information  regarding  the  localisation  of  chemistry  into  regions  of  the  upper 
gastrointestinal tract (221,222).  It has been shown that the most proximal cardia 
region  of  the  stomach  has  the  chemical  conditions  most  favourable  for  luminal 
generation of  N-nitrosocompounds (221).   The concentrations  of nitrite found in 
saliva  are  found  in  similarly  high  concentrations  throughout  the  length  of  the 
oesophagus (45).  It is known that approximately 1.5 litres of saliva is produced 
every 24 hours and all of this nitrite rich saliva passes down into the stomach.  It has 
been  observed  that  nitrite  concentrations  are  highest  in  the  cardia  region  of  the 
stomach, consistent with where nitrite in swallowed saliva enters into the gastric 
cardia from the oesophagus (221).  The more distal stomach has less nitrite present, 
in part due to dilution and also in part due to acidic gastric juice converting nitrite to 
nitrous acid and NO, with NO then able to pass into surrounding mucus and tissues.  
When  this  saliva  reaches  the  proximal  stomach,  it  is  immediately  converted  to 
nitrous acid and nitrosating species including N2O3 and NO
+.  As well as taking up 
and  secreting  nitrate,  the  salivary  glands  also  actively  take  up  and  secrete 
thiocyanate and its concentration in saliva is approximately 1mmol, and even higher 
in smokers (223).  This anion may also be secreted directly into gastric juice (223).  47 
 
In determining localised regional chemistry, it was found that high concentrations of 
thiocyanate  are  present  throughout  the  upper  gastrointestinal  tract  but  the 
concentrations in the proximal and distal stomach were 80% and 50% of those found 
in  the  saliva  (221).    Thiocyanate  reacts  with  NO
+  to  form  NOSCN  which  is 
particularly potent as a nitrosating species (98,99).  There is then the capability of 
nitrosating species to react with nitrosatable compounds such as amines and amides 
to generate potentially carcinogenic N-nitrosocompounds.  
 
The  main  inhibitor  of  luminal  acid-catalysed  N-nitrosation  is  the  aqueous 
antioxidant  ascorbic  acid,  which  is  known  to  be  present  in  gastric  juice  at  high 
concentrations.  Ascorbic acid is known to be actively secreted into gastric juice 
(96,134). In the study by Suzuki et al, it was shown that intragastric ascorbic acid 
and total vitamin C were lower in the cardia region of the stomach, as compared to 
the mid and  distal  stomach (221).  A  combination of the cardia of the stomach 
having the lowest ascorbic acid and highest nitrite means that the ratio of ascorbic 
acid to nitrite is significantly lower in the cardia.  The ratio of ascorbic acid to nitrite 
is a critical determinant of acid nitrosation (139,224).  When ascorbic acid is present 
in  excess,  acid  nitrosation  is  prevented  (139,224).    Therefore,  in  this  way  the 
conditions for luminal acid nitrosation are maximal at the cardia region, as compared 
to the rest of the stomach.  How much of a part this mechanism will play, depends, 
in part, upon the availability of ascorbic acid.  When ascorbic acid is available to 
excess, significant NO will be generated. 
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Ascorbic  acid  is  oxidised  to  dehydroascorbic  acid  in  reducing  nitrosating 
species to NO.  Peak concentrations of NO generated in this way occur in the cardia 
of the stomach, as have been shown in previous studies by our group (43).  There is 
a process of recycling of nitrite that will occur here, in the presence of initial excess 
ascorbic  acid.    It  is  through  nitrosative  stress  generated  by  NO  that  our  group 
proposes that dietary nitrate may have a role in carcinogenesis in the apparently 
healthy acid secreting stomach.  This thesis explores such chemistry in the upper 
gastrointestinal tract. 
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Figure 1.3: The  process  of  enterosalivary  recirculation  of  dietary  nitrate  and 
subsequent conversion to nitrite by bacteria on the dorsum of the tongue 
is illustrated in this figure.  Once nitrite is swallowed in saliva it meets 
the acidic gastric juice and in the presence of vitamin C is converted to 
NO.  The red arrows represent the passage of nitrate while the blue 
arrow represents the pathway for nitrite.   
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1.12 Overall 
 
It has been shown that there are potentially three mechanisms of nitrosative 
stress, with two of these occurring maximally at the cardia region of the stomach and 
the  gastroesophageal  junction.    Two  of  the  three  mechanisms,  luminal  acid 
nitrosation  and  nitrosation  from  denitrifying  bacteria  are  well  established  in  the 
literature.  However, the third mechanism of nitrosative stress in the healthy acid 
secreting stomach, from swallowed nitrite, with NO formation and the possibility of 
subsequent  diffusion  of  NO  into  tissues,  is  a  relatively  recent  addition  to  our 
understanding of nitrosative stress in the gastrointestinal tract.  The purpose of this 
study was to look further at NO related nitrosative stress in models of the upper 
gastrointestinal tract and to take this into an in vivo setting, to assess nitrosative 
stress. 
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Chapter 2:  Materials and Methods 
 
Throughout the studies, there were several techniques and analyses that were 
regularly undertaken and these will be described in this chapter.  For each series of 
experiments, there were more specific materials, methods and experimental design 
used and these will be described within the respective chapters. 
 
2.1 Methods 
 
2.1.1 NO Determination by Amperometry 
 
  NO was measured using a World Precision Instruments (WPI) ISO-NO
TM Mark 
II  NO  sensor  (World  Precision  Instrument,  Sarasota,  Florida).    This  type  of 
biosensor has been used in experiments to measure NO since 1993 (225)
 and has 
been  used  in  many  different  experimental  situations  since  then 
(43,226,227,228,229).  This was a 2mm diameter stainless steel shielded sensor as 
shown in figure 2.1.   
   
  This probe was amperometric.  NO diffused through a selective gas permeable 
membrane and was oxidised at an electrode, resulting in an electrical current.  This 
redox current was proportional to the NO concentration of the sample.  The sensors 
were connected to a WPI ISO-NO NO meter (World Precision Instrument, Sarasota, 
Florida) which showed both the NO concentration and the redox current.  The sensor 52 
 
could measure NO concentrations down to 1nM.  The meter was connected to a 
computer which converted the electrical signal (pA) to NO concentrations in µM.   
 
  The probe was calibrated to ensure accurate NO measurements.  Calibration was 
achieved using the chemical generation of NO.  A set of calibration sodium nitrite 
(NaNO2) standards were created from a 100mM NaNO2 stock solution.  The method 
of calibration is based on the following reaction: 
 
2NaNO2   +   2KI    +   2H2SO4     2NO   +   I2   +   2H2O +   2NaSO4 
 
where a known amount of NaNO2 was added to produce a known amount of NO.  
KI and H2SO4 were added to excess, making KNO2 the limiting reagent.  Since the 
reaction goes to completion, the equation above states that the ratio between NaNO2 
and NO is 1:1.  Therefore the amount of NO generated in the solution will be equal 
to the amount of NaNO2 added.  The final concentration of NO will be equal to the 
diluted concentration of NaNO2 in the solution.  As the ISO-NO sensor responds to 
partial  pressure  of  NO,  as  opposed  to  the  concentration,  the  temperature  of 
calibration had to be the same as the temperature of the experimental setting.  H2SO4 
(0.1M) and KI (0.1M) were added to a glass vial and a small magnetic stirrer was 
added to the bottom of the vial.  This was then placed in a water tank containing 
deionised H2O, maintained at 37
oC on a heater magnetic plate in a fume cupboard.  
The NO probe was suspended in the solution and allowed to settle until a steady 
baseline was achieved.  A known NaNO2 calibration standard was then added and 53 
 
the highest pA reading achieved was recorded.  The baseline recording is subtracted 
from this reading to ensure that all the change in pA is due to NO and not just from 
background noise.  This was repeated for different NaNO2 concentrations, allowing 
the sensor recording to drop to the baseline in dH2O before adding the probe to the 
next standard.   The response was linear for the range of concentrations measured.  
From these readings a calibration curve was created each time the sensor was used 
(figure 2.2). 
 
  The standard curve enabled us to determine the unknown NO concentration of a 
sample.  For any sample that had been diluted a conversion factor was allowed based 
on the degree of dilution.  The concentrations of NO determined were given in µM.  
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Figure 2.1:  Schematic diagram representing the World Precision Instruments ISO 
NO
TM Mark II NO probe.  The probe is composed of a stainless steel 
sleeve, with a gas permeable membrane tip, filled with an electrolyte 
conducting solution.  The electrode was linked to a computer recording 
the data as a pA output.   
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Figure 2.2:  Typical  NO  calibration  curve  determined  by  a  set  of  known  sodium 
nitrite standards that generate 1µM NO per 1µM of sodium nitrite.  The 
electrical current generated by the gaseous NO diffusing across the gas 
permeable  membrane  of  the  NO  senor  is  recorded  in  pAs.    NO  is 
generated by using set concentrations of sodium nitrite standards.  The 
pA  generated  is  plotted  against  the  given  nitrite  concentration.    By 
fitting  the  best  fit  straight  line  through  the  peak  pA  reached  per 
standard, a slope is created that can determine the pA per 1µM NO. 
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2.1.2 Oxygen determination by amperometry 
 
 
  A  World  Precision  Instrument  ISO2  meter  and  its  associated  OXEL-1  probe 
(World  Precision  Instrument,  Sarasota,  Florida)  were  used  to  measure  O2  levels 
within  the  experimental  design.    The  sensor  amperometrically  measured  the 
concentration  of  O2  in  an  aqueous  mixture.    The  O2  probe  housed  a  platinum 
working electrode and a silver reference electrode inside a stainless steel sleeve of 
66mm length.  The tip diameter was only 2mm, allowing detection in small vials.  At 
the  tip  end  of  the  sleeve  there  was  a  gas  permeable  polymer  membrane  which 
allowed O2 to pass.  O2 was then reduced at the platinum cathode, which was held at 
-0.7V  when  the  instrument  was  on,  thus  resulting  in  an  electrical  current.    The 
magnitude of the electrical current was determined by the rate of diffusion to the 
electrode,  which  was  proportional  to  the  partial  pressure  of  O2  outside  the 
membrane.    Measurement  modes  were  percent  O2,  parts  per  million,  and  O2 
reduction  current  in  nanoamperes.  This  could  then  be  converted  to  µM 
concentration.  The lower detection limit for ISO2 (in liquid phase) was 0.1 ppm or 
0.1%. O2 concentration, around 0.5 ppm or 0.5% and upward, could be routinely 
measured in the gaseous or in the liquid phases.  The accuracy of the sensor was 
+1.5% with a 0.1ppm resolution. 
 
  The ISO2 sensor probe was calibrated at the same temperature (usually 37
oC) as 
was used in the experiment.  Calibration took place in water saturated with nitrogen 
as per the manufacturers instructions.  57 
 
2.1.3 Protein measurement 
 
2.1.3.1 Introduction to protein measurement 
 
  Protein concentrations were measured using the Bio-Rad Protein Assay (Bio-Rad 
Laboratories Ltd, Hertfordshire, UK).  This is based on the absorbance for an acidic 
solution of Coomassie Brilliant Blue G-250 shifting from 465nm to 595nm when 
binding  to  protein  occurs  (230,231).    Protein  based  samples  were  added  to  dye 
reagent  concentrate  and  measured  against  bovine  serum  albumin  standards  on  a 
colorimetric  spectrophotometer  (Dynatech  MR  500,  Dynatech  Laboratories, 
Billingshurst, W. Sussex, UK).  The Bio-Rad kit came complete with dye-reagent 
concentrate, which was a solution of dye, phosphoric acid and methanol, and bovine 
serum albumin standardised plasma protein.  The dye reagent required a dilution of 1 
volume dye reagent concentrate with 4 volumes  dH2O, with subsequent filtering 
through Whatman No. 1 paper (RA Lamb Ltd, East Sussex, UK).   The Bio-Rad 
method was used because it is sensitive down to 1 µM of protein, is easy and rapid 
to use and has less in the way of chemical interference compared to the more basic 
Lowry and Biuret methods.   
 
2.1.3.2 Protein Standards and use of assay 
 
  Bovine serum albumin was used as the protein standard.  The stock standard was 
20 mg/100mL water.  To make up a working standard, the stock was diluted 1:5 58 
 
with  dH2O  (4mg/100mL).    Standards  were  made  of  0.25  –  2.5  mg/100mL  by 
diluting the original working standard with deionised water.  A standard curve was 
prepared  each  time  the  assay  was  performed.    The  standard  (0.2  mL)  and  its 
dilutions were placed into a test tube.  A 0.2 mL sample buffer was in a ‘blank’ test 
tube.  Diluted dye reagent (0.1 mL) was added, and the samples inverted several 
times  to  allow  mixing.    After  15  minutes  the  OD595  was  measured  against  the 
reagent blank using the colorimetric plate reader at wavelength 595nm.  The OD595 
was then plotted for the standards and the unknowns were read from the standard 
curve.  When this assay was used for tissue samples, random, human and rat, biopsy 
samples were obtained from different regions of the upper gastrointestinal tract to 
show  that  there  was  no  difference  in  the  linearity  of  protein  from  within  this 
heterogeneous group of samples.  
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2.1.4 Nitrite analysis using the modified Greiss reaction 
 
  There are many different ways to measure nitrite.  These can be divided into four 
main categories: spectroscopic detection, electrochemical detection, chromatography 
and capillary electrophoresis.  Spectroscopic methods are by far the most widely 
used and within this  category the Greiss Assay is  the most extensively assessed 
(232).  This assay was first developed in 1879. 
 
Samples in this study were analysed against known concentrations of nitrite 
(NaNO2) using the modified Greiss reaction (233).  The Greiss reagent method is 
based on the reaction shown in figure 2.3, where the reaction of nitrite and sulfanilic 
acid in an acidic environment produces an azo dye detected spectrophotometrically 
at 540 nm (232). 
 
The  Greiss  reagent  was  made  up  with  sulphanilamide,  concentrated  HCl, 
dH2O  and  NEDD  (N-1-Napthylethylene  diamine  dihydrochlorlide).    In  this 
arrangement of the Greiss reaction the NEDD is an aromatic amine acting as the 
coupler, while the sulphanilamide is the target aromatic amine.  The detection limit 
was 0.1 µM.   
 
NaNO2  standards  were  made  up  in  PBS  at  different  concentrations.    The 
general standards that were made up were 10 µM, 25 µM, 50 µM, 75 µM and 100 
µM. 60 
 
Using a 96 well plate (Labtech International Ltd, East Sussex, UK), 60 µL of 
standard solutions and samples were added to the wells before, immediately, adding 
60 µL of Greiss reagent and 60 µL of dH2O.  Three ‘blank’ wells were created, by 
adding only dH2O.  The reaction was left at room temperature for thirty minutes 
before  the  optical  density  at  540  nm  was  measured  on  the  Dynatech  MR  500 
colorimetric plate reader.  All samples and standards were analysed in triplicate. 
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Figure 2.3: The chemical reaction of the Greiss reaction 
 
                                                      
 
 
 
 
 
                                                                
                                                                                
 
 
 
                                                                                   
 
Figure 2.3:  The Greiss reaction involves the reaction of nitrite (NO2
-) under acidic 
conditions, with aromatic amines, such as sulphanilic acid, to form a 
diazonium  cation;  in  a  second  step,  this  ion  reacts  with  a  further 
aromatic amine, such as NEDD, as a target coupling amine to form a 
purple azo dye.   
HO3S  NH2 
NO2
- 
+  NH(CH2)2NH2  NH2
+  HO3S 
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2.1.5 Nitrate analysis 
 
Nitrate was measured indirectly by the reduction of nitrate to nitrite by the 
bacterial  enzyme  nitrate  reductase.    The  nitrate  reductase  was  made  up  into  a 
reaction buffer in the presence of β-Nicotinamide Dinucleotide Phosphate (NADPH) 
and  Flavin  Adenine  Dinucleotide  (FAD),  Phosphate  Buffer  Solution  (PBS)  and 
dH2O.  PBS is present as the reaction will only take place at pH 7.2-7.4.  One unit of 
nitrate reductase will reduce 1.0 µM of nitrate per minute in the presence of NADPH 
at 25
oC.  Nitrate reductase (10 units) was added to 4 mg of NADPH and 33.2 mg of 
FAD to make up the reaction buffer.  The total volume of reaction buffer that was 
used was 4000 µL which was made up of the following:  NADPH 4 mg in 800 µL, 
FAD 33.2 mg in 800 µL, PBS (pH 7.4) 800 µL, dH2O 1520 µL, nitrate reductase 10 
U/450 µL 80 µL. The reaction of nitrate reduction with nitrate reductase converts the 
nitrate  to  nitrite,  and  the  nitrite  is  subsequently  measured  by  the  Greiss  reagent 
method as described above.  As the nitrate method does not take into account any 
nitrite within the sample to start with, we also plated nitrite standards and samples 
on  a  separate  well  plate.    This  nitrite  concentration  was  subtracted  from  the 
concentration from the nitrate well samples.  The reaction of nitrate reductase relies 
on the pH of the sample being between pH 7.2 – 7.4 and therefore for alkali samples, 
from rat studies, adjustment using a ‘superbuffer’ was performed.  The superbuffer 
consisted of 0.1 M NaOH and a half volume 0.3 M HCl. 
  
Well plates for nitrate (Plate I)/nitrite (Plate II) analysis were set up as follows.  
In both plates there were three 60 µL water ‘blanks’, then three 60 µL standards for 63 
 
each concentration of nitrite.  In the nitrate plate (Plate I), there were also three wells 
for each 60 µL nitrate concentration.  Sample (60 µL) was added to each of three 
sample wells.  To plate I, 30 µL of reaction buffer was added, while 30 µL of water 
was added to each well of plate I.  Both plates were incubated at 25
oC, in the dark, 
for 2 hours, to allow the reaction buffer to convert nitrate to nitrite.  At the end of 2 
hours, 60 µL Greiss reagent and 30 µL distilled water was added to each well of 
both plates.  The plates were then left at room temperature, for 20 minutes, before 
being analysed on the colorimetric plate reader (Dynatech MR 500).  The original 
nitrate in samples was calculated from the nitrate standard curve. 
 
The reaction principle of nitrate reductase is 
 
 
          β-NADPH + Nitrate ------------------------------- β-NADP + Nitrite + H2O 
                                                         Nitrate reductase 
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2.1.6 
15N analysis 
 
Analysis for 
15N was undertaken in studies to examine the effectiveness of 
cleaning samples deliberately exposed to K
15NO2 and K
15NO3.  The analysis for 
total 
15N content (ng) was undertaken in collaboration with Dr T Preston who kindly 
performed the analysis on a tandem mass spectrometer  (ThermoFinnigan, Hemel 
Hempstead, UK). 
 
2.1.7 S-Nitrosothiols 
 
Nitrosothiols  were  measured  at  pH  7.4,  using  the  release  of  NO  from 
nitrosothiols  by  copper  in  an  acidic  environment,  in  the  presence  of  glutathione 
acting as an excess reducing agent (234,235).  The NO was measured using the WPI 
NO probe, as described above in Chapter 2.1.1. The copper used was in the form of 
copper nitrate.  To calibrate the NO probe, nitrite standards (of concentration 20, 40, 
60 and 80 µM) were used, as in the presence of excess glutathione all the nitrite 
would be converted to nitrosothiols before the NO is then released by the copper. 
 
The following reagents were used 
 
a.  pH 7.4 50 mM H3PO4/K2HPO4 Buffer.  This acts to keep the reaction at pH 7.4.  
H3PO4 of 50 mM is made up by adding 0.5 mL H3PO4 (concentrate) in 100 mL 
dH2O to give a pH of 1.7.  K2HPO4 of 50 mM is made up by dissolving 0.871g 65 
 
of K2HPO4 in 100 mL of dH2O to give a pH of 8.9.  K2HPO4  solution was put 
into a beaker and the pH adjusted by adding H3PO4 solution to give a pH of 7.4 
(roughly H3PO4:K2HPO4 = 6:100) 
b.  500  mM  Cu(NO3
-)2.    This  provides  copper,  which,  when  added  to  a 
nitrosothiol, displaces the NO from the GSNO thiol group, liberating NO.  To 
make up this solution, 0.938 g of Cu(NO3
-)2 was dissolved in 10 mL of pH 2.5 
HCl.     Cu(NO3
-)2 was used at 5mM final concentration. 
c.  100mM Glutathione (GSH).  This acts as a reducing agent and also a thiol 
donor for the production of nitrosothiols.  0.307 g of GSH is dissolved in 10 
mL of dH2O.  GSH was used as a final concentration of 1 mM 
 
From  these  standards  a  graph  can  be  plotted  and,  from  the  graph,  we  can 
determine the NO release from the unknown samples (Figure 2.4). 
 
Human biopsy samples were acidified to pH 2.5 by adding 19 µL of 0.1 M 
HCl.  GSH (1 mM) was added to act as a thiol donor group and reducing agent, thus 
allowing any nitrite present to be converted to nitrosothiols.  In a separate 1 ml 
plastic Eppendorf test tube 99 µL of buffer solution and 1 µL of 100 mM GSH were 
added  together.    The  80  µL  sample  was  then  added  to  100  µL  of  buffer  based 
solution. A calibrated WPI NO probe was placed into the Eppendorf tube before the 
NO was liberated. To the 200 µL solution, 2 µL of 500 mM of Cu(NO3
-)2  (5mM) 
was added to liberate NO.  NO production was recorded and the peak measurement 
obtained.   66 
 
 
 
 
             
 
 
Figure 2.4:  Standard calibration curve for NO release from nitrosothiols.  Nitrite 
samples  of  known  concentration  were  mixed  with  glutathione  as 
standards.    In  the  presence  of  excess  glutathione  all  the  nitrite  is 
converted  to  nitrosothiols,  which  can  then  be  measured  through  the 
release  of  NO.    NO  is  released  by  the  reduction  of  nitrosothiols  by 
copper in an acidic environment.  Since there is a linear relationship 
between pA and µM from known concentrations of nitrite standards, in 
the sample, unknown nitrosothiol concentrations can be calculated.   
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2.1.8 Ascorbic acid/total vitamin C analysis 
 
2.1.8.1 Collection and preparation of samples 
 
The aqueous phase of bench top model studies was sampled at times 0, 1, 2, 5, 
10 and 15 minutes through a sampling port.  The sample (100 µL) was added to 900 
µL of dH2O and split into two test tubes.  Both test tubes contained 0.5 mL of 2% 
metaphosphoric acid/0.5% sulphamic acid and one of the test tubes also contained 
6mg/ml dithiothreitol (DTT).  The DTT was used to regenerate ascorbic acid from 
any dehydroascorbic acid in the sample, allowing quantification of total vitamin C 
levels.  The sulphamic acid was added to remove any remaining nitrite.  
 
Ascorbic acid (ASC) and total vitamin C (TVC) samples were immediately 
frozen in a -70 
oC freezer after being obtained.  Stored samples were analysed within 
4 weeks.  Prior to analysis, samples were thawed and centrifuged briefly at 1000 g, 
using a microcentrifuge (DJB Labcare Ltd, Buckinghamshire, UK). 
 
2.1.8.2 Analysis of sample by HPLC 
 
ASC  and  TVC  levels  were  measured  by  high  performance  liquid 
chromatography (HPLC), employing an electrochemical detector.  This method is 
based on a previously validated method for ascorbic acid measurement in gastric 
juice  (43,143,221,222,236).   The instruments  comprised of an automated sample 
injector (Shimadzu SIL-10AD VP) with a 50 µL loop, a pump (Shimadzu LC-10AT 68 
 
VP), an electrochemical detector (Shimadzu L-ECD-6A) set at 350 mV and 0.2 µA 
and  an  integrator  (Shimadzu  model  C-R3A  Chromatopac).    ASC  was  separated 
using the reverse phase, ion pair chromatography on a Phenomenex 5µM C18 Luna 
150 x 4.6 mm analytical column (Phenomenex, Macclesfield, UK) protected by a 
guard column (Anachem, UK, 20 x 3 mm) hand packed with Lichroprep RP-18 (25-
40 µm, BDH-Merck Ltd, Poole, UK).  A precolumn (Phenomenex Security guard 
C18 ODS Octadecyl filters 4 x 3 mm id) was also used.  The mobile phase consisted 
of 0.1 M sodium acetate containing 0.1 M ocytlamine and 15% acetonitrile with a 
final pH of 4.3, adjusted with glacial acetic acid.  The flow rate was 0.8mL/min and 
the retention  time of  ASC  was  approximately three minutes.  An aqueous  stock 
standard solution (1 mg/mL) was prepared by adding 5 mL of ASC stock solution to 
5ml of DTT (3.5 mg/mL).  Working standards were prepared by diluting appropriate 
volumes  of  the  stock  solution  on  the  day  of  analysis.    The  autosampler  was 
programmed to inject 25 µL of standards, quality control and samples.  The first 
injection  was  DTT  solution  to  remove  oxidising  sites  on  the  column.    A  blank 
sample of 1:1 metaphosphoric acid : sulphamic acid (MS) diluted 1 in 2 using dH2O 
was processed for each run and subtracted from the measured ascorbic acid of the 
samples, as the MS solution had a positive ASC reading when analysed. 
 
After obtaining a value for both total vitamin C and ASC, the dehydroascorbic acid 
could be calculated.  All measurements were expressed in µg/mL.   
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2.1.9 Vitamin E analysis 
 
The  analysis  of  ʱ-tocopherol  which  was  used  was  based  on  a  method 
previously  described  for  non  biological  samples,  using  high  performance  liquid 
chromatography (HPLC) employing an electrochemical detector.  The analysis with 
HPLC  and  electrochemical  detection  offers  more  sensitivity  and  selectivity 
compared  with  HPLC  and  UV-visible  or  fluorescent  detection  (237).  The 
instruments comprised of an automated sample injector (Shimadzu SIL-10ADvp) 
with a 50µL loop, a pump (Shimadzu LC-10AT) and an electrochemical detector 
(Applied Biosystems 980 Programmable Fluorescent detector, Applied Biosystems, 
Warrington, UK) with excitation 295 nm and emission 340 nm.  
 
Α-tocopherol  was  separated  from  the  rest  of  the  sample  using  a  Jones 
Spherisorb 5µ silica analytical column (25 x 4 mm) with a C18 guard.  The mobile 
phase consisted of HPLC grade methanol.  The flow rate was 0.8 mL/min, giving a 
column pressure of approximately 600psi and the retention time of ʱ-tocopherol was 
approximately 4 minutes.   
 
Stock solutions of ʱ-tocopherol were used to generate a standard curve.  92mg 
of  ʱ-tocopherol  was  weighed  out  and  dissolved  in  100  mL  methanol,  giving  a 
standard stock of 920 µg/m or 2.14mM.  Before preparing the standard curve, the 
stock solution was diluted in methanol to final concentrations of 2140µM, 1070µM, 
535µM, 268µM, 134µM, 67µM and 33µM.  The autosampler was programmed to 70 
 
inject  10µL  of  standards,  quality  control  and  samples.    The  autosampler  dilutor 
solution used was filtered and degassed 50% methanol and distilled water. 
 
Data collection and processing was via Viglen p5/166 Genie ATX and Jones 
Chromatography  software  (Jones  Chromatogarphy  Ltd,  Mid  Glamorgan,  UK).  
Linear  regression  was  carried  out  within  the  program.    The  quality  control  and 
unknown sample results were calculated from parameter values generated. 
 
Using this method allowed separation of ʱ and β-tocopherol individually but 
under the chromatographic conditions γ and ʴ-tocopherol could not be separated.  In 
the experiments performed throughout this thesis, we were primarily interested in ʱ-
tocopherol and measurement of γ and ʴ tocopherol was not relevant. 
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2.1.10 N-nitrosamine measurement 
 
Nitrosamine  analysis  has  improved  greatly  over  the  past  twenty  years  but 
nitrosamines  remain  technically  difficult  to  analyse,  due  the  range  of  chemical 
interactions that they can undergo.  It is considered best for volatile nitrosamines to 
be measured by gas chromatography (GC) mass spectrometry (MS) and ideally by 
tandem mass spectrometry.  Nitrosamines present several problems in terms of their 
analysis.    In  principle,  any  secondary  nitrogen  atom  can  be  nitrosated,  with  the 
resulting formation of the corresponding N- nitrosocompound.  The potential range 
of analytes is further increased by differences in the polarity, volatility, size and 
solubility of the molecule containing the N-nitroso moiety.  The nitrosamines that 
we are interested in are the volatile nitrosamines, as they are more widely implicated 
in biological tissues.   
 
Another problem is artefactual formation of the nitrosamine.  If the sample 
contains artefactual nitrite, formation of the N-nitrosocompounds may occur during 
the  analysis,  as  a  result  of  secondary  nitrogen  compounds  in  the  sample.    It  is 
therefore  necessary,  as  a  first  step,  to  destroy  the  nitrite  with  a  suitable  agent.  
Sulphamic acid is suitable for this and forms a nitrogen gas on reacting with the 
nitrite.  The sulphamic acid more rapidly destroys nitrite in the presence of an acidic 
pH and it is therefore important to make a solution of sulphamic acid that is acidic 
for  this  purpose.    In  our  experiments  we  use  a  solution  of  0.08  M  HCl  in 
combination with sulphamic acid and saturated NaCl solution.   72 
 
2.1.10.2 N-nitrosamine extraction from aqueous phase 
 
A 1 mL aqueous phase aliquot was added to 0.5 mL 0.08 M  HCl and 5% 
sulphamic acid solution in saturated 6 M NaCl, in a 2 mL glass tube.  This sample 
was then well mixed by inversion and 10 µL of the internal standard 0.01% NDBA 
was  added.    This  sample  was  again  mixed  well  before  adding  0.5  mL  of  an 
extraction solvent mix (45: 55 v/v dichloromethane: diethylether).  This sample was 
mixed and allowed to separate into two distinct layers.  The density of the extraction 
solvent  mix  was  1.03.   The  density  of  dichloromethane  on  its  own  is  such  that 
separation  of  the  aqueous  phase  from  the  solvent  phase  is  difficult,  therefore, 
diethylether is added. This meant that the solvent formed the upper layer, with the 
nitrosamine  extracted  into  the  solvent.    The  upper  layer  from  this  sample  was 
removed by glass pipette and transferred to a tapered glass vial.  The extraction was 
carried out twice.  The sample was concentrated under a gentle stream of nitrogen, to 
concentrate the sample down to 100 µL.  The glass vial was crimp capped and stored 
at -20
oC until further analysis. 
 
2.1.10.3 Extraction of N-nitrosamine from lipid phase 
 
A 500 µL sample was taken with a glass pipette from the lipid phase and 50 µL 
0.01% NDBA was added as an internal standard.  The lipid was then subjected to 
solid phase extraction, to remove the nitrosamines from the lipid tributyrin phase.  
The solid phase extraction process involved adding 1000 µL of dichloromethane to 73 
 
the lipid phase.  This was mixed and 500 µL of the lipid/dichloromethane mix was 
added  to  1.5  mL  of  hexane  before  further  mixing.    A  DSC-Diol  solid-phase 
extraction  cartridge  (500  mg,  3  mL)  (Phenomenex,  Macclesfield,  UK)  was  then 
conditioned with solvent before the lipid mix was eluted drop-wise into the column.  
The column was washed with 1 mL hexane.  The nitrosamines were eluted into a 
glass vial using 2.5 mL methanol.  The methanol nitrosamine mix was concentrated 
to 500 µL using 35
oC Gyro-vap (Howe, Banbury, UK) for 10 minutes.  The glass 
vial  was  crimp  capped  and  stored  at  -70
oC  before  analysis  by  tandem  mass 
spectrometry.  Only NPIP and NMOR were measured within the lipid phase due to 
difficulty with our solid phase extraction method for the more volatile nitrosamine 
NDMA.  
 
2.1.10.4  N-nitrosamine  analysis  by  gas  chromatography  tandem  mass 
spectrometry 
 
To  measure  N-nitrosamine  concentrations,  a  gas  chromatography  ion  trap 
tandem  mass  spectrometer,  on  a  TRACE  GC  2000  Series  gas  chromatograph 
(ThermoFinnigan,  Hemel  Hempstead,  UK)  interfaced  to  a  Polaris  Q  mass 
spectrometer (ThermoFinnigan, Hemel Hempstead, UK), was used.  On the mass 
spectrometer  there  was  an  AS2000  autosampler  and  programmable  temperature 
vaporising (PTV) injector.   
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The N-nitrosamines within a sample were separated by chromatography on a 
ZB-5MS’fused silica capillary column, internal diameter 30m x 0.25mm, 0.5µm fill 
thickness (Phenomenex, Macclesfield, UK)). The oven temperature programme was 
as follows: 37
oC (held for 2 minutes) to 160
oC at 10
oC/min, to 250
oC at 30
oC/min 
(held for 2 minutes).  Helium was used as a carrier gas, at a flow rate of 1ml/min.  
The PTV injector was programmed from 36
oC to 115
oC (held for 2 minutes) at 
10
oC/min and a pressure of 22psi, prior to a cleaning phase at 325
oC (held for 12 
minutes).   
 
Acquisition and treatment of data obtained was performed on Xcalibur version 
2 (ThermoFinnigan, Hemel Hempstead, UK).  All samples were spiked with 10µL 
internal  standard  (0.01  NDMA),  and  tandem  mass  spectrometer  spectra  were 
calibrated with spiked standard N-nitrosamines solutions, covering concentrations 
from 0-70 µM.  The response was linear for the concentrations studied. 
 
A  standard  trace  obtained  for  NDMA,  NDEA,  NDBA,  NPIP  and  NMOR 
standards is shown in figure 2.5.  The amount of N-nitrosamine present is shown by 
the area under the curve.  It is from the area under the curve that calculations can be 
made  of  how  much  actual  sample  is  present,  adjusting  for  differences  between 
individual nitrosamines.  Calculations are also based on a correction factor for the 
internal standard.  There is therefore both an internal and external standard.   
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Figure 2.5:  Chromatogram of GC-MS/MS for the N-nitrosamine standards.  Due to 
different  volatilities  and  mass  of  daughter  compounds,  the  various 
nitrosamines  have  different  retention  times  within  the  mass 
spectrometer  and  are  detected  at  different  times.  Their  abundance  is 
shown  on  the  y  axis  representing  the  signal  intensity.  (RT=retention 
time, AA=area under curve, SN=signal intensity). 
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2.2 Materials - Chemical Reagents Used   
 
Sigma-Aldrich (Poole, UK) 
Acetonitrile HPLC grade (15%), Ascorbic acid, Butylated hydroxytoluene (BHT), 
Copper  nitrate  (Cu(NO3
-)2),  Dichloromethane,  Diethylether  Flavin  adenine 
dinucleotide  (FAD),  Glutathione  Hexane,  Hydrochloric  acid,  Dibasic  potassium 
phosphate  (K2HPO4),  Metaphosphoric  acid  (2%),  N  1-Naphthylethylenediamine 
dihydrochloride (NEDD), N-acetyl cysteine (NAC), Nitrate reductase, Octylamine 
(0.1M),  Phosphate  buffer  solution  (PBS),  Phosphoric  acid  (H3PO4),  Potassium 
iodide (KI), Pronase E from Streptomyces griseus, Sodium acetate, Sodium nitrate 
(NaNO3
-), Sodium nitrite (NaNO2
-), Sodium thiocyanate (NaSCN), Sulphamic acid 
(0.5%),  Sulphanilamide,  Sulphuric  acid  (H2SO4),  Triacetin  (Glyceryl  triacetate), 
Tributyrin  (Glyceryl  tributyrate),  ʱ-tocopherol,β  Nicotinamide  dinucleotide 
phosphate (NADPH), β-carotene  
 
Qmx Laboratories (Thaxted, UK) 
N-nitrosodibutylamine,  N-nitrosodiethylamine,  N-nitrosodimethylamine,  N-
nitrosomorpholine, N-nitrosopiperidine  
 
Bio-Rad (UK) 
Bio-Rad Protein Assay Kit 
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BDH Ltd (Liverpool, UK) 
EDTA 
 
Rathburn Chemicals (UK) 
Methanol (HPLC grade) 
 
RA Lamb Ltd (Eastbourne, UK) 
Whatman No1 paper 
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2.3 Statistical Methods  
 
Using  online  statistical  software,  Smiths  Statistical  Package,  median  values 
with 1
st and 3
rd quartile values were obtained.  Where appropriate, the data was 
analysed in this way to allow for inter individual variation to be shown without 
altering  the  statistical  pattern  of  results.    Statistical  significance  was  determined 
using  a  1-sample  Wilcoxon  test  for  paired  data  and  Mann-Whitney  U  test  for 
unpaired data.   
 
Smith  Statistical  Package  was  also  used  to  obtain  mean  values,  standard 
deviation and analysis of variance (F Statistics for p value analysis).   
 
Correlation  analysis  was  performed  using  Mini  Tabs  statistical  analysis 
software  to  determine  Spearmans’  rank  correlation  coefficient  (p  value)  for  non 
parametric rank testing  and Pearson  coefficient of correlation (r
2) for  parametric 
testing. 
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Chapter 3  Nitrosamine formation in a single and two-phase model 
representing the healthy gastroesophageal junction  
 
3.1 Introduction 
 
The relationship between dietary nitrate and ascorbic acid induced nitrosative 
stress,  at  the  gastroesophageal  junction  and  cardia  of  the  stomach,  has  been  the 
subject  of  increasing  research  (43,44,144,221,238,239).    It  had  previously  been 
thought that nitrosative stress was inhibited within the upper gastrointestinal tract by 
ascorbic acid (240-242).  This is explained by the antioxidant effect of ascorbic acid 
on nitrite, forming NO within the lumen.  However, in the upper gastrointestinal 
tract there is both a luminal compartment and a lipid rich environment.  There are 
two major sources of lipids:  the first is the mucosa where there is both a lipid 
bilayer formed by epithelial cells, which also creates intraepithelial compartments, 
and there is also lipid within the cells.  A high intracellular fat content is found in 
intestinal  metaplastic  epithelium  (243),  the  same  epithelium  in  which  there  is 
development  of  gastroesophageal  junction  cancers.    Unlike  normal  gastric  or 
oesophageal  epithelium,  intestinal  metaplasic  epithelium  absorbs  luminal  fat,  a 
process facilitated by bile salts (243).  As well as lipids from the mucosa, it has been 
shown  that  lipids  sit  within  the  more  proximal  region  of  the  stomach  in  the 
postprandial state (244).  There are, therefore, two potential areas where lipid will 
alter the chemistry within the upper gastrointestinal tract.   
 80 
 
The aim of this study was to generate a model to simulate the chemistry at 
the gastroesophageal junction and cardia of the stomach, that allowed the addition of 
a lipid phase, to examine the effect this had on the nitrosative chemistry.  The model 
prepared would also allow chemical manipulation of the lipid phase. 81 
 
3.2 Experimental design 
 
 
3.2.1 Bench Top Model 
 
A bench top model was designed to enable us to study the influence of lipid 
on  the  nitrite  chemistry  occurring  when  nitrite  swallowed  in  saliva  encounters 
gastric acid (figure 3.1).  The model consisted of a 250 mL specially designed glass 
beaker containing 50 mL HCl pH 1.5 representing the stomach.  The pH of 1.5 was 
chosen  as  it  has  previously  been  shown  that  this  is  the  pH  in  the  post  prandial 
situation in the proximal region of the stomach (245).  NaSCN (1mM) was also 
added to the gastric compartment, representing its physiological  concentration in 
gastric juice.  EDTA (1mM) was added to chelate metals known to be present in 
chemical reagents.  Secondary amines were added to the aqueous solution to allow 
us to monitor N-nitrosation, by measuring the generation of N-nitrosamines.  The 
secondary  amines  used  were  one  of  morpholine  (5mM),  piperidine  (5mM)  or 
dimethylamine (5mM).  Experiments were performed with and without ascorbic acid 
(1mM).   
 
To  investigate  the  influence  of  lipid,  studies  were  undertaken  with  and 
without lipid added to the acidic aqueous solution.  Two different lipids were used, 
tributyrin (glyceryl tributyrate) and triacetin (glyceryl triacetate).  These two lipids 
both  have  a  higher  density  than  water  and  sink,  forming  a  layer  in  the  case  of 
triacetin, and a globule in the case of tributyrin, in the bottom of the beaker.  The 
lipid was added by slowly injecting the lipid out of a syringe with a 21 gauge needle  82 
 
  
 
Figure 3.1:  Bench  top  model  used  to  represent  the  gastroesophageal  junction  in 
single and two-phase models.  The aqueous phase total volume was 50 
mL,  consisting  of  HCl  (pH  1.5),  NaSCN  (1  mM),  EDTA  (1  mM), 
secondary  amine  (5  mM)  and  NaNO2  (range  of  concentrations)  ± 
ascorbic acid (1 mM).  To create a two-phase model a lipid (tributyrin 
or triacetin) was added. 
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(outer  diameter  0.813mm,  internal  diameter  0.495mm)  into  the  bottom  of  the 
aqueous phase. Varying volumes of lipid were added, giving ratios of aqueous to 
lipid ranging from 50:1 to 5:1.  The majority of the studies were performed with a 
ratio  of  10:1  aqueous  to  lipid,  as  this  is  most  likely  to  represent  the  luminal 
conditions  of  the  upper  part  of  the  stomach.    It  is  known  that  20-30%  of  solid 
ingested food is present as a form of fat.  This will also be diluted by gastric juices, 
hence the reason we chose 10% as a percentage of fat to other contents in the model 
stomach.    Secondary  amines  were  also  added  to  the  lipid  phase  in  some  of  the 
experiments.    The  three  secondary  amines  (morpholine,  piperidine  or 
dimethylamine), were added to the lipid phase, at a concentration of 5mM.  The 
experiments were all performed at 37
oC, for a time period of 15 or 60 minutes.  The 
contents of the beaker were constantly stirred using a magnetic stirrer suspended in 
the aqueous phase.  The experiments were initiated by adding NaNO2 (100 µM). 
 
Throughout the study dissolved O2 and NO concentrations were monitored in 
the aqueous phase, using the probes and sensors as described in Chapter 2.1.1 and 
2.1.2.  Samples (100 µL) were obtained at 0, 1, 2, 5, 10, and 15 minutes after adding 
nitrite, for determination of ascorbic acid and total vitamin C.  At the end of the 15 
minute  experiment,  a  1  mL  aqueous  sample  was  removed  for  N-nitrosamine 
measurement.  A 500 µL sample of the lipid phase with ascorbic acid present, from 
experiments  involving  piperidine  and  morpholine,  was  taken  at  15  minutes  for 
analysis of the nitrosamine content in the lipid phase.   In experiments lasting 60 
minutes a 500 µL aqueous sample was taken at times 15 and 60 minutes. 84 
 
 
3.2.2 Increasing the surface area of the lipid phase 
 
As  well  as  having  the  tributyrin  lipid  phase  present  as  only  one  single 
globule at the bottom of the beaker, a model was also created where several globules 
of tributyrin were present.  Tributyrin was injected into the aqueous phase using a 
needle and syringe.  In order to create different globules the injection had to be 
started and stopped such that the 5 mL volume was separated into four equal parts of 
1.25 mL.  These four globules then had to remain distinct and not coalesce during 
the 15 minutes over which the experiment was run for the results to be recorded.  
NO and O2 concentrations were monitored and samples were taken for ascorbic acid 
and N-nitrosamine, as previously described. 
 
3.2.3 Triacetin as the lipid phase 
 
Experiments  were  performed  using  the  lipid  triacetin  as  a  substitute  for 
tributyrin.  Like tributyrin, triacetin has a higher density (d=1.16 g/mL at 25
oC)) than 
water and therefore sinks into the aqueous phase.  A difference with triacetin is, that 
rather than forming a globule, it sinks to the bottom of the beaker model to form a 
bottom layer.  Experiments were then performed as for tributyrin, although we were 
unable to form globules with this lipid. 85 
 
3.3 Results 
 
3.3.1 Studies in aqueous solution with no lipid (single phase model) 
 
3.3.1.1 In the absence of ascorbic acid 
 
When nitrite was added to HCl pH 1.5 containing thiocyanate (1mM) but without 
ascorbic acid, nitrosation of the secondary amines was observed.  After 15 minutes 
6.71 (±0.82) µM NMOR, 0.014 (±0.005) µM NPIP and 0.58 (±0.21) µM NDMA 
were present (figure 3.2).  In these experiments, the addition of nitrite produced only 
a very small increase in the concentration of  NO.  This increase was small and 
steady throughout the 15 minutes of the experiment, to a maximal concentration of 2 
µM (figure 3.3).  There was only a small decline over time of the O2 concentration 
from 180 µM to 175 µM (figure 3.3).  
 
3.3.1.2 In the presence of ascorbic acid 
 
The presence of ascorbic acid markedly inhibited the nitrosation of each of 
the  secondary  amines.    The  concentration  of  each  N-nitrosamine  formed  was 
significantly less for each amine (figure 3.2). NMOR and NDMA concentrations 
were just over 5% of the total found in the absence of ascorbic acid, with mean 
values of 0.37 (±0.08) µM and 0.03 (±0.01) µM, while the concentration for NPIP 
was only 0.01 (±0.005) µM compared to 0.014 (±0.005) µM. 86 
 
In the presence of ascorbic acid (1mM), the addition of nitrite produced a 
rapid increase, followed by slow decline in NO concentrations.  Within 60 seconds 
of adding nitrite (100µM) the dissolved NO concentration was approximately 80µM.  
This rapid rise in NO was followed by a rapid fall in the dissolved O2 concentration.  
Within  60  seconds  of  adding  the  nitrite,  no  dissolved  O2  was  detected  until  10 
minutes  later,  when  the  concentration  slowly  increased  to  reach  5–10%  of  its 
maximal concentration (figure 3.4). 
 
The addition of nitrite also produced a fall in the ascorbic acid concentration.  
It rapidly fell from its original concentration of 970 (± 75) µM to 580 (±40) µM at 2 
minutes and then slowly fell to 480 (± 40) µM at 15 minutes (Figure 3.5). 
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Figure 3.2:  N-nitrosamine  (µM)  produced  in  a  single  phase  system,  both  in  the 
presence (red column) and absence (blue column) of ascorbic acid (1 
mM),  for  the  three  secondary  amines  morpholine,  piperidine  and 
dimethylamine, after the addition of nitrite (100 µM). Data labels show 
mean  nitrosamine  concentration.    Error  bars  represent  1  standard 
deviation. (n=18) 
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Figure 3.3:  Mean NO (blue line with diamond markers) and O2 concentrations (red 
line with square markers) in a single phase system, after the addition of 
nitrite (100µM) over 15 minutes (n=18) 
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Figure 3.4:  Aqueous  NO  and  aqueous  O2  concentrations  in  a  two-phase  model 
representing the chemistry occurring at the gastroesophageal junction, 
after the addition of sodium nitrite (100 µM).  The acidic aqueous phase 
contained  the  aqueous  antioxidant  ascorbic  acid  to  an  excess 
concentration  of  1000  µM.    The  experiment  was  performed  over  15 
minutes. (n=18) 
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Figure 3.5:  Ascorbic acid and dehydroascorbic acid concentrations in a two-phase 
model  representing  the  chemistry  occurring  at  the  gastroesophageal 
junction  after  the  addition  of  sodium  nitrite  (100  µM).    The  acidic 
aqueous phase contained the aqueous antioxidant ascorbic acid, to an 
excess concentration of 1000 µM, at initiation of the experiment.  The 
experiment was performed over 15 minutes. (n=18) 
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3.3.2 Studies in aqueous solution containing 10% tributyrin globule (two-phase 
model) 
 
3.3.2.1  Aqueous  phase  in  absence  of  ascorbic  acid  with  amine  in  both   
phases (two-phase model) 
 
When  nitrite  was  added to  HCl pH 1.5  containing thiocyanate (1 mM), no 
ascorbic acid and a 10% globule of tributyrin, nitrosation of the secondary amines 
was observed.  The concentrations generated were different from those found in the 
single  phase  study  in  the  absence  of  ascorbic  acid  (p<0.001)  although  the  same 
pattern was seen. Aqueous phase mean concentrations observed were 4.33 (±0.8) 
µM NMOR, 0.19 (±0.07) µM NPIP and 0.64 (±0.29) µM NDMA (figure 3.6).  
 
3.3.2.2  Aqueous  phase  in  presence  of  ascorbic  acid  with  amine  in  both 
phases (two-phase model) 
 
In marked contrast to the observations in the absence of the lipid globule, the 
addition  of ascorbic  acid did  not  inhibit the generation of  N-nitrosamines  in  the 
presence  of  the  lipid  globule.    Indeed,  in  the  presence  of  the  lipid  globule,  the 
ascorbic  acid  actually  increased  the  concentration  of  N-nitrosamine  formed.  The 
degree to which this happened varied with the different secondary amines.  The 
concentration of NMOR formed in the absence of ascorbic acid (4.82 µM ± 0.60 
µM)  was  only  slightly,  and  not  significantly,  higher  than  that  in  the  absence  of 92 
 
ascorbic acid.  However, the concentration of NDMA formed in the presence of 
ascorbic acid (2.18 µM ± 0.31 µM) was approximately four fold higher than in the 
absence of ascorbic acid.  The most dramatic effect occurred with piperidine, where 
the concentration of NPIP formed in the presence of ascorbic acid (6.15 µM ± 0.54 
µM) was thirty-two fold higher than in the absence of ascorbic acid (figure 3.6). 
 
In the presence of lipid, the addition of nitrite produced similar changes in 
the concentrations of NO, O2 and ascorbic acid to those seen in the absence of lipid.   
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Figure 3.6:  Aqueous N-nitrosamine (µM) produced in a two-phase system, both in 
the presence (red column) and absence (blue column) of ascorbic acid, 
for the three secondary amines morpholine (MOR), piperidine (PIP) and 
dimethylamine (DMA), after the addition of 100µM nitrite.  The second 
phase  is  formed  by  the  lipid  tributyrin  in  a  ratio  of  1:10  with  the 
aqueous  phase  volume.  Error  bars  represent  1  standard  deviation. 
(n=18) 
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3.3.2.3 Aqueous phase N-nitrosamine in absence of ascorbic acid with amine 
(5mM) in aqueous phase only (two-phase model) 
 
The concentrations of N-nitrosamine generated in the aqueous phase were not 
significantly lower for NMOR and NDMA, than when the amine was present in both 
phases in the absence of ascorbic acid.  The mean concentrations formed for the 
individual nitrosamines were 3.90 (±0.42) µM NMOR and 0.41 (±0.15) µM NDMA.  
This compares to 4.33 (±0.8) µM for NMOR and 0.64 (±0.29) µM for NDMA when 
amine was present in both phases.  However, there was significantly less NPIP when 
the amine was present only in the aqueous phase as compared to when it was in both 
phases.    The  mean  NPIP  concentration  when  piperdine  was  present  ony  in  the 
aqueous phase was 0.013 (±0.02) µM compared to 0.19 (±0.07) µM when piperidine 
was present in both phases (p=0.0003). 
 
3.3.2.4 Aqueous phase N-nitrosamine in absence of ascorbic acid with amine in 
lipid phase only (two-phase model) 
 
The concentrations of NMOR and NDMA were nearly half those seen when 
amine  was  present  in  both  phases  in  the  absence  of  ascorbic  acid.    The  mean 
concentrations of NMOR and NDMA generated were 2.64 (±0.37) µM and 0.31 
(±0.15)  µM  respectively.  The mean concentration of NPIP  was  not statistically 
different from those seen when amine was in both phases in the absence of ascorbic 
acid, with a mean concentration of 0.24 (±0.09) µM. 95 
 
3.3.2.5 Aqueous phase N-nitrosamine in presence of ascorbic acid with amine in 
aqueous phase only (two-phase model) 
 
There was a dramatic reduction in the nitrosamines formed in this system 
with amine present in the aqueous phase only, as compared to the same model but 
with amine present in both phases.  The mean NMOR concentration in the aqueous 
phase at 15 minutes was only 0.08 (±0.01) µM, the lowest concentration of NMOR 
found in any of the experiments.  Mean NPIP and NDMA concentrations were also 
very low, with mean values of only 0.01 (±0.01) µM and 0.02 (±0.01) µM generated 
within this system, suggesting little partitioning of these amines in that time period. 
 
3.3.2.6 Aqueous phase N-nitrosamine in presence of ascorbic acid with amine in 
lipid phase only (two-phase model) 
 
The concentrations in these experiments were the closest of any where the 
amine was omitted from one phase compared to when amine was present in both.  
The  mean  concentrations  of  NMOR,  NPIP  and  DMA  in  this  model  were  not 
significantly different when compared to concentrations in a two-phase model in the 
presence  of  ascorbic  acid  with  amine  present  in  both  phases.    The  mean 
concentrations were 4.20 (±0.66) µM, 6.43 (±0.85) µM and 2.12 (±0.58) µM for 
NMOR, NPIP and NDMA respectively. 
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3.3.2.7 Lipid phase in the presence of ascorbic acid (1mM) with amine in both 
phases (two-phase model) 
 
Measurement of N-nitrosamine concentration was undertaken in two-phase 
15 minute experiments, where ascorbic acid  (1mM) was present, fifteen minutes 
after the addition of sodium nitrite (100µM).  N-nitrosamines measured in the lipid 
phase  were  present  in  higher  concentrations  than  in  the  corresponding  aqueous 
phase.  The mean NMOR present in lipid was 11.5 fold higher (55.3 ± 6.7µM) and 
NPIP 17.8 fold higher (109.7 ± 17.5µM) than that of the aqueous phase with amine 
present in both phases in the presence of ascorbic acid (1mM).    
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3.3.3  Aqueous  phase  N-nitrosamine  in  two-phase  studies  wth  ascorbic  acid 
present with prolonged time period 
 
When experiments were allowed to run for 60 minutes rather than just 15 
minutes  there  was  a  significant  increase  in  N-nitrosamine  production.    The 
concentration increase however, was not proportional to the increase in time.  There 
was just over double the concentration of NMOR and NPIP when the time interval 
was increased four fold.  The mean NMOR concentration at 60 minutes was 10.14 
(±1.12)  µM  compared  to  4.82  (±0.6)  µM  after  15  minutes.    The  mean  NPIP 
concentration increased from 6.15 (±0.5) µM at 15 minutes to 14.02 (±1.84) µM at 
60 minutes.  During this time NO and O2 were both still present, as was ascorbic 
acid.    The  NO  concentration  gradually  fell  to  approximately  15µM,  while  O2 
concentrations were 100 µM at the end of the 60 minute experiment.  Ascorbic acid 
continued to be gradually consumed but there was still 220 (±36) µM present at the 
end of the 60 minute experiment. 
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3.3.4  Two-phase studies with different volumes of tributyrin in the presence of 
ascorbic acid with amine in both phases 
 
Increasing the ratio of the lipid phase tributyrin to the acidic aqueous phase 
increased the concentration of N-nitrosamine produced in the aqueous phase at 15 
minutes.    For  all  three  of  the  N-nitrosamines  examined,  there  was  a  non  linear 
relationship  between  the  volume  increase  in  tributyrin  and  concentration  of  N-
nitrosamine  produced.    For  NMOR,  the  mean  concentration  produced  increased 
from 2.03 (±0.5) µM with a ratio of 1:50 to 4.82 (±0.6) µM with a ratio of 1:10.  The 
concentration of NMOR produced was greater again when a ratio of 1:5 was used 
with  8.74  (±0.72)  µM  produced  giving  over  a  four  fold  increase  in  NMOR 
production  when  increasing  the  lipid  volume  ten  fold.    There  were  similar 
percentage increases in NPIP and NDMA concentrations with increasing tributyrin 
to aqueous ratios.   NPIP concentrations increased from 2.75 (±0.30) µM to 6.15 
(±0.51) µM when the tributyrin ratio was increased from 1:50 to 1:10 and to 10.26 
(±0.52) µM when the ratio was increased further to 1:5.  The rise in concentration of 
NDMA  with  increasing  volumes  of  tributyrin  followed  a  similar  pattern,  with 
concentrations 0.80 (±0.29) µM, 2.18 (±0.0.31) µM and 3.82 (±0.57) µM NDMA in 
experiments  with  tributyrin  to  aqueous  ratios  of  1:50,  1:10  and  1:5  respectively 
(figure 3.7). 
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Figure 3.7:  N-nitrosamine  production  with  ascorbic  acid  present  in  a  two-phase 
system with different ratios of lipid to aqueous phase.  The ratio was 
altered by adjusting the volume of lipid placed in the aqueous solution.  
The three ratios assessed were 1:5 (blue column), 1:10 (red column) and 
1:50 (green column).  The aqueous solution remained at a fixed 50mls.  
One of three secondary amines (5mM) was present in both aqueous and 
lipid  phases:  morpholine  (MOR),  piperidine  (PIP)  or  dimethylamine 
(DMA).  The corresponding N-nitrosamine concentration was measured 
from the aqueous phase.  The mean values are annotated and the error 
bars represent 1 standard deviation.  (n=12) 
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3.3.5  Two-phase studies with varying surface area of lipid in the presence of 
ascorbic acid with amine in both phases 
 
With  the  greater  surface  area  provided  by  the  division  of  the  volume  of 
tributyrin  into  smaller  globules,  there  was  a  significant  increase  in  the  aqueous 
concentration of N-nitrosamine produced.  For both NMOR and NPIP there was a 
more than two fold increase in the production of the nitrosamine.  The mean NMOR 
concentration was increased from 4.82 (±0.60) µM when a single lipid globule was 
present to 9.93 (±0.72) µM when the same total volume of tributyrin was divided 
into four globules, in a 15 minute experiment.  A similarly significant increase in 
mean NPIP concentration was observed with 13.25 (±1.11) µM NPIP formed when 
4 globules were present compared to 6.15 (±0.54) µM with a single globule (figure 
3.8). 
 
There  was  no  measurable  statistically  significant  difference  in  NO  and  O2 
concentration within the aqueous phase in the presence of four globules of tributyrin 
compared to a single globule (data not shown). 
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Figure 3.8:  Mean  N-nitrosamine  concentrations  (µM)  from  two-phase  model 
experiments  where  the  lipid  phase  is  either  a  single  globule  (blue 
column), or the tributyrin is divided into four globules (red column).  
These  experiments  were  performed  for  two  secondary  amines, 
morpholine  (MOR)  and  piperidine  (PIP),  with  the  corresponding 
nitrosamine measured from the aqueous phase.  Experiments were run 
over  15  minutes  after  the  addition  of  100µM  nitrite  to  an  acidic 
aqueous phase containing 1mM ascorbic acid.  Error bars represent 1 
standard deviation. (n=12) 
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3.3.6 Triacetin as the lipid phase 
 
In two-phase studies where the lipid triacetin was used in place of tributyrin 
as the lipid phase, very similar results were observed.  In the absence of ascorbic 
acid, mean concentrations of NMOR, NPIP and NDMA in the aqueous phase were 
4.13 (0.30) µM, 0.11 (0.02) µM and 0.42 (0.17) µM.  In the presence of excess 
ascorbic acid there was a mean NMOR concentration of 4.21 (0.44) µM, mean NPIP 
concentration of 5.28 (0.63) µM and a mean NDMA concentration of 1.84 (0.28) 
µM,  15  minutes  after  the  addition  of  100  µM  nitrite.    These  results  are  not 
statistically different from the results from experiments using tributyrin as the lipid 
phase. 
 
NO,  O2  and  ascorbic  concentrations  were  all  comparable  in  experiments 
where triacetin was used in place of tributyrin (data not shown). 
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3.4 Discussion 
 
These  studies  indicate  that  the  presence  of  lipid  profoundly  alters  the 
nitrosative  chemistry  in  the  bench  top  model.    The  lipid  is  able  to  convert  the 
influence  of  ascorbic  acid  from  one  that  protects  against  nitrosation  to  one  that 
promotes it.  This effect is due to the ability of the NO formed by the ascorbic acid 
within the aqueous phase to regenerate nitrosative species within the lipid. 
 
In  the  studies  performed  without  lipid,  and  without  ascorbic  acid,  the 
addition of nitrite to HCl pH 1.5 containing thiocyanate resulted in nitrosation of the 
three secondary amines.  The main nitrosating species formed under these conditions 
is NOSCN (137,223,246).  It reacts with the secondary amine, in its unprotonated, 
uncharged state (247).  The amount of the secondary amine, in its nitrosatable form, 
depends upon its –log dissociation constant (pKa).  The pKa of the amines studied is 
8.33  for  morpholine,  10.68  for  dimethylamine  and  11.123  for  piperidine.    The 
amount of the secondary amine in a form available for nitrosation by NOSCN will, 
therefore, be greatest for morpholine and least for piperidine. The differences in pKa 
can partly explain why different concentrations of the three N-nitrosamines were 
generated.   
 
In the above experiments performed in the absence of lipid, the addition of 
ascorbic acid effectively prevented the nitrosation of the three amines.  This can be 
explained by the ascorbic acid competing with the secondary amines for the NOSCN 104 
 
(239,240).  In the reaction between ascorbic acid and NOSCN, the latter is reduced 
to NO and the former oxidised to dehydroascorbic acid.  Consistent with this, we 
observed a rapid rise in the concentration of  NO and a fall in the ascorbic acid 
concentration.  There was also a rapid fall in the O2 concentration.  This can be 
explained by the NO reacting with dissolved O2 to form N2O3 (248,249).  The N2O3 
formed  in  this  way  is  a  nitrosating  species  and  again  preferentially  reacts  with 
ascorbic acid and is reduced back to NO (243).  This recycling continues until either 
the O2 or the ascorbic acid is consumed.  Under our experimental conditions the O2 
was the first to be depleted.  Stoichemically one mole of ascorbic acid can reduce 
two moles of nitrite to NO.  The greater consumption of ascorbic acid observed is 
due to this recycling of NO. 
 
In the presence of the lipid, nitrosamines were formed despite the presence of 
ascorbic acid.  Indeed, the concentrations of the nitrosamines formed were higher in 
the experiments  with  lipid  and ascorbic acid  than experiments  without lipid  and 
without  ascorbic  acid.    This  was  particularly  the  case  for  NPIP,  where  the 
concentrations formed in the experiments  with ascorbic  acid  and lipid  were 440 
(6.15 μM in the presence of lipid versus 0.014μM in the absence of lipid) times 
higher than those without lipid and without ascorbic acid.  Though the presence of 
lipid markedly altered the amount of the nitrosamine formed in the experiments with 
ascorbic acid, it did not alter the changes in the concentrations of NO, O2 or ascorbic 
acid. 
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What is the explanation for the ability of the lipid to convert the effect of the 
ascorbic  acid  from  being  an  inhibitor  to  a  promoter  of  nitrosation?    The  effect 
observed is likely to be mediated by the NO produced by the reaction between the 
ascorbic acid and the nitrosating species.  In the absence of the lipid this NO can 
react  with  O2  to  form  the  nitrosating  species  N2O3  (248,249).    However,  in  the 
aqueous phase the N2O3 formed in this way does not nitrosate the secondary amines 
as it preferentially reacts with the ascorbic acid which reduces it back to NO (243).  
The ascorbic acid, in the aqueous phase, thus protects against nitrosation by both the 
nitrosating species NOSCN, formed by the acidification of nitrite in the presence of 
the thiocyanate, and by N2O3 formed by the NO (produced by the reaction between 
NOSCN and ascorbic acid) and O2 (250).  However, when a globule of lipid is 
present, the NO, formed by the reaction between the nitrosating species and ascorbic 
acid, diffuses into the lipid and within it reacts with O2 to form N2O3.  As ascorbic 
acid is not lipid soluble, it will be unable to enter the lipid and, thus, the N2O3 
generated within the lipid will be able to nitrosate the secondary amines within the 
lipid.  The N-nitrosamines generated within the lipid in this way will then diffuse out 
of the lipid  and produce the  rise in  their  concentration observed in the aqueous 
compartment. 
 
The potential of NO to generate nitrosating species by reacting with O2 was 
recognised many years ago.  More recently the potential for this reaction to occur 
preferentially within lipids was recognised.  Liu et al (251) demonstrated that the 106 
 
reaction between NO and O2 was 300 times faster in lipid than in aqueous solutions 
and that this was due to the increased solubility of both gases in lipids. 
 
These  studies  also  indicated  that  the  relative  extent  to  which  the  lipid 
promoted nitrosation varied between the different secondary amines studied.  In the 
absence of lipid and absence of ascorbic acid, morpholine was nitrosated to a greater 
extent than dimethylamine and the latter more than piperidine.  As discussed above, 
this can be explained by their different pKa and, consequently, the proportion present 
in protonated form, with the resulting susceptibility to nitrosation by NOSCN and 
N2O3.  However, in the studies with lipid and with ascorbic acid, piperidine was 
nitrosated more than morpholine and the latter more than dimethylamine.  Previous 
studies have shown that this nitrosation of secondary amines in organic solvents is 
unrelated to their pKa (253).  The relative lipid solubility of both the amine and N-
nitrosamine may explain the results observed.  Piperidine is the most hydrophobic 
and therefore more of the secondary amine is likely to accumulate in the lipid phase, 
compared to morpholine and dimethylamine (252).   
 
The importance of the nitrosation occurring within the lipid can be seen in 
the  two-phase  experiments,  where  the  availability  of  the  secondary  amine  was 
changed from being in both phases to being present in one or other of the lipid or 
aqueous phase.  When the amine was present in the lipid phase only, in the presence 
of ascorbic acid, the concentrations of the three N-nitrosamines produced was not 
significantly different from those observed when amine was in both phases of the 107 
 
model.   When  the  amine  was  present  only  in  aqueous  phase  in  the  presence  of 
ascorbic acid the concentrations of the N-nitrosamines were only just detectable.  
This also shows that the partitioning of these amines into the lipid phase does not 
occur, as these experiments took place over 15 minutes.  If there had been more 
rapid partitioning of amine into the lipid phase, then it could be expected that more 
amine would have been nitrosated and hence detectable after 15 minutes.   
 
    These  studies  also  show  that  changing  the  surface  area  and  therefore  the 
interface between the aqueous and lipid phase, has an effect on the concentration of 
N-nitrosamine generated.  By simply increasing the surface area, by splitting one 
lipid  globule  into  four,  around  double  the  concentration  of  N-nitrosamine  was 
generated.  This suggests that the increased surface area allows more NO to diffuse 
over and also increases the diffusion back into the aqueous phase of generated N-
nitrosamine,  dependent  on  its  partition  co-efficient.    This  has  relevance  for  the 
situation we would expect to find in vivo.  There are two potential situations in the 
upper gastrointestinal tract where this lipid chemistry is important.  Firstly, with 
regard to ingested fat in foodstuffs (244), and secondly in relation to lipid within the 
surrounding epithelial cells (243).  As regards ingested fat, it is unlikely that all of 
this will sit as one globule within the proximal stomach but rather would be expected 
to form a larger surface area by being split up.  The other area of lipid is within the 
epithelial layer of cells in the gastric cardia and the gastroesophageal junction.  The 
surface area here is potentially very large, giving more in the way of an interface 
between the aqueous and lipid phases, thus allowing increased NO diffusion into the 108 
 
epithelial cells.  The ratio of lipid to aqueous phase also makes a difference to the 
generation of N-nitrosamine.  This may simply be due to the larger surface area of 
the globule resulting from the increased volume since the increase in total volume is 
not  matched  by  a  proportionate  increase  in  the  N-nitrosamine  generated.    These 
studies highlight the importance of the interface between the lipid and aqueous phase 
for the nitrosative chemistry occurring.  
 
The explanation of why the presence of lipid lowers the concentration of 
NMOR found at 15 minutes is not entirely clear.  In these two-phase model studies 
in the presence of ascorbic acid, where morpholine is replaced by piperidine, the 
concentration of piperidine is slightly higher than in a single phase model, while 
when dimethylamine is substituted as the amine there is no statistical difference.  It 
would be attractive to suggest from these studies that NMOR has a higher affinity 
for  lipid  than  the  other  two  N-nitrosamines.    However,  NMOR  has  a  low  lipid 
solubility  while  the  the  lipid  solubility  of  NPIP  is  the  highest  of  the  three  N-
nitrosamines  used  in  this  study  (ClogP  0.73  compared  with  ClogP  of  -.033  for 
NMOR and 0.01 for NDMA).  It is therefore not clear why the NMOR present in the 
aqueous phase is significantly lower in the absence of ascorbic acid in a two-phase 
model compared to a single phase model.  Differences in partitioning of the amines 
and  N-nitrosamines  between  the  lipid  and  aqueous  phase  may  contribute  to  the 
differences.  It is important to note that partition coefficients into a lipid may not 
fully represent what will happen in vivo.  This is because, for small nonelectrolytes, 
Overton’s  rule  of  permeability  coefficients  correlating  well  with  oil/water 109 
 
coefficients cannot be applied to lipid bilayer membranes.  The membrane behaves 
more like a polymer than a liquid hydrocarbon (254). 
 
Within the lipid phase of two-phase studies, the measured NMOR and NPIP 
were significantly higher than the concentrations found in the aqueous phase, in the 
presence of ascorbic acid.  The mean concentration of lipid NMOR was 11.5 times 
higher than aqueous concentrations and mean NPIP lipid concentration was 17.8 
times  higher  than  aqueous    There  were  technical  difficulties  measuring  NDMA 
using the methods described above.  However, further published work shows that 
NDMA concentrations are also higher in the lipid phase as compared to the aqueous 
phase (255) when a suitable method of measuring NDMA within the lipid was used.  
This once again suggests that the generation of N-nitrosamines is occurring within 
the lipid layer.  The proposed mechanism for this is shown in figure 3.9.  The higher 
percentage increase in NPIP formation over NMOR formation can be explained by 
the lipophilicity of both piperidine and NPIP being higher than the lipopholicity of 
morpholine and NMOR (253).  This means that there will be more amine present 
within the lipid to be nitrosated by NO and its nitrosating products, and also that the 
N-nitrosamine generated within the lipid is more likely to stay within the lipid layer 
than diffuse into the aqueous phase. 
 
The shift in nitrosative chemistry from the aqueous to the lipid phase in the 
presence of ascorbic acid is not confined to one form of lipid.  The results discussed 
so far have related to tributyrin.  However, when triacetin replaced tributyrin in two-110 
 
phase  models,  nitrosative  stress  was  again  shown  when  NO  was  formed  from 
acidified nitrite in the presence of ascorbic acid.  The concentrations of NMOR, 
NPIP and NDMA were similar when comparing the lipid triacetin and tributryin for 
the different experimental conditions measured.  
 
The above studies highlight the way in which lipid can profoundly alter acid 
induced  nitrosative  chemistry.    Our  studies  were  stimulated  by  the  chemistry 
occurring when salivary nitrite enters the acidic stomach.  Traditionally, the ascorbic 
acid secreted in gastric juice has been considered to be beneficial, by converting the 
nitrosating species to NO and thus inhibiting generation of potentially carcinogenic 
N-nitrosocompounds, within the gastric lumen.  However, the NO produced in this 
way may itself induce nitrosation as it diffuses into lipid in the lumen or in the lipid 
bilayer membrane of the epithelial cells.  The ascorbic acid therefore appears to have 
the  potential  to  transfer  the  nitrosative  stress  from  the  aqueous  phase  into  the 
adjacent lipid compartments.   
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Figure 3.9:  The proposed mechanism of N-nitrosamine formation in the lipid layer 
of a two-phase model of the gastroesophageal junction.  The aqueous 
antioxidant  ascorbic  acid  (ASC)  shifts  nitrosative  stress  from  the 
aqueous to lipid phase. 
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Chapter 4  Lipid antioxidant effect on nitrosative chemistry in a model of the 
gastroesophageal junction 
 
4.1 Introduction and Aims 
 
The generation of N-nitrosocompounds within the upper gastrointestinal tract 
has been the subject of much research.  Studies in Chapter 3 showed that, as well as 
acid-catalysed nitrosative stress in the absence of the aqueous ascorbic acid, there is 
a potential for NO induced nitrosative stress in the presence of ascorbic acid when 
lipid is present.  These studies have shown that fat counteracts the ability of ascorbic 
acid to prevent nitrosation. 
 
In  biological  systems  there  are  lipid  antioxidants  as  well  as  aqueous 
antioxidants.  The interaction between lipid and aqueous antioxidants is thought to 
be  important  within  these  biological  systems.    Three  major  chain  breaking  lipid 
antioxidants are ʱ-tocopherol, β-carotene and butylated hydroxytoluene (BHT).  Α-
tocopherol is the major vitamin E compound found in the lipid fraction of living 
organisms  (256-258).    It  is  thought  to  be  one  of  the  most  powerful  naturally 
occurring  lipid  antioxidants  known  (145,259)  and  has  previously  been  shown  to 
inhibit the formation of nitrosamines in an in vitro gastrointestinal model system 
(260).  Β-carotene is another naturally occurring antioxidant that has been found in 
many biological systems (261).  BHT is a synthetic phenolic lipid antioxidant that is 113 
 
used in food preservatives (147,262).  These, and other, lipid antioxidants may be 
important in preventing nitrosative stress occurring at the gastroesophageal junction. 
 
The aim of the studies described in this chapter was to assess the effect on 
nitrosative stress, as determined by nitrosamine formation, of the lipid antioxidants 
ʱ-tocopherol, β-carotene and butylated hydroxytoluene in a model simulating the 
chemistry occurring at the gastroesophageal junction. 
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4.2 Experimental design 
 
A two-phase bench top model was created to assess the chemistry occurring at 
the gastroesophageal junction as described in Chapter 3.  This model was modified 
such that a given concentration of one of three antioxidants, ʱ-tocopherol, β-carotene 
or  BHT was  present  within the lipid  phase tributyrin (figure 4.1).    This  model 
consisted of a 250 mL glass beaker.  Into this beaker an aqueous phase consisting of 
50 mL HCl (pH 1.5) was added together with NaSCN (1mM) and EDTA (1mM).  
Ascorbic acid (1mM) was added to the aqueous phase in certain experiments.  This 
provided an  excess  of ascorbic as  compared to the later  added nitrite.   In other 
experiments  a  smaller  dose  of  ascorbic  acid  was  added  such  that  all  available 
ascorbic acid would be consumed.  The aqueous phase represents the lumen of the 
stomach, with solutions present in physiological concentrations.  Into the beaker was 
added  5  mL  of  a  lipid,  to  generate  a  second  phase.    The  two  lipids  used  were 
tributyrin and triacetin.  A secondary amine was added to both the lipid and aqueous 
phases to allow monitoring of the nitrosative stress, by measuring the generation of 
N-nitrosamines.   The three secondary amines used were morpholine, piperidine and 
dimethylamine  at  concentrations  of  5  mM.    To  determine  the  effect  of  various 
antioxidants  on  nitrosative  stress,  one  of  the  lipid  antioxidants  ʱ-tocopherol,  β-
carotene  or  BHT  was  added  in  various  concentrations  to  the  lipid.    The 
concentrations used were 1 µM, 10 µM, 100 µM, 1 mM, 10 mM and 100 mM. 
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The contents of the beaker were stirred with a magnetic stirrer during the 
course of the experiment.  Experiments were performed at 37
oC, the temperature 
being  kept  constant  by  having  the  beaker  set  up  in  a  heated  water  bath.    The 
experiments  were  initiated  by  adding  NaNO2  to  the  aqueous  phase.    Nitrite 
concentrations of 25 µM and 100 µM, after addition to the aqueous phase, were used 
in different experimental conditions. 
 
Dissolved O2 and NO concentrations were monitored in the aqueous phase 
throughout the study.  At the end of the experiment, or at a given time point, a 1 mL 
aqueous sample was removed through a sampling device in the upper port of the 
beaker model for measurement of the relevant N-nitrosamine.  Experiments were 
performed over 15 minutes, except  in  those studies where the time interval  was 
being evaluated and in these experiments the time interval for sampling was 30 and 
60 minutes. 
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Figure 4.1:  This schematic diagram represents the two-phase bench top model used 
to represent the gastroesophageal junction with lipid antioxidant.  The 
aqueous phase consisted of 50 mL HCl (pH 1.5), NaSCN (1mM) and 
EDTA (1mM) +/- ascorbic acid (either 25µM or 1mM).  The addition of 
nitrite (either 25µM or 100µM) initiated the experiments.  The addition 
of the lipid tributyrin to an aqueous phase created a two-phase model.  
The lipid had varying concentrations of lipid anti-oxidant present. AO = 
antioxidant. 
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4.3 Results 
 
4.3.1   Two-phase studies with presence of lipid antioxidant in lipid and 
ascorbic acid (1mM) in aqueous phase 
 
4.3.1.1  Α-tocopherol Present in the Lipid 
 
The presence of ʱ-tocopherol in the lipid component of the experimental design 
inhibited nitrosation at concentrations of 10 µM and greater, when nitrite (100 µM) 
was added to an acidic aqueous phase (figure 4.2).  This was the same for all three 
nitrosamines measured.  Addition of only 1 μM of ʱ-tocopherol had no statistically 
significant effect on the concentration of any of the aqueous N-nitrosocompounds 
(p>0.05)  with  a  mean  NMOR  concentration  of  4.64  (±0.76)  μM,  mean  NPIP 
concentration of 6.32 (±0.53) μM and mean NDMA concentration of 2.04 (±0.48) 
μM.  When 10 µM of ʱ-tocopherol was added to tributyrin, and the experiments run 
over 15 minutes, 1.11 (±0.24) µM NMOR, 1.28 (±0.22) µM NPIP and 0.93 (±0.13) 
µM  NDMA  were  measured  in  the  aqueous  phase.    This  reduction  in  mean  N-
nitrosocompounds  concentration  is  statistically  significant  (p<0.00002).    A 
concentration of ʱ-tocopherol of 100 μM and above resulted in only 0.01 (±0.01) 
µM  of  the  respective  N-nitrosamines  being  produced.    NO  and  dissolved  O2 
concentrations  followed  a  pattern  consistent  with  that  found  when  there  was  no 
antioxidant in the lipid.   When the lipid triacetin was used in place of tributyrin 
similar results were found (data not shown). 118 
 
  
 
 
Figure 4.2:  Mean  aqueous  N-nitrosamine  concentrations  for  three  different 
secondary amines are shown.  The blue columns represent mean NMOR 
concentration, the red columns mean NPIP concentration and the green 
column NDMA concentration.  In these experiments 100µM nitrite was 
added to an acidic aqueous phase containing 1mM ascorbic acid.  The 
ratio  of  lipid  to  aqueous  phase  was  1:10.    The  concentration  of  ʱ-
tocopherol  present  in  the  lipid  phase  is  shown  on  the  x  axis.  
Experiments  were  performed  over  15  minutes.    Mean  values  of  the 
nitrosamine concentration are labeled.  Error bars represent 1 standard 
deviation. (n=18)   
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4.3.1.2 Β-carotene present in the lipid 
 
Β-carotene  concentrations  of  1  mM  and  greater  were  required  to  have  a 
significant inhibitory effect on nitrosation.  In the aqueous phase, 15 minutes after 
the addition of nitrite (100 μM) to HCl  (pH 1.5) in the presence of thiocyanate 
(1mM)  and  ascorbic  acid  (1mM)  and  with  1mM  β-carotene  present  in  the  lipid 
tributyrin 1.17 (±0.24) μM NMOR, 1.34 (±0.28) μM NPIP and 0.74 (±0.12) μM 
NDMA were measured.  This compared to 4.36 (±0.23) μM NMOR, 5.85 (±0.52) 
μM NPIP and 2.24 (±0.41) μM NDMA when 100µM beta carotene was present in 
the tributyrin (figure 4.3).  While these concentrations show a slight reduction from 
results  when there is  no antioxidant  present,  they  are not  statistically significant 
(p>0.05).  NO and dissolved O2 concentrations during the 15 minute experiment 
were similar to those obtained when no antioxidant was present in the lipid.  When 
the lipid triacetin was used in place of tributyrin for the lipid phase, similar results 
were found (data not shown). 
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Figure 4.3:  Mean  aqueous  N-nitrosamines  concentration  for  three  different 
secondary amines are shown.  The blue columns represent mean NMOR 
concentration, the red columns mean NPIP concentration and the green 
column NDMA concentration.  In these experiments 100 µM nitrite was 
added to an acidic aqueous phase containing 1mM ascorbic acid.  The 
ratio  of  lipid  to  aqueous  phase  was  1:10.    The  concentration  of  β-
carotene present in the lipid phase is shown on the x axis.  Experiments 
were  performed  over  15  minutes.    Mean  values  of  the  nitrosamine 
concentration are labeled.  Error bars represent  1 standard deviation. 
(n=18)   
 
4.82 4.73 4.79
4.36
1.17
0.01 0.01
6.15 6.08 6.01 5.85
1.34
0.01 0.01
2.18 2.1 2.34 2.24
0.74 0.01
0.01
0
1
2
3
4
5
6
7
8
0 1μM 10µM 100µM 1mM 10mM 100mM
µM 
nitrosamine
µM β-carotene
NMOR
NPIP
NDMA
p>0.05 
P<0.0008 121 
 
4.3.1.3  BHT present in the lipid 
 
Of the three antioxidants used in our studies, Butylated Hydroxytoluene (BHT) 
had the least inhibitory effect on nitrosation.  Concentrations of 10mM and greater 
BHT in tributyrin were required to inhibit nitrosation after the addition of 100μM 
nitrite  to  HCl  (pH  1.5)  in  the  presence  of  thiocyanate  and  ascorbic  acid  in  the 
aqueous phase.  With a BHT concentration of 10 mM, 0.13 (±0.05) μM NMOR, 
0.13 (±0.02) µM NPIP and 0.15 (±0.02) µM NDMA were measured in the aqueous 
phase (figure 4.4).  When only 1 mM BHT was present within the lipid 3.27 (±0.54) 
µM NMOR, 5.26 (±0.22) µM NPIP and 1.49 (±0.26) μM NDMA were measured.  
The  NO  and  dissolved  O2  concentrations  measured  in  the  aqueous  phase  were 
similar to those in the experiments where no antioxidant was present in the lipid 
phase.  Results for the lipid phase with triacetin in place of tributyrin were similar to 
those seen with tributyrin.   
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Figure 4.4:  Mean  aqueous  N-nitrosamine  concentrations  for  three  different 
secondary amines are shown.  The blue columns represent mean NMOR 
concentration, the red columns mean NPIP concentration and the green 
column NDMA concentration.  In these experiments 100µM nitrite was 
added to an acidic aqueous phase containing 1mM ascorbic acid.  The 
ratio of lipid to aqueous phase was 1:10.  The concentration of BHT 
present in the lipid phase is shown on the x axis.  Experiments were 
performed  over  15  minutes.    Mean  values  of  the  nitrosamine 
concentration are labeled.  Error bars represent  1 standard deviation. 
n=18   
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4.3.2   Two-phase study with aqueous phase containing nitrite (25µM) and 
ascorbic acid (25µM) with a range of α-tocopherol concentrations in the 
lipid phase 
 
In  this  experiment,  there  is  not  an  excess  of  ascorbic  acid,  but  rather,  the 
ascorbic acid should all be consumed in the reaction with nitrite to generate NO.  
There was a mean NO concentration produced of 21 µM, maximal at 30 seconds.  
There was a loss of O2 after 30 seconds, but this was measurable in the aqueous 
phase again just after 3 minutes (Figure 4.5).  This therefore suggests there should be 
less nitrosative stress.  Despite this, it was found in these experiments that some of 
the inhibition of nitrosation seen with the smaller concentrations of ʱ-tocopherol was 
lost.  Compared to the model where there was an excess of ascorbic acid, where a 
concentration  of  only  10  μM  ʱ-tocopherol  was  enough  to  prevent  nitrosation,  a 
concentration  of  10  mM  is  required  to  achieve  near  complete  inhibition  of 
nitrosative stress in these experiments.    In the absence of any lipid antioxidant the 
mean  NMOR  concentration  produced  was  1.53  (±0.26)  μM.    There  was  a 
statistically significant degree of inhibition with ʱ-tocopherol concentrations of 10 
µM and above but even at 1mM concentrations the mean NMOR concentration was 
0.47 (±0.05) μM showing there is still nitrosation occurring (figure 4.6).  
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Figure 4.5:  Mean  aqueous  NO  and  O2  concentration  (µM)  over  time  after  the 
addition of nitrite (25 µM) to an acidic aqueous phase in the presence of 
ascorbic  acid  (25µM).  Error  bars  represent  1  standard  deviation.  
(n=18) 
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Figure 4.6:  Aqueous NMOR concentrations produced over a 15 minute period in a 
single and two-phase system with ascorbic acid present.  In a two-phase 
system  there  is  either  no  alpha  tocopherol  or  a  range  concentrations 
from 1 μM to 10 mM.  Only 25 µM ascorbic was present in the aqueous 
phase and 25 µM nitrite was added. Data labels represent mean values.  
Error bars represent 1 standard deviation. (n=18) 
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4.3.3 Two-phase studies with nitrite (25 µM) but no ascorbic acid in the 
aqueous phase and either no, or one of a range of concentrations of α-
tocopherol  
 
In a single phase system there is generation of NMOR as expected due to acid-
catalysed nitrosation with a mean NMOR concentration of 1.73 (±0.38) μM.   The 
concentration of NMOR is not significantly lower when there is lipid without any 
antioxidant.  However there is a trend towards there being slightly less NMOR, with 
a  mean  NMOR  concentration  in  the  aqueous  phase  of  1.58  (±0.20)  μM.  
Concentrations  of  ʱ-tocopherol  in  the  lipid  phase  of  1  and  10  µM  do  not 
significantly  change  the  concentration  of  NMOR  produced  (p>0.05).    Higher 
concentrations of 100 μM, 1 mM and 10 mM ʱ-tocopherol do result in significantly 
less NMOR concentrations of 1.08 (±0.13) μM, 0.84 (±0.05) μM and 0.74 (±0.12) 
µM  respectively  (p=0.0007)  (figure  4.7).    However  these  concentrations  are 
significantly greater than those found when there was ascorbic acid present, whether 
in excess or only at a concentration of 25 µM (p<0.000003).  
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Figure 4.7:  Aqueous  NMOR  generation  in  a  single  and  two-phase  system  with 
single dose of 25μM nitrite but no ascorbic acid present.  In the two-
phase system there was increasing concentrations of a-tocopherol from 
0μM to 10mM.  Data labels show mean values of µM NMOR.  Error 
bars represent 1 standard deviation. n=12 
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4.3.4  Two-phase  studies  (increased  time  interval)  with  α-tocopherol  present 
and  ascorbic  acid  (1mM)  and  nitrite  (100µM)  present  in  the  aqueous 
phase  
 
Increasing  the  time  interval  from  15  to  60  minutes  increased  the  NMOR 
concentration produced, for all concentrations of ʱ-tocopherol examined.   There 
was a three fold increase in NMOR concentrations with increased time from 15 to 60 
minutes, for ʱ-tocopherol concentrations of 100 µM and 1 mM (p=0.0006).  Where 
10 µM ʱ-tocopherol was present as lipid antioxidant there was a greater increase in 
NMOR produced, such that at 60 minutes there was a concentration of 8.46 (±0.90) 
µM (figure 4.8).  This is 20 times the concentration of NMOR observed with 100 
µM and 1 mM ʱ-tocopherol at the same time interval.  This concentration of 8.46 
µM is significantly nearer the concentration found when there is no lipid antioxidant 
present (NMOR concentration of 10.14 µM). 
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Figure 4.8:  Aqueous NMOR concentrations in a two-phase model with nitrite (100 
µM) added to an aqueous phase containing ascorbic acid (1mM).  In the 
lipid phase system there was a range of concentrations of ʱ-tocopherol 
(0μM to 10mM).  The concentration of ʱ-tocopherol used is shown on 
the x axis labels.  Data is shown for both 15 minute experiments (blue 
column) and 60 minute experiments (red column).  Data labels show 
mean values of µM NMOR.  Error bars represent 1 standard deviation. 
n=12 
 
 
4.82
1.11
0.01 0.01
10.1
8.46
0.03 0.03
0
2
4
6
8
10
12
none 10uM 100uM 1mM
µM 
NMOR
α-tocopherol concentration
15 mins
60 mins130 
 
4.4 Discussion 
 
These results indicate that both lipid and aqueous antioxidants are required to 
prevent nitrosation in a model simulating the gastroesophageal junction.  We have 
previously  demonstrated  an  inhibitory  effect  of  ascorbic  acid  in  preventing  acid 
nitrosation in a single aqueous phase system.  This inhibitory effect is lost when 
lipid is added as a second phase into this model.   However, the combination of 
ascorbic acid with any of the lipid antioxidants is effective in having an inhibitory 
effect  on  nitrosative  stress,  if  sufficient  concentrations  are  present.    The 
concentrations required to achieve this inhibition can be very low (10µM), as can be 
seen for ʱ-tocopherol.  The co-operative and synergistic effect of lipid and aqueous 
antioxidants has been extensively researched over the past five decades (171,263-
266). 
 
The  aqueous  antioxidant  ascorbic  acid  competes  for  acidified  nitrite  (240, 
267,268).  The reaction product from this is NO.  NO is a small, gaseous, lipophilic 
molecule.  It diffuses from the aqueous phase into the lipid phase as it is 9 times 
more soluble in lipid (251).  In the lipid, NO meets O2.  NO reacts readily with O2 to 
form the nitrosating species N2O3 (250).  The rate of this reaction is related to the 
square of the NO concentration multiplied by the O2 concentration.  The reaction is 
therefore  favoured  by  high  NO  concentrations,  such  as  those  generated  when 
swallowed nitrite meets acidic gastric juice.  The reaction of NO with O2 is some 
300 times faster in lipid than in an aqueous phase (251).  The resulting nitrosating 
species N2O3 is then able to nitrosate the secondary amine to form the corresponding 131 
 
N-nitrosamine  (98).    Previous  work  by  Mergens  et  al  had  demonstrated  that  ʱ-
tocopherol may be able to prevent N-nitrosamine formation (269). The models used 
in these experiments were both an emulsified aqueous solution of ʱ-tocopherol in 
vitro  and  the  addition  of  ʱ-tocopherol  to  shredded  tobacco  to  prevent  NDMA 
formation in tobacco smoke.  Mergens et al have also shown that ʱ-tocopherol may 
be  able  to  prevent  formation  of  nitrosamines  in  an  in  vitro  model  of  the 
gastrointestinal system, although this was in the context of nitrosative stress from 
luminal acid-catalysed nitrosation in the absence of ascorbic acid (260).  It is thought 
that, although NO does not react directly with ʱ-tocopherol, it can react through 
oxidation products such as N2O3 (158). 
 
The  experiments  performed  in  our  model  of  the  gastroesophageal  junction 
confirm that ʱ-tocopherol, as well as other lipid antioxidants, are able to prevent 
nitrosative stress in the presence of ascorbic acid.  We found a concentration of 10 
µM of ʱ-tocopherol, 1 mM β-carotene and 10 mM BHT was sufficient to prevent 
nitrosamine formation in the presence of excess ascorbic acid.  These findings are in 
keeping with the relative and absolute effectiveness of various lipid chain breaking 
antioxidants (270).  Howard et al found that ʱ-tocopherol was the most powerful 
lipid antioxidant > other vitamin E compounds > β-carotene > BHT based on rate 
kinetics when assessing styrene autoxidation.   The antioxidant activities of these 
compounds are the same as their biological activities (256).  Stereoelectronic factors 
relating to the position of the methoxy group on the aromatic ring, and also the 132 
 
stabilising effect of the ethereal O2 on the phenoxy radical, can explain the superior 
reactivity of ʱ-tocopherol (145,148). 
 
In the studies with ascorbic acid present and ʱ-tocopherol added to the lipid 
compartment  at  concentrations  of  10  µM  and  greater,  the  nitrosative  stress  is 
inhibited.  With concentrations of 10 µM ʱ-tocopherol nitrosamines are still formed 
(1.1 µM NMOR, 1.1 µM NPIP and 0.9 µM NDMA) but to a lesser extent than in 
studies  in  which  no  lipid  antioxidant  is  added.    This  would  suggest  that  the  ʱ-
tocopherol is being overwhelmed to some extent.  An ʱ-tocopherol concentration of 
10 µM is still, however, a surprisingly low concentration to be able to inhibit the 
nitrosative stress from 100 µM nitrite in this model.  The stoichiometry of chain 
breaking lipid antioxidants is complex.  In a classical inhibitory scheme two peroxyl 
radicals are consumed for every antioxidant molecule oxidised (148).  However, 
radical intermediates may drain antioxidants from the system.  It is still, therefore, 
surprising that ʱ-tocopherol of such a low concentration (10µM) can be effective.  
This may possibly be explained by the recycling, or ‘sparing’, of ʱ-tocopherol by 
ascorbic acid.  Over the past 60 years there has been ongoing debate as to whether 
recycling  between  ascorbic  acid  and  ʱ-tocopherol  exists.    Tappel  et  al  first 
postulated the concept that ascorbic acid is able to replenish the reducing capacity of 
ʱ-tocopherol (165).  In vitro evidence to support the concept of recycling in both 
homogenous  solutions  and  liposomal  membrane  systems  is  extensive 
(171,173,263,264,265,271).  This does not, however, seem to be borne out when 
some in vivo studies are undertaken (174) while others have postulated an in vivo 133 
 
process  of  recycling  does  exist  (175).    Our  own  unpublished  in  vitro  studies 
presented  in  Chapter  5  of  this  thesis,  using  the  same  model  as  in  these  current 
experiments, suggest that there may be recycling, as ascorbic acid is consumed to a 
greater extent when ʱ-tocopherol is present. 
 
As the incubation time was increased from 15 to 60 minutes there was a similar 
effect on N-nitrosamine generation in the presence ʱ-tocopherol as there was in the 
presence of a two-phase model in the absence of a lipid antioxidant.  There was a 2-
3 fold increase in mean N-nitrosamine concentrations.  The exception to this was at 
concentrations  of  only  10  µM  ʱ-tocopherol.    In  15  minute  experiments  this 
concentration had only inhibited N-nitrosation to a limited degree.  When the time 
interval  was  increased  to  60  minutes  there  was  eight  times  more  N-nitrosamine 
generated.  The final NMOR concentration, at 60 minutes, was only slightly less 
than the concentration of NMOR generated when there was no lipid antioxidant.  
This suggests that the ʱ-tocopherol was overwhelmed in this scenario.  It may be 
that the ascorbic acid was not sufficient to replenish the ʱ-tocopherol, although it is 
unlikely that the ascorbic acid in the system was totally depleted as ascorbic acid 
was present in excess.  Unfortunately ascorbic acid was not measured in the aqueous 
phase during these experiments, although in retrospect this would have been useful. 
 
When the concentration of the nitrite entering this system was lowered to 25 
µM in the absence of ascorbic acid, the mean NMOR concentration measured in the 
aqueous phase in the absence of ʱ-tocopherol was 1.58 µM.  This was only slightly 134 
 
less than the mean concentration in a single phase system with no lipid where 1.73 
µM  NMOR  was  generated.    These  mean  concentrations  are  less  than  half  the 
concentrations  seen  when  100  µM  nitrite  was  added  to  the  system.    This  acid-
catalysed nitrosation appears to be inhibited at lower concentrations of ʱ-tocopherol 
when  25  µM  nitrite  was  added  as  compared  to  100  µM  nitrite  being  added.  
Concentrations of 100 µM ʱ-tocopherol were effective in inhibiting nitrosation when 
25 µM nitrite was added compared to 10 mM being required when 100 µM nitrite 
was added.  This shows that the generation of nitrosating compounds is less and 
suggests that smaller concentrations of ʱ-tocopherol were able to compete for the 
nitrosating species. 
 
In the experiments discussed thus far we have observed that either a very high 
concentration  of  ʱ-tocopherol  in  the  absence  of  ascorbic  acid,  or  a  very  low 
concentration  of  ʱ-tocopherol  in  the  presence  of  excess  ascorbic  acid,  results  in 
inhibition of nitrosation.  While in the immediate post prandial state there may be 
excess production of ascorbic acid relative to nitrite at the gastroesophageal junction 
and gastric cardia (221), this may not always be the case.  There may be more of a 
balance between nitrite and ascorbic acid concentrations.  In studies using 25µM 
ascorbic acid and 25µM nitrite the ʱ-tocopherol concentration required to inhibit 
nitrosation was considerably greater than when there was an excess of ascorbic acid.  
A  proposed  mechanism  for  this  is  that  all  the  ascorbic  acid  is  oxidised  to 
dehydroascorbic  acid  in  the  initial  reaction  with  nitrite.    When  ascorbic  acid  is 
present to excess it will replenish the reducing capacity of ʱ-tocopherol, but when all 135 
 
the ascorbic  acid  is  oxidised to  dehydroascorbic acid  in  the initial  reaction with 
nitrite this will not occur. 
 
In  our  studies  β-carotene  and  BHT  require  higher  concentrations  than  ʱ-
tocopherol to have an inhibitory effect on nitrosamine production.  Β-carotene is 
present in many tissues throughout the human body and has an important antioxidant 
role to play.  BHT is a synthetic antioxidant that is present in food preservatives.  
There  is  some  in  vitro  and  in  vivo  evidence  that  β-carotene  together  with  both 
vitamins C and E provides synergistic protection against oxidation by peroxynitrite 
(266).    The  mechanism  proposed  for  this  is  similar  to  the  replenishment  of 
tocopherol by ascorbic acid, in that there is an electron transfer reaction in which β-
carotene radical is  repaired by  vitamin C.  BHT has  not  been shown  to  have a 
capacity to be replenished by aqueous antioxidants.  However, it may work in a co-
operative  manner  with  other  antioxidants.  Our  studies,  thus  far,  have  not 
investigated for synergism between β-carotene and ascorbic acid, or between lipid 
antioxidants, although this may be worthwhile in the future. 
 
It is interesting to note that concentrations of vitamin E in the human stomach 
are highest in the more proximal regions, in subjects who are Helicobacter pylori 
negative.  In the presence of Helicobacter pylori there is a loss of proximal vitamin 
E, while more distal stomach concentrations are maintained.  This may represent 
mobilization of antioxidant defenses to the sites of maximal stress (272).   
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The  model  in  which  we  have  assessed  the  effectiveness  of  antioxidants  in 
preventing  nitrosative  stress  is  one  designed  to  represent  the  gastroesophageal 
junction.  Gastroesophageal junction and gastric cardia cancers have been increasing 
over the past 20 years in the Western World.  The mutagen behind this rise is as yet 
unknown, but the carcinogenic potential from nitrite is currently being explored.   It 
has been shown that the potential for generation of harmful N-nitrosocompounds 
exists  within  the  area  of  the  upper  gastrointestinal  tract  where  swallowed  nitrite 
meets acidic gastric juice.  Antioxidants, such as those studied in this model, may 
have a role in preventing the formation of harmful N-nitrosocompounds within the 
upper gastrointestinal tract. 
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Chapter 5  Interaction between ascorbic acid and α-tocopherol  
 
5.1 Introduction and Aims 
 
The synergistic activity between vitamins C and E was first suggested in 1941, 
when it was found that although ascorbic acid alone was a very poor antioxidant for 
lard and oil, it enhanced the antioxidant activity of tocopherols (164).  It was not 
until  1968  that  Tappel  suggested  that  vitamin  C  might  reduce  the  tocopheroxyl 
radical formed from tocopherol during the scavenging of free radicals in vivo, thus 
permitting a single molecule of vitamin E to scavenge many radicals (165).  There 
has  been  some  controversy  in  this  field  regarding  the  synergy  between  the  two 
vitamins. 
 
In experiments performed in Chapter 4 of this thesis, using a two-phase model, 
it was noticed that the concentration of ʱ-tocopherol required to prevent nitrosation 
was much smaller than expected, with 10 µM of ʱ-tocopherol inhibiting nitrosation 
when 100 µM of nitrite was added to a two-phase model generating NO.  This could 
be  explained  by  ascorbic  acid  reducing  the  tocopheroxyl  radical  produced  in 
inhibiting nitrosation.  This would, therefore, allow one molecule of ʱ-tocopherol to 
reduce many nitrosating species.  It was also found that, in two-phase experiments 
where  we  used  only  the  same  concentration  of  ascorbic  acid  as  of  nitrite,  the 
concentration  of  ʱ-tocopherol  that  had  been  effective  in  inhibiting  nitrosation  in 
experiments with an excess of ascorbic acid was now much less effective.  This 138 
 
suggests, that in experiments where there was an excess of ascorbic acid, ascorbic 
acid was replenishing the reducing capacity of ʱ-tocopherol.  In experiments where 
the ascorbic acid concentration was reduced, ascorbic acid became more deplete in 
the  initial  reaction  with  nitrite  and  subsequently  was  not  so  readily  available  to 
replenish the ʱ-tocopherol. 
 
The aim of the experiments in this chapter was to determine if there was any 
interaction  between  vitamin  C  and  E  in  experimental  models  representing  the 
chemistry occurring at the gastroesophageal junction. 
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5.2 Experimental Design 
 
5.2.1 Single and two-phase models of the GO junction 
 
Bench top models were used as in experiments in Chapters 3 and 4 (figures 3.1 
and 4.1).  These models were adjusted to provide different chemical environments.  
 
5.2.1.1 With reduced ascorbic acid concentration 
 
In these experiments there was not an excess of ascorbic acid using just the 
same concentration of ascorbic acid as that of sodium nitrite which was used to 
initiate the experiment.  This should mean that there is no excess of ascorbic acid 
present to react with other compounds such as ʱ-tocopherol.  Therefore, 100 µM 
nitrite was added to the acidic environment containing 100 µM ascorbic acid.  These 
experiments were performed over 30 minutes.  
 
5.2.1.2 Several pulsed boluses of nitrite 
 
Sodium nitrite at various concentrations (1 µM, 2.5 µM and 10 µM) was added 
to the aqueous phase at times 0, 7.5, 15 and 22.5 minutes.  The concentration of 
ascorbic acid in the aqueous phase of these experiments was 100 µM.  The purpose 
of adding several boluses of nitrite to the experimental model was to simulate the in 140 
 
vivo situation.  It has previously been shown that after a nitrate-rich meal there are 
boluses of salivary nitrite reaching the acidic gastric juice (213).  
 
 
5.2.2 Three-phase model of the GO junction 
 
 
 
Our experiments thus far in this thesis have only looked at the aqueous layer as 
a provider of ascorbic acid leading to generation of NO in an acidic environment 
and.  It is consumption of ascorbic acid from this phase that has previously been 
observed.  A three-phase model was constructed as a better way of representing the 
in vivo environment.  This three-phase model consisted of two aqueous layers and a 
lipid layer (figure 5.1).  The lipid layer provided complete separation of the aqueous 
layers but allowed the passage of NO and O2.  This allowed analysis of ascorbic acid 
away  from  the  initial  site  of  its  antioxidant  reactions  in  the  luminal  side  of  the 
model.  It allowed for examination of ascorbic acid consumption in the epithelial 
compartment to see if it is consumed when there is the potential for nitrosative stress 
in this compartment.   
 
A modified cylindrical Delrin model was constructed.  Delrin is an engineering 
plastic also known as polyoxymethylene.  The model was made to a total volume of 
6700 µl.  The model was constructed in two halves to allow the creation of all 
replaceable three layers.  The two halves could be tightened together without any 
leak of aqueous contents.  The lower half had a port through which sodium nitrite 141 
 
could be added to initiate the generation of NO in this lower layer.  This lower port 
was sealable with a plastic cap.  
 
The upper layer had a total volume of 4000 µl.  It consisted only of 150 µM 
ascorbic acid in PBS to a pH 7.4.  It was from this layer that samples were taken to 
measure ascorbic acid and total vitamin C concentrations.  WPI NO and O2 probes, 
as described in Chapter 2.1.1 and 2.1.2, were placed at the bottom of this layer, just 
above the middle layer, to continuously monitor NO and O2 concentrations during 
the experiment. The middle layer was made up of a composite membrane used in the 
design  of  NO  probes  (Donation  from  World  Precision  Instruments,  Sarasota, 
Florida)), with 800 µL of the liquid lipid triacetin spread evenly over the surface of 
the membrane.  The composite membrane was known to allow free passage of NO 
and O2 through the membrane.  The lipid used was triacetin as its density at 37
oC is 
such that it forms a layer.  In some of the experiments ʱ-tocopherol was added to the 
lipid.  The concentrations of ʱ-tocopherol varied from 10 µM.  The lower layer was 
an  aqueous  layer  designed  to  resemble  the  chemistry  at  the  gastroesophageal 
junction.    In  this  layer  HCl  provided  an  acidic  environment  with  a  pH  of  1.5.  
NaSCN (1 mM) and EDTA (1 mM) were added, together with ascorbic acid (1 
mM).  The ascorbic acid was added in a concentration that was in excess of the 
concentration of sodium nitrite (100 µM) used to initiate the experiment.  This layer 
was used to generate NO.  The total volume of the lower layer was 1900 µl. 
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In  terms  of  relating  this  in  vitro  model  to  conditions  in  the  human  upper 
gastrointestinal tract, the upper layer represents the intracellular compartment, while 
the middle layer  represents  the lipid  membrane.  The lower layer  represents  the 
lumen of the upper gastrointestinal tract 
 
Experiments were performed at 37
oC for 30 minutes.  The temperature was kept 
constant by performing the experiments on a hot plate.  Samples (100µL) were taken 
at time 0, 1, 2, 5, 10, 16, 23 and 30 minutes from the upper layer of the model for 
ascorbic acid and total vitamin C. The usual methods for processing ascorbic acid 
samples had to be adapted.  This occurred because the initial procedure involved 
diluting the samples twenty fold and it was noticed that the samples were being 
diluted beyond the point where the ascorbic acid was detectable.   Therefore, 80 µL 
of upper layer aqueous sample was taken from the top layer of the model.  This was 
equally divided and the 40 µL samples added to 120 µL of either MS or MS:DTT. 
This gave a final dilution of 1 in 4.  In all experiments there was a control sample of 
MS and MS:DTT which was analysed to make sure the sample was the source of 
ASC.  The model had an open top through the upper layer allowing oxygen to enter.  
Samples were then analysed as described in Chapter 2.1.8. 
 
To ensure that the model was suitable for purpose, NO diffusion across the 
lipid layer was monitored in the upper phase.  In all experiments NO was detected to 
be entering into the upper aqueous phase after diffusion through the middle lipid 
layer.  There was a standard pattern of diffusion, with a gradual increase in the NO 143 
 
concentration recordings from time 2 minutes after the nitrite was added to the lower 
phase.  The maximum mean NO concentration achieved was 20 µM after 30 minutes 
(figure 5.2).   144 
 
 
 
 
 
  
 
Figure 5.1:  Representation  of  the  Delrin  model  and  constituents  used  to  form  a 
three-phase model.  The lower layer was representative of acidic gastric 
juice and experiments were initiated by adding 100 µM nitrite.  The 
middle layer was composed of the lipid triacetin sitting on a composite 
hydrophobic membrane.  The upper layer consisted of 150 µM ascorbic 
acid in a neutral environment. 
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Figure 5.2:  NO and O2 concentrations in the upper phase of a three-phase model.  
The concentrations of NO and O2 were measured just above the middle 
layer in a three-phase model, over a 30 minute period, representing the 
chemistry at the gastroesophageal junction after the addition of 100 µM 
sodium nitrite to an acidic lower layer containing 1 mM ascorbic acid.  
Data labels show the mean NO concentration at a given time.  n=18 
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5.3 Results 
 
5.3.1  Two-phase  model  with  α-tocopherol  present  in  the  presence  of  excess 
ascorbic acid (1mM) relative to nitrite (100µM) with increased time 
 
In 15 minute two-phase experiments in the presence of ascorbic acid it has been 
seen that concentrations of 10 µM ʱ-tocopherol and greater were enough to almost 
fully  inhibit  nitrosation,  as  only  0.01  (±0.01)  µM  NMOR  was  produced  for 
concentrations  of  100  µM,  1  mM,  10  mM,  while  a  mean  concentration  of  1.11 
(±0.24) µM NMOR was produced when 10 µM ʱ-tocopherol was present.  When the 
time period of the experiment was increased to 60 minutes the NMOR concentration 
generated  was  significantly  increased  in  all  experiments  using  different 
concentrations of ʱ-tocopherol.  However, the biggest increase occurred with 10 µM 
ʱ-tocopherol,  as  eight  times  NMOR  was  produced  at  60  minutes  (p=0.00004), 
compared to three times for greater concentrations of ʱ-tocopherol (p>0.0002). 
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5.3.2  Two-phase  model  with  α-tocopherol  and  reduced  ascorbic  acid  
(100µM) relative to nitrite (100µM) 
 
The  NMOR  concentration  produced  in  these  experiments  was  higher  for 
concentrations of 10 µM ʱ-tocopherol and greater than those NMOR concentrations 
seen using 100 µM nitrite with an excess of ascorbic acid.  In a system containing no 
ʱ-tocopherol  there  was  a  mean  NMOR  concentration  of  2.45  (±0.6)  µM.    A 
concentration of 10 µM ʱ-tocopherol partially inhibited NMOR generation such that 
the mean NMOR concentration at 15 minutes was 1.23 (±0.16) µM (p=0.0001).  
Even  at  the  higher  concentration  of  1  mM  ʱ-tocopherol  the  mean  NMOR 
concentration was 0.38 (±0.09) µM at 15 minutes (p=0.00006) (figure 5.3).  These 
results show a similar pattern to those seen in the experiments in Chapter 4.3.2, 
where smaller doses of 25µM nitrite and ascorbic acid were used in the experimental 
design.  
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Figure 5.3:  Mean aqueous phase NMOR concentrations (µM) at 15 minutes from a 
two-phase model where experiments were initiated by the addition of 
nitrite  (100µM)  to  an  acidic  aqueous  phase  containing  only  100µM 
ascorbic acid.  In this model the lipid phase contains concentrations of 
ʱ-tocopherol (AT) ranging from 0 to 10 mM.  Data labels show the 
mean  value  for  each  experimental  condition.    Error  bars  represent  1 
standard deviation. n=12 
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5.3.3  Two-phase  model  with  α-tocopherol  with  reduced  ascorbic  acid  
(100µM) relative to nitrite (100µM) with increased time interval  
 
NMOR  concentrations  changed  dramatically  with  increased  time.    After  15 
minutes,  at  concentrations  of  10  µM  and  above,  ʱ-tocopherol  had  managed  to 
provide  a  significant  degree  of  inhibition  of  nitrosation,  although  the  degree  of 
inhibition was not as great as when there was an excess of ascorbic acid.  However, 
after 60 minutes the inhibition was almost completely lost where concentrations of 
10 µM and 100 µM ʱ-tocopherol were used with mean NMOR concentrations of 
9.55 (±0.71) µM and 9.28 (±1.17) µM respectively.  These concentrations of NMOR 
were not significantly different from the mean NMOR concentration in a two-phase 
model in the absence of lipid antioxidant which was 10.1 (±1.1) µM. 
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5.3.4  Ascorbic acid consumption during 30 minute experiments in a single and 
two-phase  model  in  the  presence  and  absence  of  α-tocopherol  when 
ascorbic  acid  (1mM)  is  present  in  excess  relative  to  the  nitrite 
concentration (100µM) 
 
In single phase experiments the mean percentage of ascorbic acid present at 30 
minutes compared to the starting ascorbic acid was 37.2 (±4.1) %.  The biggest drop 
in ascorbic acid concentration occurs within the first few minutes after the addition 
of nitrite.  Similar mean percentages of ascorbic acid remaining at 30 minutes were 
found in a two-phase model using tributyrin, and also in a two-phase model where 
the lipid was made into several globules.  The mean percentages of ascorbic acid 
remaining at 30 minutes were 33.6 (±2.1) % for lipid in single globule and 36.2 
(±3.6) % for lipid in the form of several globules.  There is no statistical significance 
between  any  of  the  percentage  ascorbic  acid  remaining  at  30  minutes  for  these 
experiments (p=0.068). 
 
In a 2 phase model where the lipid antioxidant ʱ-tocopherol was present, at a 
concentration of 10 mM (a concentration shown to inhibit nitrosation), the ascorbic 
acid present at 30 minutes was only 14.6 (±5.1) % that of the concentration.  This is 
a statistically significant reduction in the available ascorbic acid (p=0.00007).  There 
was no statistically significant difference when the lipid was present in globules with 
ʱ-tocopherol  present  (p=0.29).    Similar  results  were  found  for  ʱ-tocopherol 
concentrations of 100µM and 1mM (figure 5.4). 151 
 
 
 
 
 
 
 
Figure 5.4:  The mean percentage ascorbic acid remaining at 30 minutes in different 
experimental models is shown.  In all experiments there was an initial 
excess of ascorbic acid to nitrite in the aqueous phase (1mM ascorbic 
acid to 100µM nitrite).  In 2 phase experiments the lipid had either no ʱ-
tocopherol present or 10mM ʱ-tocopherol (AT) present.  The lipid was 
either present as a single phase or as multiple globules (glob).  Data 
labels show mean percentages for each experimental condition.  Error 
bars represent 1 standard deviation. n=18 
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5.3.5  Ascorbic acid consumption during 30 minute experiments using pulsed 
nitrite in a single phase two-phase model with and without α-tocopherol  
 
There was rapid oxidation of ascorbic acid using several boluses of nitrite as 
compared to a single bolus.  When 10µM nitrite was added at time 0, 7.5, 15 and 
22.5 minutes, there was no detectable ascorbic acid at 30 minutes.  On changing the 
dose to 1µM nitrite there was little difference in the ascorbic acid concentrations at 
the  beginning  and  end  of  the  experiments.    A  midrange  nitrite  concentration  of 
2.5µM, pulsed into the two-phase model, at the same time intervals as before, was 
used in the absence of lipid antioxidant.  At the end of the 30 minute experiment the 
mean  ascorbic  acid  percentage  remaining  was  61.6  (±17.2)  %.    There  was  a 
considerable  reduction  in  the  concentration  of  ascorbic  acid  remaining  when 
concentrations of 100 µM ʱ-tocopherol and higher were present in the lipid phase 
(figure  5.5).    The  mean  percentage  ascorbic  acid  remaining  when  100  µM  ʱ-
tocopherol was present was 8 (±4) %.  With concentrations greater than 1 mM there 
was no ascorbic acid present at the end of the experiment and only a mean ascorbic 
acid percentage of 5 (±2) % at 15 minutes. 
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Figure 5.5:  The mean % ascorbic acid remaining at given time intervals is shown 
for three different lipid designs in a two-phase model.  Into an acidic 
aqueous phase containing 100 µM ascorbic acid was added a 2.5 µM 
bolus of nitrite at times 0, 7.5, 15 and 22.5 minutes (this is represented 
by the arrows at the top of the diagram).  The lipid phase had one of: no 
antioxidant (AO) (green line), 100 µM ʱ-tocopherol (red line) or 1mM 
present (blue line).   n=12 
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5.3.6  Α-tocopherol concentration from 2 phase model experiments in the 
presence of excess ascorbic acid (1mM) and in conditions where ascorbic 
acid (100 µM) will be consumed 
 
In 30 minute two-phase experiments with 100 µM ʱ-tocopherol present in the 
lipid phase in the presence of excess ascorbic acid (1 mM) relative to nitrite (100 
µM), the mean ʱ-tocopherol present at the end of the 30 minute experiment was 34 
(±7) µM.  In experiments where 100 µM ascorbic acid and 100 µM nitrite were 
added to otherwise the same experimental design, there was statistically significant 
reduction (p<0.01) in the mean ʱ-tocopherol present, with a concentration of 8 (±6) 
µM.  When smaller concentrations of ʱ-tocopherol were assessed, the results were 
more dramatic:  In experiments where 10 µM ʱ-tocopherol was used in the lipid, 
with an excess of ascorbic acid (1mM), and 100 µM nitrite added, the mean ʱ-
tocopherol concentration at 30 minutes was 7.2 (±0.4) µM.  However, when 100 µM 
nitrite was added to aqueous solution containing 100 µM ascorbic acid, there was no 
ʱ-tocopherol present at 30 minutes in all twelve replicate experiments. 
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5.3.7  Ascorbic acid consumption in a three-phase model 
 
In  the  upper  layer  of  a  three-phase  system,  where  the  lipid  phase  has  no 
antioxidant present, there was a mean % ascorbic acid, remaining at 30 minutes, of 
77.3 (±4.6) %.  The available ascorbic acid at 30 minutes when there was 10mM ʱ-
tocopherol present was 71.9 (±3.1) % of the starting concentration.  The difference 
in  available  in  ascorbic  acid  at  30  minutes  in  experiments  with  ʱ-tocopherol  is 
statistically significant (p=0.004) (figure 5.6).  
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Figure 5.6:  Mean percentage ascorbic acid in the upper layer of a three-phase model 
compared to the original concentration is shown against the 30 minutes 
of the experiment.  The upper layer contained 150 µM ascorbic acid at 
pH 7.4 at the start of the experiment.  Experiments were initiated by 
adding 100 µM nitrite into a lower phase containing 1 mM ascorbic acid 
in an acidic aqueous phase.  NO generated in this lower aqueous phase 
diffuses through a middle lipid layer into the upper layer.  The middle 
layer was composed of triacetin supported on a hydrophobic membrane, 
with 10 mM ʱ-tocopherol (AT) either present (red line) or absent (blue 
line).  n=12 
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5.4 Discussion 
 
The  possible  replenishment  of  the  reducing  capacity  of  ʱ-tocopherol  by 
ascorbic acid has been an area of interest for five or six decades.  Previous studies 
have  provided  contradictory  evidence  for  this  recycling  process 
(174,175,263,264,265).    The  experiments  performed  within  this  chapter  would 
suggest that this process does occur, at least in an in vitro setting representative of 
the chemistry occurring at the gastroesophageal junction.   
 
Initially, our interest in this area of antioxidant recycling was stimulated by 
finding that the concentration of  ʱ-tocopherol required to  inhibit nitrosation was 
only 10µM.  This is a surprisingly low concentration of antioxidant to inhibit the NO 
concentrations  of  over  80µM  which  were  generated  within  this  system.    This 
suggests  that  one  molecule  of  ʱ-tocopherol  is  able  to  scavenge  many  radicals. 
Normally one molecule of ʱ-tocopherol would reduce one molecule of NO by a one 
or two electron transfer reaction (150).  Therefore 10µM of ʱ-tocopherol would only 
be expected to reduce 10µM of NO.  We also found that when the time course of the 
experiment  was  increased  from  15  to  60  minutes,  the  inhibitory  effect  of  ʱ-
tocopherol was largely overcome, as 9.55 (±0.71) µM NMOR was produced at 60 
minutes  when  10µM  ʱ-tocopherol  was  present  in  the  lipid  phase.    This  loss  of 
inhibition of nitrosative stress was also observed when a smaller concentration of 
aqueous ascorbic acid relative to initiating nitrite concentration was used in a two-
phase  model.    It  is  known  that  one  molecule  of  ascorbic  acid  will  convert  two 
molecules of NO (137).  Therefore, in the model used, the ascorbic acid would be 158 
 
expected  to  be  consumed  and  this  was  confirmed  in  our  experiments.    In  fact, 
ascorbic acid was consumed within 5 minutes of the addition of nitrite.   A proposed 
explanation for the results seen in our model using low concentrations of ascorbic 
acid  is  that  a  small  concentration  of  ascorbic  acid  was  quickly  consumed  in 
inhibiting  nitrosative  stress  within  the  lipid  phase,  so  that  there  was  little 
regeneration of oxidised ʱ-tocopherol by ascorbic acid.  Therefore, nitrosation of the 
morpholine was able to take place uninhibited after the small concentration of ʱ-
tocopherol was consumed.  Consequently, this means that NMOR produced in a 
two-phase model with 10µM ʱ-tocopherol, and a reduced concentration of ascorbic 
acid,  is  much  greater  than  the  NMOR  concentration  where  ascorbic  acid 
concentrations are in excess. 
 
In the models used in these experiments we were able to control the aqueous 
and lipid phases, and also able to sample relevant concentrations of the chemical 
reagents from them.  This allowed us to measure directly the ascorbic acid and ʱ-
tocopherol concentrations.  This required minor revisions to our method of ascorbic 
acid measurement, as initially some of the samples were too dilute.  Nevertheless, 
once  this  problem  was  overcome,  accurate  measurements  of  ascorbic  acid 
concentration were able to take place.   
 
In  a  single  phase  model,  where  ascorbic  acid  was  in  the  aqueous  phase  to 
excess compared to the nitrite concentration added, the ascorbic acid concentrations 
fell quickly in the initial few minutes, and then there was only a gradual loss of 159 
 
ascorbic acid and increase in dehydroascorbic acid.  This reflects the fact that the 
ascorbic acid is initially reacting with nitrous acid to generate NO.  This reaction 
occurs rapidly in the first few minutes and thereafter there is a recycling of this 
process, as NO reacts with O2 to form RNOS such as N2O3, and ascorbic acid reacts 
with this to form further NO (248).  This process gradually reduces the available 
ascorbic acid.  In our single phase model there was initially total consumption of the 
O2, but after 10 minutes there was once again a measurable O2 concentration within 
the system.  Despite O2 being present there was not complete consumption of all 
ascorbic acid within this model.  There was a mean concentration of just over a third 
of the starting ascorbic acid available at 60 minutes.  In two-phase models, for both 
single globule and multiple globules of tributyrin, the ascorbic acid concentration 
profile with time, showed no significant difference to that found in the single phase 
system.  Although the aqueous chemical reactants were not changed by adding the 
lipid phase, given that NO is very lipophilic (251) it would be expected to diffuse 
into  the  lipid.    Despite  this,  the  measurable  NO  and  O2  were  not  significantly 
different in the single and two-phase models. Therefore, it is not surprising that the 
ascorbic acid concentrations were similar in these models.  However, in a two-phase 
model where ʱ-tocopherol was present there was a significant reduction in ascorbic 
acid concentration as NMOR production is inhibited.  A proposed model for the 
chemical reactions occurring to account for these findings is shown in figure 5.7.   
 
At the gastroesophageal junction in humans it has been suggested that pulses, 
rather than a one off bolus of NO, are generated after foodstuff has been swallowed 160 
 
(221).  The pulsing of NO leads to pulses of nitrosative stress and this appears to be 
more effective than a single bolus in overwhelming the antioxidant effect of ascorbic 
acid and ʱ-tocopherol.  In our experiments using several boluses of nitrite there was 
a considerable increase in the oxidation of ascorbic acid to dehydroascorbic acid, 
and even at low concentrations of initiating nitrite, ascorbic acid was very quickly 
consumed. 
 
The three-phase model allowed us to look at an experimental model where the 
ascorbic acid was present in an environment with a constant O2 supply.  We were 
also able to control the delivery of NO into the acid rich environment with ascorbic 
acid present as the NO diffused through a lipid layer into the aqueous environment 
from where the ascorbic acid was measured.  The phase from which the ascorbic 
acid was being measured was representative of the epithelial compartment.  This 
means that the ascorbic acid in this compartment was in a different aqueous phase 
from the ascorbic acid that was involved in the generation of NO from nitrite.  This 
may partly explain why the consumption of ascorbic acid in this phase was not as 
great as had been seen in two-phase experiments with the same concentrations of ʱ-
tocopherol  present.  It  is  likely  that  most  of  this  difference  was  due  to  the 
concentration of NO that was present in the upper layer.  Nonetheless the difference 
in ascorbic acid oxidation between experiments where higher concentrations of ʱ-
tocopherol were present and absent was statistically significant.  There was not a 
significant  difference  in  ascorbic  acid  oxidation  when  the  concentration  of  ʱ-
tocopherol was less than 1mM.  This may be due to effective recycling of the ʱ-161 
 
tocopherol by ascorbic acid from the lower compartment.  It is likely that most of the 
nitrosative stress was occurring at the interface between the lower and middle layers. 
 
The in vitro models do not fully represent the in vivo setting, in that there was 
neither the full array of chemical reactants in the epithelial compartment to generate 
all the possible nitrosating compounds nor the physical conditions such as blood 
flow.    However,  the  experiments  discussed  in  this  chapter  add  to  the  body  of 
evidence to support a process of recycling between ascorbic acid and ʱ-tocopherol. 
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Figure 5.7:  Proposed method of recycling of ʱ-tocopherol by ascorbic acid.  In the 
reaction of NO with O2 in the luminal compartment nitrite is formed.  
Nitrite  is  reduced  to  NO  by  ascorbic  acid,  which  is  oxidized  to 
dehydroascorbic acid.  In the lipid NO and O2 react to form nitrite and 
nitrosating species such as N2O3.  In the presence of ʱ-tocopherol N2O3 
forms  NOx  (including  NO)  while  ʱ-tocopherol  is  oxidized  to 
tocopheroxyl  radical.    The  ascorbic  acid  is  able  to  replenish  ʱ-
tocopherol through its conversion from the tocopheroxyl radical.  In this 
process the nitrosation of amines is inhibited.  
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Chapter 6  Development of silastic tubing model suitable for measuring in vivo 
nitrosative stress 
 
6.1   Introduction and Aims 
 
N-nitrosation from dietary nitrate may be, in part, responsible for the increasing 
incidence in adenocarcinoma at the gastroesophageal junction.  Work presented in 
this thesis adds to the growing body of evidence, (44,144,221,222) from in vitro 
work, suggesting that there is the chemical potential for nitrosation at and around the 
gastroesophageal junction in the healthy acid-secreting stomach.  However, there has 
not been any previous in vivo work that effectively assesses N-nitrosation, in the 
presence of ascorbic acid, in this region.  The purpose of the following study was to 
develop an in vitro model that would measure nitrosation and could subsequently be 
used in vivo.  The tubing had therefore to be suitable not only to allow nitrosation 
within the lumen, but also be comfortable for a human subject to swallow.  The 
tubing  would  thereafter  sit  within  the  oesophagus  and  stomach,  straddling  the 
gastroesophageal  junction.    It  was  considered  important  to  know  what  was 
happening chemically along the length of the tube at various sites within the upper 
gastrointestinal  tract,  therefore  the  tubing  had  to  be  compartmentalised  into 
chemically distinct and intact segments of a given length.  There have been previous 
studies examining nitrosative stress in bench top models, using silastic tubing to 
form  an  epithelial  compartment  (44).    These  studies  showed  that  in  conditions 
simulating the healthy proximal stomach and gastroesophageal junction, there was 164 
 
accumulation of nitrite and N-nitrosamine within an amine rich neutral environment, 
contained in a silastic tube lumen.  The silastic tubing used in these experiments was 
very thin, with an internal diameter of 500µm and wall thickness of 250µm.  Such 
tubing  would  therefore  not  be  suitable  for  easy  passage  into  the  upper 
gastrointestinal tract, and the volumes contained within a 1cm section of this tubing 
would be very small, resulting in too small a volume for chemical analysis.  The aim 
of this chapter was to develop the silastic tubing model further, such that it could be 
used in human subjects.  
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6.2   Experimental design 
 
6.2.1 Silastic Tubing 
 
It has been shown in vitro that a hydrophobic silastic membrane has similar 
properties to an epithelial membrane, in terms of NO and O2 diffusion (273-276).  
Previous work has shown nitrosative stress within the lumen of the tubing made 
from such material, when NO has been present outside and a nitrosatable compound 
inside (44).  Silastic tubing from Altec was used (Altesil High Strength Silicone 
Tubing, Altec, UK).  This is a blended silicone elastomer tubing which is non toxic 
and translucent,  also  known as  polydimethylsiloxane.   It  withstands  a  maximum 
temperature  of  220
oC  and  a  minimum  temperature  of  -55
oC  with  a  density  of 
1.13g/cm
3.    The  core  diameter  had  to  allow  a  volume  adequate  for  subsequent 
analysis of a contained liquid, while the thickness of the silastic wall had to be 
suitable for diffusion of O2 and NO.  Silastic tubing of core diameter 2.5 mm and 
wall diameter 0.5 mm was chosen, as this allowed internal content of 80-100 µL per 
1.5 cm length of the tube, while allowing diffusion of NO and O2 through the wall. 
 
6.2.2 Compartmentalisation of silastic tubing 
 
In order to determine nitrosation occurring at different sites along the upper 
gastrointestinal tract, the silastic tube had to be compartmentalised into chemically 
distinct sections.  Compartments were made at approximately 1.5 cm intervals along 166 
 
the  tubing  after  filling  the  lumen  with  a  solution  of  pH  7.4,  with  a  range  of 
concentrations of morpholine present.  To ensure that the tubing was adequately 
compartmentalised  and  that  each  individual  compartment  would  not  receive 
contamination  from  neighbouring  compartments,  the  tubing  was  twisted  at  the 
appropriate length (1.5 cm).  Over the top of this twist a double knot was applied 
using vicryl suture ties (Ethicon, Gibco, Paisley, UK).  The double knot was placed 
at both ends of the twist.  
 
Several studies were performed to ensure that the compartmentalisation was 
successful, both in terms of direct fluid contamination between segments, and also as 
regards gaseous contamination along the length of the tubing.  In order to be of any 
value the silastic tubing had to be compartmentalised into sections that could later 
provide  detail  on  nitrosative  stress  related  to  the  anatomy  of  the  upper 
gastrointestinal tract.  The integrity of the sections, therefore, had to be maintained 
both in the liquid and gaseous phases.  This is particularly important as it is known 
that NO diffuses through lipids rapidly (251,273).  Such diffusion could alter where 
nitrosative stress would appear to be occurring in relation to sections of the tubing, 
thus  misrepresenting  the  true  site.  Fluid  volume  from  within  the  lumen  was 
removed using a glass syringe and this sample was subjected to analysis for nitrite 
and NMOR concentrations. 
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6.2.3 Experimental models used 
 
 
Four  different  models  were  used  in  the  following  experiments.    All  of  the 
models are similar but there are significant differences that allow different aspects of 
the chemistry, and of the silastic tubing, to be assessed. 
 
Model 1 - This was the basic model used within this chapter. It can be used to 
generate NO in aqueous phase with silastic tubing present.  It was set up as follows: 
A 50 mL glass scintillation vial was filled with:  Hydrochloric acid pH 1.5, 
ascorbic acid (1 mM), EDTA (1 mM), NaSCN (1 mM), and varying concentrations 
of NaNO2 (10-100µM). 
Silastic  tubing,  filled  with  varying  concentrations  of  the  secondary  amine 
morpholine (5 mM, 10 mM, 25 mM and 100 mM) buffered to pH 7.4 using 100 mM 
PBS,  was  placed  into  the  scintillation  vial  and  completely  surrounded  by  the 
aqueous solution within the glass vial (figure 6.1). 
 
The model was placed in a water bath at 37
oC for 15 minutes.  From previous 
studies we know that in an acidic environment in the presence of a reducing agent 
such as ascorbic acid, the nitrous acid formed in an acidic environment from nitrite, 
is converted to NO.  It can therefore be expected that NO will be formed in the 
aqueous environment in the scintillation vial.  This will diffuse through the silastic 
tubing wall and, through the formation of nitrosating species (principally N2O3), will 168 
 
nitrosate the morpholine to form NMOR.  A large accumulation of nitrite would also 
be expected intraluminally in the silastic tubing.   
 
At the end of the 15 minute incubation, the silastic tubing was taken out of the 
scintillation vial and laid lengthwise along a bench.  The fluid from each individual 
compartment was then removed, using a 100 µL steel Thomson syringe.  Of this 
volume,  10  µL  was  taken  for  nitrite  analysis  and  40  µL  was  subjected  to  an 
extraction process for NMOR.  These experiments were repeated twelve times. 
 
Model 2 – This was a modification of the basic model to allow for assessment 
of  diffusion  of  NO  along  the  length  of  the  tubing  causing  contamination  of 
neighbouring compartments which had not been directly exposed to NO.  In order to 
do this we modified the in vitro experiment to only submerge half of the tube rather 
than the entire length.  Therefore only four out of the eight were being exposed 
directly to NO.  Morpholine (25 mM) was present in the tube to allow assessment of 
nitrosation.  If nitrite and NMOR were detected in the unexposed compartments it 
would suggest that there had been diffusion through either the wall of the tubing, or 
through  the  knots  which  are  meant  to  be  compartmentalising  the  tube.    In  all 
experiments involving model 2, the added nitrite concentration was 100 µM (Figure 
6.2). 
 
Model 3 – In this model there was a coating of ʱ-tocopherol on either the 
inside  or  outside  of  the  silastic  tubing.    To  coat  the  outside  of  the  tubing 169 
 
concentrated >96% a-tocopherol was  smeared along  a length of it.  To coat  the 
inside of the tubing concentrated >96% a-tocopherol was injected into the lumen and 
then squeezed through the inside of the tube to form a thin film along its length.  The 
tubing was then placed such that it passed through two beakers.  In Beaker 1 it was 
exposed to an aqueous environment in the presence of nitrite, and in Beaker 2 the 
aqueous environment had ascorbic acid in addition to the nitrite.  This allowed us to 
determine the effect of HNO2 versus NO.  The nitrite concentration used was 1mM 
NaNO2, to allow for more in the way of ʱ-tocopherol induced nitrosative stress, in 
the absence of ascorbic acid, to occur.  The concentration of ascorbic acid present in 
Beaker 2 was increased to 5mM to allow for excess ascorbic acid over nitrite in 
these experiments.  The silastic tubing was compartmentalised such that in each 
beaker there was one compartment with ʱ-tocopherol either inside or outside the 
tubing.  In all experiments, the incubation lasted 15 minutes before removing the 
silastic tubing fluid for nitrite analysis (Figure 6.3).   
 
Model  4  -  In  this  model  experiments  were  performed  with  ʱ-tocopherol 
smeared on the outside of the tubing, while varying the pH of the tubing contents 
through 0.6, 1.5, 2.5, to 4.5.  Thiocyanate was also either present or absent within 
the tubing.  The surrounding conditions in the aqueous phase were HCl (pH 1.5), 
EDTA (1 mM), NaNO2 (1 mM) and NaSCN (1 mM).  There was no ascorbic acid in 
the aqueous phase (Figure 6.4).  All experiments were replicated twelve times.  
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Figure 6.1:  Model 1 was composed of two parts.  A silastic tubing filled with a 
range of concentrations of the secondary amine morpholine buffered to 
pH 7.4 by PBS.   The silastic tubing was  surrounded by an aqueous 
phase within a glass scintillation vial.  The aqueous phase consisted of 
HCl (pH 1.5), ascorbic acid (1 mM),  EDTA (1 mM), NaSCN (1 mM), 
and  a  reaction  forming  NO  was  initiated  by  the  addition  of  varying 
concentrations of NaNO2 (10 µM, 25 µM, 50 µM, 100 µM).  The model 
was placed on a magnetic hot plate to keep the aqueous phase at 37
oC, 
under constant stirring. 
 . 
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MOR 
Aqueous phase: HCl (pH 
1.5), ASC (1mM), EDTA 
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NaNO2 (10-100µM).  Total 
volume 50 mL. 
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Magnetic stirrer 
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Figure 6.2:  In model two the silastic tube contained 25 mM morpholine buffered to 
pH  7.4  by  100  mM  PBS.    The  tube  was  compartmentalized  into  8 
sections.  Only sections 3-6 of the tubing were exposed to the aqueous 
phase contained within a glass scintillation vial.  Sections 1, 2, 7, 8 lay 
exposed to air only.  Section numbers are shown in the above diagram.  
The aqueous phase had a total volume of 50 mL, and consisted of HCl 
(pH 1.5), EDTA (1 mM), NaSCN (1 mM) and ascorbic acid (1 mM).  
100  µM  NaNO2  was  added  to  the  aqueous  phase  to  initiate  the 
generation of NO.  The model was placed on a magnetic hot plate to 
keep the aqueous phase at 37
oC, under constant stirring. 
 
 
Magnetic hot plate 
1 
2 
3 
4  5 
6 
7 
8 
Aqueous phase: HCl 
(pH 1.5), ASC (1mM), 
EDTA (1mM), NaSCN 
(1mM), NaNO2 
(100µM).  Total volume 
50 mL 
 
 Waterbath: 
Temp 37
oC 
 
Magnetic stirrer 
 
Silastic tubing: PBS (pH 
7.4), 25mM MOR, 
compartmentalised into eight 
sections 172 
 
 
 
 
                   
 
 
 
 
 
 
 
Figure 6.3:  Model  3  consisted  of  two  glass  beakers  of  50  ml  total  volume.    In 
beaker 1 there was HCl (pH 1.5) with NaSCN (1 mM), EDTA (1 mM) 
and NaNO2 (1 mM).  Beaker 2 had the same contents as beaker 1 but 
with ascorbic acid.  Two sections of silastic tubing were then placed 
into each of the beakers, while four others lay out with.  The lumen of 
the tubing contained PBS (pH 7.4), EDTA (1 mM) and in one section of 
tubing per beaker a thin lining of concentrated >96% ʱ-tocopherol (ʱ-
TP).  In each beaker, exposed to the aqueous phase, a control length of 
tubing  had  no  ʱ-tocopherol  present.    The  model  was  placed  on  a 
magnetic  hot  plate  to  keep  the  aqueous  phase  at  37
oC  and  to  allow 
stirring of the beaker contents through a magnetic stirrer. 
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Figure 6.4:  In model 4 silastic tubing was coated with concentrated ʱ-tocopherol on 
the outside while in others the silastic tubing was unaltered.  Silastic 
tube luminal pH was one of 0.6, 1.5, 2.5 or 4.5 adjusted by using HCl 
and PBS.  NaSCN (1 mM) was either absent or present in the silastic 
tubing.  The tube was placed into a glass beaker containing an acidic 
aqueous  phase.    The  aqueous  phase  was  made  up  of  HCl  (pH  1.5), 
EDTA  (1mM),  NaSCN  (1  mM)  and  NaNO2  (1mM)  was  added  to 
initiate the reaction.  In all experiments using this model there was no 
ascorbic acid present. 
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6.3 Results 
 
6.3.1 Experiments using silastic tubing in model 1 
 
6.3.1.1 NO concentrations within the aqueous phase  
 
NO was generated in the aqueous phase of model 1, at a peak concentration of 
89 (± 4) µM at time 30 seconds, and continued to be produced in high concentrations 
throughout the time course of the experiments, when the 100 µM nitrite was the 
concentration added to the experimentantal model (figure 6.5).  The relationship of 
NO produced was linear to the concentration of nitrite added (r
2=0.96) (figure 6.5). 
 
6.3.1.2  Silastic Tubing Nitrite Concentration 
 
The  mean  silastic  tubing  nitrite  concentration  at  15  minutes  when  100µM 
nitrite was added into the aqueous phase of the bench top model was 705 (±25) µM.  
When other concentrations of nitrite were added to the aqueous environment the 
silastic tubing mean nitrite concentration showed a linear relationship (r
2=0.92) to 
the concentration of nitrite added as shown in figure 6.6.   
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Figure 6.5:  Mean NO concentrations within the aqueous phase of the model 1 are 
shown in relation to time (minutes).  Concentrations of NO are shown 
for four different concentrations of nitrite (10, 25, 50 and 100µM) which 
were added to the acidic aqueous phase containing 1mM ascorbic acid.  
Data  labels  show  the  mean  concentration  at  1  minute  (maximal 
concentration)  and  15  minutes.  Error  bars  represent  1  standard 
deviation.  n=12 
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Figure 6.6:  Mean silastic tubing concentrations are shown at the end of a 15 minute 
experiment, where silastic tubing with a neutral luminal compartment 
was exposed to an acidic phase containing ascorbic acid, to which was 
added one of four nitrite concentrations (10, 25, 50 and 100µM) at time 
0 minutes. Data labels show the mean nitrite concentration within the 
lumen.  Error bars represent 1 standard deviation from the mean value.  
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6.3.1.3  Silastic tubing NMOR concentrations with different silastic tubing 
morpholine concentrations 
 
Model 1 was used but on this occasion varying concentrations of morpholine 
were placed within the silastic tubing (5 mM, 10 mM, 25 mM, 33 mM, 50 mM and 
100  mM).    Keeping  all  other  experimental  conditions  the  same,  there  was  an 
increase in the mean NMOR concentration formed as the morpholine concentration 
was  increased  (figure  6.7).    However,  this  relationship  was  not  linear  (r
2=0.69).  
When  100  µM  nitrite  was  added  to  the  aqueous  phase  surrounding  the  silastic 
tubing, the mean concentration of NMOR at 15 minutes, when 5 mM morpholine 
was present within the tubing, was 8.24 (± 3.11) µM.  The mean silastic tubing 
NMOR  concentrations  at  15  minutes  was  49.0  (±13.9)  µM,  when  25  mM 
morpholine  was  present  within  the  tubing  at  the  start  of  the  experiment.    This 
represents a nitrite to NMOR ratio of 1:14. 
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Figure 6.7:  NMOR concentrations (µM) in the silastic tubing at the end of a 15 
minute incubation, according to the concentration of secondary amine 
present (5, 10, 25, 33, 50, 100 mM).  The tube was exposed to an acidic 
aqueous phase in the presence of ascorbic acid, with 100 µM sodium 
nitrite  added  to  initiate  the  experiment.    Data  labels  show  the  mean 
NMOR concentration within the tube.  Error bars represent 1 standard 
deviation from the mean. n=12 
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6.3.2 Compartmentalisation of silastic tubing using Model 2 
 
Two separate experiments were performed to assess for compartmentalisation.  
The first of these experiments looks at physical compartmentalisation in the aqueous 
phase,  while  the  second  experiment  determines  the  effectiveness  of 
compartmentalisation as regards the diffusion of gaseous NO. 
 
6.3.2.1  pH  Studies  to  determine  successful  compartmentalisation  of 
silastic tubing in Model 2 
 
This experiment was performed to assess for liquid compartmentalisation of 
the  silastic  tubing  into  sections.    Into  one  open  end  of  the  silastic  tube  was 
introduced a solution of HCl (pH 1.5) using a Thomson injector needle, while into 
the other end was added PBS (pH 7.4).  The pH was recorded at the start of the 
experiment, and also at the end of twelve hours to allow for any diffusion.  This 
experiment was repeated six times.  There was no recordable-statistical difference 
between the starting pH and the final pH in any of the experiments, indicating that 
there was no liquid diffusion contamination (table 6.1). 
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Table 6.1:  Starting and finishing pH in 12 hour aqueous diffusion experiment to 
assess compartmentalisation of silastic tubing 
 
  Starting pH 
(average of 6 
experiments) 
Finishing pH 
(average of 6 
experiments) 
Acid  
Compartment 
 
1.5 ± 0 
 
1.51 ± 0.01 
Neutral 
Compartment 
 
7.4 ± 0 
 
7.38 ± 0.03 
 
 
6.3.2.2  Studies  to  Assess  Gaseous  Contamination  of  Neighbouring 
Sections of Tubing 
 
Given  that  NO  can  diffuse  through  the  membrane,  these  studies  were 
undertaken to determine whether NO could diffuse through the length of the wall of 
the tubing and contaminate neighbouring sections.  Model 2 allows us to assess for 
nitrosation, by measuring nitrite and NMOR from sections deliberately exposed to 
NO, as opposed to neighbouring sections deliberately not exposed to NO.  In this 
model 100 µM nitrite was added to the aqueous phase containing ascorbic acid.  
Results from this model show that only those compartments exposed to NO had 
significant concentrations of nitrite and NMOR (table 6.2).  The concentration of 181 
 
nitrite in those compartments not exposed to NO was 5 (±2) µM, while the average 
concentration in the compartments exposed to NO was 689 (±36) µM.  The mean 
NMOR  in  the  compartments  exposed  to  NO  was  50.13  (±11.5)  µM  while  no 
detectable NMOR was found in any of the compartments not subjected to NO. 
 
Table 6.2:  Luminal NMOR (μM) and NO2 (mM) ± SD according to the section of 
silastic tube analysed at 15 minutes 
 
Compartment  Submerged in 
NO containing 
aqueous phase 
Mean nitrite 
µM (±SD) 
Mean NMOR 
µM (±SD) 
1  No  3 (±2.5)  N.D. 
2  No  8 (±3.0)  N.D. 
3  Yes  705 (±35)  53.8 (±9.5) 
4  Yes  657 (±28)  48.1(±10.6) 
5  Yes  721 (±42)  46.3 (±11.0) 
6  Yes  676 (±39)  52.3 (±14.7) 
7  No  7 (±1.5)  N.D. 
8  No  5 (±0.5)  N.D. 
 
This series of results demonstrates appropriate compartmentalisation such that 
there is no aqueous diffusion through the twists and no diffusion of NO along the 
length of the silastic tubing. 182 
 
6.3.3  Studies using model 3 with α-tocopherol on the outside and inside of the   
tube with luminal pH 1.5 
 
Comparison between tubing smeared with ʱ-tocopherol on the inside and the 
tubing not so treated showed that, in the presence of ascorbic acid, when the tube 
was exposed to 1 mM acidified nitrite, there was a significant reduction in the nitrite 
concentration  where  ʱ-tocopherol  was  present  (p=0.0000002)  (figure  6.8).    The 
mean nitrite concentration in the tubing without ʱ-tocopherol was 1831 (± 60.5) µM 
whereas the mean nitrite concentration was 1172 (± 65.6) µM when ʱ-tocopherol 
(1mM) was present.  In the absence of ascorbic acid there was a doubling in the 
mean  nitrite  concentration  when  ʱ-tocopherol  was  present  inside  the  tubing 
(p=0.000006).  In experiments where there was no ascorbic acid there was a mean 
nitrite concentration of 229 (± 32.7) µM in tubing without ʱ-tocopherol compared to 
478 (± 20.1) µM when ʱ-tocopherol was present inside the tubing.  For experiments 
with ʱ-tocopherol smeared on the outside of the tube, in the absence of ascorbic 
acid, the mean nitrite concentration from the inside of the tubing was 838 (± 45) µM.  
This  reflects  a four  fold increase in  nitrite concentration as  compared  to  studies 
where there was no ascorbic acid and no ʱ-tocopherol (p=0.0000004), and is double 
the concentration compared to when ʱ-tocopherol is on the inside of the tubing.  
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Figure 6.8:  The  mean  silastic  tubing  nitrite  under  different  experimental 
conditions  after  the  addition  of  1mM  sodium  nitrite  into  an  acidic 
aqueous phase surrounding silastic tubing.  The different experimental 
conditions are in the absence of ascorbic acid (asc) and ʱ-tocopherol 
(ʱ-TP) (dark blue column), absence of ascorbic acid with concentrated 
ʱ-tocopherol smeared on the inside of the tubing (red column), in the 
absence of ascorbic acid with concentrated ʱ-tocopherol smeared on 
the outside of the tubing (green column), 5mM ascorbic acid present in 
the  aqueous  phase  with  concentrated  ʱ-tocopherol  smeared  on  the 
inside  of  the  tubing  (purple  column),  5mM  ascorbic  acid  present 
within  the  aqueous  phase  with  no  ʱ-tocopherol  present  (light  blue 
column).    Data  labels  show  mean  values.    Error  bars  represent  1 
standard deviation. 
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6.3.4   Model 4 with Α-tocopherol on the outside of silastic tubing with varying 
pH of the luminal silastic tube compartment and no ascorbic acid in the 
aqueous phase 
 
At pH 4.5 no nitrite was found within the tubing whether thiocyanate was 
present  or  not.    In  experiments  with  reduced  pH,  there  was  increased  nitrite 
formation within the tubing in the presence of ʱ-tocopherol, with six times the nitrite 
concentration  present  at  pH  0.6  compared  to  pH  2.5  (p<0.001)  (figure  6.9).  
Thiocyanate  made  the  greatest  percentage  increase  in  silastic  tube  nitrite,  in  the 
presence of ʱ-tocopherol when the pH was 1.5, as it led to over a doubling of nitrite 
concentration compared to when ʱ-tocopherol was present alone (326 μM to 823 
μM).  At a pH of less than 4.5 the acidity of the solution made no difference to the 
effect of thiocyanate on silastic tube mean nitrite concentrations, in the absence of ʱ-
tocopherol (p>0.2).  There was also no difference in silastic tube mean nitrite across 
the range of pH’s less than 4.5 in the absence of both thiocyanate and ʱ-tocopherol 
(p>0.05).    
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Figure 6.9:  The mean nitrite concentration within silastic tubing with different pH 
of the silastic tubing compartment.  Within the silastic tubing there was 
one of four experimental conditions.  There was a combination of the 
presence or absence of ʱ-tocopherol (ʱTP) and thiocyanate (SCN).  The 
tubing was bathed in an acidic aqueous phase which always contained 
EDTA  (1  mM),  NaSCN  (1  mM)  and  ascorbic  acid  (5  mM),  and  to 
which was added NaNO2 (1 mM) to initiate the generation of NO. Data 
labels  show  the  mean  nitrite  concentration.    Error  bars  represent  1 
standard deviation. n=12 
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6.4 Discussion 
 
This chapter describes the design of a useful model for nitrosative stress in 
vitro which can be transferred to the in vivo setting.  Silastic membranes have been 
known to behave in a similar way to epithelial lipid membranes, in terms of NO and 
O2 diffusion, for some time, and have been successfully used in several different 
experimental models  (44,273-277).   In previous  studies, silastic tubing had been 
used to show nitrosative stress in bench top models of the chemistry occurring in the 
upper gastrointestinal tract, where salivary nitrite meets acidic gastric juice (44).  We 
have taken this model and made adjustments to provide a potentially useful tool for 
in vivo studies.  This model has had to be developed in stages to show robustness, 
allowing its use in vivo, while still demonstrating nitrosative stress.  The model has 
been adapted further still, to create a more physiologically representative situation 
where lipid antioxidants are also present.  The use of lipid antioxidants in this setting 
has provided information relating to the chemistry of nitrosative stress, secondary to 
the generation of NO from nitrite.  
 
In  model  1,  after  the  addition  of  nitrite  to  the  acidic  aqueous  phase  in  the 
presence of ascorbic acid, NO is generated.  NO will rapidly diffuse into and through 
the silastic membrane (120,251).  As NO passes through the silastic tubing, it reacts 
with O2 to form N2O3, (273).  N2O3 can then nitrosate secondary amines such as 
morpholine (120,278).  N2O3 also reacts with water in the neutral pH of the lumen of 
the tubing, to form nitrite (279).  The nitrite formed in this way is trapped within the 187 
 
lumen  and  is  indicative  of  the  flux  of  NO  into  the  tubing.    The  exact  NO 
concentrations generated within the lumen of the human upper gastrointestinal tract, 
at any one time, depend mainly on the delivery of nitrite from saliva.  There is 
evidence that after a nitrate rich meal there, high concentrations of NO in excess of 
100µM are produced (43,45,280).  This study, showed that across a range of NO 
concentrations from 10-100µM detectable levels of nitrite are generated within the 
neutral  lumen  of  silastic  tubing.    This  is  particularly  useful  information,  as  the 
thickness of the wall of tubing used in these experiments was considerably greater 
than those used in a previous model developed by Iijima et al (44).  It may have been 
that with the increased thickness, there was not sufficient passage of NO to generate 
nitrosative  stress,  at  the  concentrations  of  NO  we  expect  to  find  in  vivo.    The 
thickness of the tubing was increased to facilitate passing it nasogastrically, without 
coiling in the oropharynx.  This also allowed us to use a tube with a greater internal 
capacity, and thus provide us with more volume for subsequent nitrite and NMOR 
analysis.    The  silastic  tubing  nitrite  concentrations  increased  linearly  with  the 
increase in aqueous phase NO concentrations used in these experiments making the 
tubing a useful tool for measuring the amount of nitrosative stress produced over the 
range  of  NO  concentrations  we  would  expect  to  encounter  at  and  around  the 
gastroesophageal junction. 
 
There  was  an  increase  in  the  NMOR  concentration  generated  as  the 
concentration of morpholine was increased within the silastic tubing, although this 
relationship was not linear.  At the concentrations of NO we may expect to find in 188 
 
vivo after a nitrate meal, the most suitable morpholine concentration was 25mM as 
this provided a NMOR concentration which was within the range of concentrations 
which were easily measurable, using the same nitrosamine analysis and calculations 
as were already in place for previous experiments.   The simultaneous increase in 
NMOR and nitrite suggests this is largely mediated by NO produced by the reaction 
of nitrite with ascorbic acid, in the acidic aqueous phase of model 1.  Previous work 
has  shown that in  the absence of ascorbic acid  in  the aqueous  phase, there was 
accumulation of nitrite within the luminal compartment of silastic tubing, although 
the  concentration  found  was  not  as  high  as  when  ascorbic  acid  was  present.  
However, only very low concentrations of silastic tubing N-nitrosamine were formed 
when there was no ascorbic acid present.  The accumulation of some nitrite can be 
partly  explained  by  nitrous  acid  passing  through  the  membrane,  and  also  by 
chemical  species  such  as  N2O3  passing  through  the  membrane  in  small 
concentrations into the lumen of the tubing, where they can then be oxidised to 
nitrite (44).   
 
In  order  to  be  useful  for  defining  anatomical  areas  of  increased  nitrosative 
stress there had to be compartmentalisation of the silastic tubing into small sections.  
To provide enough volume from the lumen, the tubing was divided into individual 
sections  every  1.5  cm.    This  section  length  was  also  the  smallest,  technically 
feasible,  with  the  diameter  of  tubing  and  the  tying  required.    Several  different 
methods  of  forming  suitable  compartments  were  attempted  before  the  method 
described above was proven to be successful.  The compartmentalisation had to be 189 
 
intact, so that there was no aqueous diffusion between neighbouring sections.  pH 
studies confirmed that there was little if any diffusion of aqueous contents of the 
tubing between sections.  As NO is very lipophilic (251), we also had to ensure that 
there  was  no  diffusion  of  NO  along  the  length  of  the  tubing,  into  neighbouring 
sections.  The results presented confirm that there is minimal, if any, NO diffusion 
along the length of the tubing.  Therefore, if a section of the tube is situated within a 
certain  anatomical  region,  then  the  nitrite  and  NMOR  concentrations  from  that 
section represent the nitrosative stress arising at that anatomical location. 
 
The last part of this chapter looks at the presence of ʱ-tocopherol inside and 
outside the silastic tubing.  The intention in using ʱ-tocopherol, had been to build up 
a physiologically relevant model, which was more representative of the conditions in 
vivo.  There were limitations using models 3 and 4.  The most important is that 
controlling the exact concentration of ʱ-tocopherol smeared along the tubing was not 
possible.  It may also be that where ʱ-tocopherol was smeared on the outside of the 
tubing there was some of the lipid antioxidant distributed into the aqueous phase as 
small particles.  There were, however, some interesting results from these studies.  
When ascorbic acid was present in an aqueous phase, ʱ-tocopherol within the tubing 
resulted in a reduction in silastic tube nitrite of approximately 35% compared to 
when there was no ʱ-tocopherol.  However, in the absence of ascorbic acid in the 
aqueous phase ʱ-tocopherol inside the tubing led to more than a doubling of the 
silastic tube nitrite concentration compared to when there was neither ascorbic acid 190 
 
or ʱ-tocopherol.  The silastic tube nitrite concentration was higher still when ʱ-
tocopherol was smeared on the outside of the tubing, in the absence of ascorbic acid.   
 
The reaction of ʱ-tocopherol with NO was an area of much controversy in the 
mid 1990s.  Reports of a direct oxidant effect of NO with ʱ-tocopherol generating ʱ-
tocopheroxyl radical were suggested by several researchers (153-155).  Other groups 
found that ʱ-tocopherol was stable in the presence of NO (157,281).  It appears that 
NO does not directly react with ʱ-tocopherol, but rather ʱ-tocopherol oxidation is 
due  to  oxidised  metabolites  of  NO  such  as  N2O3.    The  oxidised  products  of  ʱ-
tocopherol include ʱ-tocopheroxyl radical and ʱ-tocopheryl quinine (158).  It has 
been suggested that, in  this way, ʱ-tocopherol acts as an antioxidant to an even 
greater extent than aqueous antioxidants.  Other studies have gone on to suggest a 
complex  and  as  yet  undefined  oxidation  process  between  ʱ-tocopherol  and  NO, 
resulting in compounds such as the nitrite ester of ʱ-tocopherol (282).  It is known 
that when nitrite reacts with tocopherol NO is generated (283,284).  This chemistry 
has relevance to the findings in our studies.  In the presence of ascorbic acid in the 
aqueous phase, NO is generated, and diffuses across the silastic membrane, where it 
reacts with O2 to form N2O3.  In the absence of ʱ-tocopherol, nitrite will accumulate 
from the reaction of this N2O3 with water.  When ʱ-tocopherol is present inside the 
tubing  it  will  compete  for  the  reaction  with  N2O3,  resulting  in  less  nitrite 
accumulating  within  the  tubing.    In  an  acidic  aqueous  environment,  but  in  the 
absence  of  ascorbic  acid,  and  with  no  ʱ-tocopherol  associated  with  the  silastic 
tubing, there is still a small accumulation of nitrite within the tubing.  This can be 191 
 
explained  by  the  fact  that  the  pKa  of  nitrous  acid  is  3.23  and  that  in  acidic 
environments nitrous acid is produced.  This nitrous acid will diffuse  across the 
silastic  membrane,  although  the  rate  of  diffusion  of  this  molecule  will  be 
considerably slower than the highly lipophilic NO molecule.   
 
When ʱ-tocopherol was smeared on the outside of the silastic tubing nitrite, and 
nitrous  acid,  will  react  with  ʱ-tocopherol  in  the  aqueous  phase  of  the  model, 
producing NO which then diffuses across the silastic membrane into the aerobic 
neutral environment, producing nitrite within the lumen of the tubing.  This can 
explain  the  high  nitrite  concentrations  in  silastic  tubing  when  ʱ-tocopherol  was 
smeared on the outside of the tubing in the absence of aqueous ascorbic acid.  That 
proposed mechanism of the production of ʱ-tocopherol derived NO facilitates its 
diffusion from aqueous phase to silastic tubing is supported by results showing an 
altered intraluminal silastic tubing pH and the presence or absence of thiocyanate.  A 
silastic tubing pH of 4.5 is above the pKa of nitrite (pKa 3.23).  This explains why 
there was no accumulation of nitrite in any of the experimental conditions where ʱ-
tocopherol was smeared on the outside of the tubing.  As the pH within silastic 
tubing became more acidic there was a proportional rise in silastic tubing nitrite 
concentrations when ʱ-tocopherol was present on the outside of the tubing.  There 
was no change in the silastic tubing nitrite concentrations with thiocyanate in the 
absence of ʱ-tocopherol as the pH was more acidic.  The presence of thiocyanate 
does however lead to higher nitrite concentrations in the presence of ʱ-tocopherol.  
These findings suggest that the increase in epithelial nitrite, when ʱ-tocopherol was 192 
 
smeared on the outside of the tubing in the absence of aqueous ascorbic acid, was 
influenced by the presence of nitrosating species and therefore largely NO mediated. 
 
 It was also found that, even when ʱ-tocopherol was smeared on the inside of 
the silastic tubing, in the absence of aqueous ascorbic acid, there was an increase in 
nitrite  accumulation.    In  these  experiments  however,  the  concentration  of  nitrite 
within the tubing was only half that seen when ʱ-tocopherol was smeared on the 
outside of the tubing.  This is a more difficult observation to explain but may be due 
to  ʱ-tocopherol  incorporating  its  structure  into  the  silastic  membrane  and  thus 
presenting its polar antioxidant head into the aqueous nitrite rich environment where 
NO can be formed and subsequently diffuse over the membrane. 
 
The studies with ʱ-tocopherol show the versatility of the silastic tubing model 
and how it could be manipulated to answer questions in vivo.  However, given that 
the concentrations of ʱ-tocopherol cannot be accurately determined, and that some 
of the mechanisms behind the NO ʱ-tocopherol interaction are yet to be defined, it 
would be premature to use this model in vivo at present. 
 
There is good evidence from the studies presented within this Chapter that the 
adapted  silastic  tubing  with  compartmentalisation  into  1.5  cm  segments,  will 
potentially be able to provide accurate information on nitrosative stress at different 
sites in the upper gastrointestinal tract. 
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Chapter 7  In vivo studies to determine sites of nitrosative stress at and around 
the  gastroesophageal  junction  in  subjects  with  a  healthy  acid 
secreting stomach. 
 
The work presented within this Chapter was carried out in collaboration with Dr J 
Winter. 
 
7.1   Introduction 
 
This  thesis  has,  so  far,  concentrated  on  bench  top  models  to  evaluate  the 
chemistry  occurring  at  and  around  the  gastroesophageal  junction,  in  relation  to 
dietary nitrate.  It is however recognised that these models do not necessarily fully 
represent  in  vivo  conditions.  Thus far, it has  not  been possible to  determine the 
dynamic effects of changing the luminal environment from normal to being rich in 
nitrite on human tissue.  It has been established that increased dietary nitrate leads to 
increased NO levels at the gastroesophageal junction (45).  It is proposed that the 
high concentrations of NO generated, at and around the gastroesophageal junction, 
will  lead  to  nitrosative  stress  in  those  individuals  with  a  healthy  acid  secreting 
stomach.  The compartmentalised silastic tubing, designed in Chapter 6, provides a 
tool for measuring nitrosative stress along the length of the oesophagus and stomach, 
and  in  particular  around  the  gastroesophageal  junction  in  human  subjects.    The 
following studies were therefore performed to assess any nitrosative stress in the 
upper gastrointestinal tract in vivo in healthy volunteers.    194 
 
7.2  Materials and Methods 
 
7.2.1 Silastic tubing  
 
Compartmentalised silastic tubing similar to Model 2 described in Chapter 6 
was created.  This tubing was filled with 25mM morpholine, which was buffered at 
intracellular pH 7.4 using 2mM phosphate buffer solution. Compartmentalisation of 
the tube into 21 compartments was performed as outlined previously (Chapter 6.2.2).  
In  order  to  simultaneously  monitor  luminal  pH,  a  customised  four  channel  pH 
catheter was attached to the silastic tubing by tying with Vicryl sutures and securing 
with Sleek waterproof tape.  To assist passage of the tubing, a 5 cm length of 10F 
gastric tubing containing a radio-opaque marker was secured to the distal end of the 
pH catheter.   The radio-opaque marker was also used to locate the end of the tubing 
and  ensure  the  tubing  was  sitting  in  the  appropriate  place  in  the  stomach  by 
radiography (Figure 7.1). 
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Figure 7.1:  Silastic tubing used in in vivo studies.  The sections shown represent the 
region that traversed the gastroesophageal junction.  The pH probe 1 
was  in  line  with  section  10.    This  was  the  probe  that  was  used  to 
determine if there was significant reflux of acidic stomach contents into 
the oesophagus. The pH probes 2 and 3 were tied beside sections 13 and 
14.  These probes were used to determine the pH step up point where 
the  acidic  stomach  contents  met  the  neutral  pH  environment  of  the 
oesophagus, and thus helped to define the gastroesophageal junction in 
these healthy volunteers.  The individual sections were 15mm in length 
each  containing  approx  80-100  µL  of  PBS  (pH  7.4)  with  25  mM 
morpholine.  
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7.2.2 Healthy human subjects and protocol 
 
Six male volunteers were recruited, with a median age of 42 years.  Ethical 
approval for the studies was granted by the West Glasgow’s University NHS Trust 
Ethical Approval Committee.  The subjects were healthy volunteers with no history 
of  reflux  disease  and  were  Helicobacter  pylori  negative  on  carbon  urea  breath 
testing.  These subjects attended, fasting, on two separate days.  On each day, they 
had the silastic tubing passed nasogastrically, such that sections 1-13 lay within the 
oesophagus and sections 14-21 lay within the stomach.  This was achieved using the 
pH sensors and confirmed radiologically (figure 7.2).  The tip of the tube lay 12 cm 
within the stomach.  Thirty minutes after the insertion of the tube, the subjects were 
administered one of the two study drinks.  On Day 1, the volunteer was given a 
control drink of 60 mL of water.  On Day 2, the volunteer was given 60 mL of water 
containing potassium nitrate (2 mmole).  This amount of KNO3 equates to the total 
in a standard meal of fish and chips 
 
The tube remained  in  situ for  two hours after the drink  had been  ingested.  
During this time, the pH was monitored, using the four channel pH catheter, at each 
site  every  four  seconds,  giving  a  detailed  assessment  of  the  acidity  around  the 
gastroesophageal  junction,  and  at  points  within  the  oesophagus  and  stomach.  
Immediately  before  the  drink  and  at  15  minute  intervals  after  it,  a  1  mL  saliva 
sample and a 10 mL blood sample were collected for measurement of serum nitrate 
and salivary nitrate concentrations.    197 
 
 
Figure 7.2: Radiograph  of  the  lower  chest  and  upper  abdomen,  and  4  channel 
continuous pH study of a healthy volunteer with silastic tube in situ.  
The pH channel probes are radio-opaque and are shown together with a 
radio-opaque marker secured at the most distal end of the pH catheter.  
Sections 13 and 14 lay either side of the gastroesophageal junction, as 
recognised by the pH step up point between probes 2  (green)  and 3 
(purple).  Probe 1 (red), adjacent to section 10, lay in the neutral pH 
oesophagus.  Probe 4 (blue), adjacent to section 19, lay within the more 
distal acidic stomach. 
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7.2.3 Serum nitrate analysis 
 
Blood  samples  (10  mL)  were  taken  from  a  20G  i.v  cannula  sited  in  the 
antecubital fossa at times 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes.  The first 5 
mL of this sample were discarded to allow for dead space within the cannula.  The 
serum sample (2 mL) was stored at –20°C prior to analysis. On thawing, 400 µL of 
sample  was  centrifuged  through  a  10-kilodalton  ultrafilter  to  remove  high-
molecular-weight  proteins.  Samples  were  then  mixed  with  a  nitrate  reductase  in 
reaction buffer and analysed as described in Chapter 2.1.5.  
 
7.2.4 Salivary nitrite analysis 
 
Salivary  samples  of  1  mL  were  obtained,  passively  without  stimulation  of 
salivation, at times 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes.  Samples were 
mixed  with  10  µL  of  5.0  M  NaOH.  This  rendered  the  samples  alkaline  and 
prevented loss of nitrite. Samples were stored at 4°C, then centrifuged and analyzed 
the same day, on 96-well microplates using the modified Griess reaction described 
in Chapter 2.1.4. 
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7.2.5 Silastic tube nitrite and NMOR concentrations  
 
Immediately after removal of the tube after 2 hours, each section of tubing was 
carefully  aspirated  using  a  100  µL  glass  syringe.    A  total  of  10  µL  of  sample 
removed from each section of tubing was used for measurement of the silastic tube 
nitrite concentration, while 40 µL was used for analysis of NMOR.  Analysis for 
concentrations of nitrite and NMOR were carried out as described in Chapter 2.1.10. 
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7.3  Results 
 
7.3.1 pH studies  
 
During the study, only small pH variations at the electrodes lying either side of 
the gastroesophageal junction were recorded.  There were changes in pH at these 
sites mainly related to movement with respiration and on swallowing.  There was 
excursion  of the tubing at  the  gastroesophageal junction  of 3-4  cm  with normal 
respiration as detected by fluoroscopic screening.  Actual reflux was recorded as a 
pH of less than 4 in the electrode placed 5 cm above the gastroesophageal junction 
(see figure 7.1 – probe 1 lying beside section 10 of the silastic tubing).  There was 
only one volunteer in whom reflux was observed and this was for a very short period 
of time.  It occurred only on the day that the control drink was given.  Overall, reflux 
was seen for a median of only 0.1% of the total time (interquartile range 0%-1.0%).  
The  pH  of  section  13  which  was  primarily  on  the  oesophageal  side  of  the 
gastroesophageal junction had a pH of less than 2 for only 7% of the time, while 
section 14, which was mainly on the gastric side of the gastroesophageal junction, 
had a pH of less than 2 for 63% of the time.  Section 19 was always exposed to an 
acidic environment.  
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7.3.2 Serum nitrate 
 
The  median  serum  nitrate  concentration  prior  to  the  administration  of  the 
control drink was 16.9 (interquartile range, 7.9 - 20.3) µM.  45 minutes after the 
administration  of  the  control  drink,  the  serum  nitrate  concentration  did  not 
significantly change (p>0.05) from the basal reading, with a median concentration of 
14.1 (interquartile range, 7.2-17.7) µM and this continued to the case up to the end 
of the experiment at 120 minutes.  However, after ingestion of a 2 mmole potassium 
nitrate  drink,  a  significant  increase  (p<0.005)  in  the  median  serum  nitrate 
concentration  was  observed,  from  12.7  (interquartile  range,  6.9-16.1)  µM  on 
sampling prior to administration of the drink to a peak of 47.1 (interquartile range, 
23.2-57.9)  µM  45  minutes  after  the  drink  was  given.    The  serum  nitrate 
concentration  remained  at  this  higher  level  concentration  for  the  duration  of  the 
study (figure 7.3). 
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Figure 7.3:  Median serum nitrate concentration (µM) in healthy volunteers at the 
given time intervals (minutes) during the 2 hours of the experiment after 
either a control drink or 2 mmole KNO3
- drink has been ingested at time 
0 minutes.  Interquartile ranges are shown by the error bars. 
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7.3.3 Salivary nitrite 
 
For volunteers, on the day they consumed the control drink, the median salivary 
nitrite concentration prior to the administration of the control was 63.7 (interquartile 
range, 43.5 – 89.4) µM.  75 minutes after the administration of the control drink, the 
salivary nitrite concentration did not significantly change (p>0.05) from the basal 
reading, with a median concentration of 57.3 (interquartile range, 38.6 – 87.5) µM.  
However, on the day the volunteers were given a 2 mmole potassium nitrate drink 
there  was  a  significant  increase  (p<0.0005)  in  the  median  salivary  nitrite 
concentration from 30.5 (interquartile range, 21.6 - 38.3) µM on sampling prior to 
administration of the drink to a peak of 330.9 (interquartile range, 250.2 – 398.5) 
µM  75  minutes  after  the  drink  was  ingested.    The  salivary  nitrite  concentration 
reached peak concentrations at 45 minutes (311.1 μM), and remained significantly 
elevated for the remainder of the study (figure 7.4). 
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Figure 7.4: Median salivary nitrite concentrations (µM) in healthy volunteers taken 
at  the  given  time  intervals  over  the  120  minute  time  course  of  the 
experiment.  Red columns represent the mean concentrations on the day 
the  KNO3  drink  was  ingested,  while  the  blue  columns  represent  the 
control day.  The concentration on the day a control drink was given is 
compared to a day on which a 2mmole nitrate drink was given.  Error 
bars represent the interquartile range. (n=6) 
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7.3.4 Silastic tube nitrite 
 
Nitrite was not detected within the tube sections lying within the oesophagus, 
whereas, nitrite was present in tube sections exposed to gastric acid, on both control 
and KNO3 administered days.  In the tubing from the control day the median total 
nitrite  formed  within  the  tube  was  13.1  (interquartile  range,  6.9-22.2)  nmoles 
whereas there was significantly more (p=0.001) nitrite formed within the tubing of 
volunteers when they were administered the KNO3 drink with the median value of 
42.1  (interquartile  range,  27.8  -  60.3)  nmoles.    The  concentration  profile  of  the 
sections of tubing was similar on both study days, with the highest concentration 
being  detected  in  sections  15  and  16  (figure  7.5).    These  sections  are  the  first 
sections to be exposed constantly to intragastric acidity.  Peak median concentrations 
of nitrite were detected in section 15, being 54.6 (interquartile range, 35.0-65.2) µM 
after the control drink and increasing to 128.9 (interquartile range, 46.1-148.7) µM 
after nitrite.  The peak median concentration of tubing nitrite was found in section 
16 on the day the nitrate drink was given, with a concentration of 180.8 (interquartile 
range,  95.0-229.7)  µM.    This  compares  to  a  median  concentration  of  53.0 
(interquartile range, 35.6-67.1) µM for the same section on the day a control drink 
was  given.    This  is  therefore  over  a  three  fold  increase  in  nitrite  concentration 
between the control drink group and those administered the nitrate drink (figure 7.5). 
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Figure 7.5:  Median silastic tubing nitrite concentrations for individual sections of 
tubing at the end of the 2 hour experiment.  The gastroesophageal (GO) 
junction is represented by the vertical line between sections 13 and 14.  
Results  are  shown  after  administration  of  either  the  control  drink  or 
nitrate drink. The data values shown below the graph are median values 
for each section after both control and KNO3. Median concentrations are 
shown with interquartile range indicated for each section by the error 
bars. 
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7.3.5 Silastic tube NMOR 
 
Throughout the sections of silastic tubing lying within the oesophagus, there 
was no NMOR detected.  However, NMOR was detected in the sections of tubing 
exposed to gastric acid in volunteers after administration of both control and nitrate 
drinks.  There was a significant difference in the NMOR formed in the tubing after 
administration of potassium nitrate (2 mmole) compared to the control, with a near 
doubling in the median concentration of NMOR (p=0.008) (Figure 7.6).  The median 
NMOR formed within the tube was 2.1 (interquartile range, 0.8-2.9) nmols on the 
control day and 4.3 (interquartile range, 2.3-6.6) nmols on the day the potassium 
nitrate drink was given.  In the control experiments, the peak NMOR concentration 
was  8.2 (interquartile range, 1.9-9.8) µM, measured in  section 15 of the tubing.  
However, the concentration profile was different on the day the volunteers were 
given the potassium nitrate drink.  There was a plateau of increased concentrations 
in the gastric lying sections of the tubing, rather than a peak concentration.  The 
peak NMOR concentration after nitrate drink was measured in section 19, where the 
concentration of 9.3 (interquartile range, 4.0-15.7) µM was almost four times the 2.3 
(interquartile range, 0-4.1) µM detected in section 19 on the day of the control drink.  
In  fact,  the  most  striking  differences  between  the  control  day  and  nitrate  drink 
NMOR concentrations occurred in the most distal section of gastric tubing.  Even in 
section  21,  the  most  distal  section  of  gastric  tubing,  there  was  3.5  (interquartile 
range, 0 – 7.3) µM NMOR formed on the day the volunteers had a nitrate drink 
compared to 1.0 (interquartile range 0 -2.1) µM on the control day 208 
 
 
 
 
Figure 7.6: Median  silastic  tube  NMOR  concentrations  at  the  end  of  a  2  hour 
experiment. The gastroesophageal (GO) junction is represented by the 
vertical  line  between  sections  13  and  14.    Results  are  shown  after 
administration  of  either  the  control  drink  or  nitrate  drink.  The  data 
values shown below the graph are median values for each section after 
both  control  and  KNO3.    Median  concentrations  are  shown  with 
interquartile range indicated for each section by the error bars. 
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7.3.6 Correlation of silastic tube nitrite with NMOR 
 
There  was  a  near  four  fold  increase  in  the  peak  silastic  tube  nitrite 
concentration  after  the  administration  of  nitrate.    However,  there  was  only  a 
doubling  in  the  peak  NMOR  concentration.    The  ratio  of  NMOR  to  nitrite  was 
therefore  calculated  for  each  gastric  tube  section.    The  median  of  all  ratios  of 
NMOR:nitrite  concentration  was  0.1258  (interquartile  range,  0.0903-0.1691)  µM 
after the control drink.  There was a significantly lower ratio of 0.0580 (interquartile 
range, 0.0445-0.0711) µM after the nitrate drink (p=0.0047).  For oesophageal tube 
sections  there  were  small  concentrations  of  nitrite  found  in  the  lower  two 
oesophageal sections in one of the subjects.  This subject was the same volunteer in 
whom there was a small degree of reflux recorded on the day the control drink was 
given.  There was no recordable NMOR found within these sections and therefore no 
ratios have been calculated. 
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7.4   Discussion 
 
A novel mechanism whereby dietary nitrate can produce nitrosative stress at 
and  around  the  gastroesophageal  junction  has  been  proposed.    This  has  been 
supported by the results of in vitro experiments using bench top models, described in 
this thesis, and by others working within this area of research (43,44,144,285,286).  
In this hypothetical model, NO is generated in extremely high concentrations where 
salivary  nitrite,  generated  from  dietary  nitrate,  meets  acidic  gastric  juice  in  the 
presence of ascorbic acid, as has been shown to be the case in human subjects after a 
nitrate  meal  (44,280).      The  model  suggests  that  NO  then  diffuses  into  the 
surrounding epithelial compartments or lipid where it can form nitrosating species 
such as dinitrogen trioxide through the reaction of NO with O2.     
 
This study indicates that the hypothetical model for N-nitrosation proposed 
above has relevance in an in vivo situation in subjects with a healthy acid secreting 
stomach.  Overall, healthy volunteers showed an increase in nitrosative stress in the 
upper gastrointestinal tract after a nitrate rich drink was given.  This was indicated 
by an increase in the total silastic tube nitrite and NMOR concentrations.  The site of 
all  of  the  nitrosative  stress  was  within  the  stomach  with  the  exception  of  one 
volunteer who had a short lived period of proven acidic reflux into the oesophagus.   
 
The highest concentrations of nitrite were seen within the sections of tubing 
that lay in the proximal stomach.  This was seen on both the control day and on the 211 
 
day a nitrate rich drink was given.  These findings would be in keeping with the 
anatomical site where high concentrations of salivary nitrite are first meeting with 
acidic gastric juice containing ascorbic acid (221).  Nitrite can enter into the lumen 
of the silastic tubing by one of two routes (44).  The first, and in these experiments 
the one likely to be more important, is the generation of NO from the reaction of 
nitrosating species with ascorbic acid.  The NO can then diffuse through the wall of 
the silastic tubing and both within the wall and within the lumen of the tubing, react 
with O2 to form N2O3.  N2O3 can then either react with nitrosatable species such as 
the amine present in the lumen or it can react with water to form nitrite as shown in 
the reaction: 
 
N2O3 + H2O  2NO2
- + 2H
+ 
 
In  an  acidic  environment  nitrite  will  largely  form  nitrous  acid  as  shown  by  the 
reaction: 
 
HNO2 H
+ + NO2
- 
 
The second mechanism through which nitrite can accumulate within the lumen of 
the tube depends on the pKa of nitrous acid being 3.34.  At the acidic pH found in 
subjects with a healthy acid secreting stomach nitrous acid is in the relatively non 
polar  form  HNO2.    This  HNO2  can  then  slowly  diffuse  through  the  wall  of  the 212 
 
silastic tube.  Once within the neutral environment of the tube lumen HNO2 will 
quickly form nitrite. 
 
One of the more surprising results from this study was the plateau effect of 
the distribution of NMOR within the sections of tubing extending into the more 
distal regions of the stomach.  The tubing extended into the stomach some 12.5cm.  
It had been expected that the nitrosative stress in this region would be less than at the 
gastroesophageal  junction  and  cardia  region  of  the  stomach.    These  results  can, 
however, be explained by the availability of chemical reactants within the lumen of 
the healthy acid secreting stomach.  We found that the peak nitrite concentration was 
in  the  sections  that  lay  within  the  proximal  stomach,  while  the  NMOR 
concentrations  appeared  in  the  proximal  stomach  and  concentrations  began  to 
plateau  in  the  more  distal  sections  in  the  stomach.    The  peak  concentration  of 
NMOR was seen several centimetres below the gastroesophageal junction in section 
19.  Therefore, there was a tendency for the ratio of nitrite to NMOR to be lower in 
the proximal stomach after the nitrate drink. The ratio of NMOR:nitrite within the 
silastic tube is an expression of NO:nitrite in the lumen of the gastrointestinal tract.  
NMOR only can be formed, within the epithelial compartment, by the diffusion of 
NO, whereas nitrite can be formed via the diffusion of either NO or nitrous acid, as 
discussed above.  The administration of nitrate resulted in a 230% increase in peak 
silastic  tube  nitrite  concentrations,  but  only  a  45%  increase  in  peak  NMOR 
concentrations.    Therefore,  the  nitrate  meal  actually  reduced  the  ratio  of 
NMOR:nitrite, although not the amount of NMOR produced.  This suggests that the 213 
 
entire increased amount of swallowed salivary nitrite was not being converted to NO 
in the proximal stomach, but rather some of it remained in the form of nitrous acid 
and nitrosating species in the lumen of the stomach itself.  This could occur if the 
high  proximal  stomach  nitrite  concentrations  have  exhausted  the  ascorbic  acid 
concentration.  This would then allow nitrite to enter the tubing as nitrous acid rather 
than NO.  There was intragastric variation in concentrations of ascorbic acid, with 
the concentrations being lower in the cardia region of the stomach than the more 
distal  region  (221).    The  reason  for  ascorbic  acid  concentrations  varying  within 
different regions of the stomach is not clear, although it is known that in the fasting 
state vitamin C is actively secreted into the stomach (96,134).  It has previously been 
observed that the ratio of nitrite to ascorbic acid is highest in the most proximal 
stomach, with the authors proposing that this was potentially the maximal site within 
the stomach for the well recognised acid-catalysed nitrosation (221).  The current 
studies  would  support  this  argument,  and  would  suggest  that  there  are  two 
mechanisms for nitrosation due to salivary nitrite in the human subject.  The first of 
these  is  the  well  established  and  analysed  acid-catalysed  nitrosation,  the  second 
being NO production in the presence of an antioxidant and a lipid phase.  The factor 
determining which mechanism of nitrosative stress is dominant in the human subject 
is the availability of ascorbic acid.    
 
Further studies using this silastic tube in vivo model have been performed by 
one of my colleagues (Winter J), with whom the initial studies were performed.  
Data from these studies are now published (286).  A further 12 ‘healthy’ volunteers 214 
 
were studied by the same methods described in this chapter.  The results for silastic 
tubing nitrite, NMOR and the correlation between them are reassuringly similar to 
the results presented within this thesis.  There was good correlation between the 
studies  in  terms  of the  sections  of tubing identified with  peak  concentrations  of 
nitrite and NMOR, and the median values for each section of tubing are remarkably 
consistent.    The  additional  12  patients  did  however  provide  an  interesting 
observation that helps support the argument for acid-catalysed nitrosation and NO 
mediated nitrosative stress.  One of the twelve volunteers was not included in the 
results of the studies, as they were found to be achlorhydric through recording from 
the pH probes in this study.  The silastic tube luminal contents from this volunteer 
did not contain any detectable nitrite or NMOR.  This is not to say that this person is 
at no risk of nitrosative stress.  There is another well recognised mechanism for 
nitrosation  within  the  human  stomach  and  that  is  through  denitrifying  bacteria 
generating nitrosating species and N-nitrosocompounds.  These bacteria can colonise 
an  achlorhydric  stomach  mucosa.    This  mechanism  is  thought  to  be  relevant  to 
patients  who  develop  noncardia  gastric  cancer,  secondary  to  atrophic  gastritis 
(68,287). 
 
Further studies were also performed using the silastic tube model to examine 
patients who were known to have Barrett’s oesophagus (286).  This group of patients 
was  chosen  as  they usually have severe  acid  reflux disease.  Within this  group, 
nitrite and NMOR were found in the oesophageal sections of the silastic tube lumen 
as well as the gastric sections.  The extent to which the nitrite and NMOR were 215 
 
detected was directly related to the degree of reflux as recorded on the pH probe 
lying within the oesophagus (286).   
 
Overall the studies in this chapter indicate that, in an in vivo setting, there are 
two mechanisms through which there is the potential for nitrosative stress within the 
upper  gastrointestinal  tract  from  dietary  nitrate.    There  is  the  well  established 
luminal acid-catalysed N-nitrosation in the absence, or exhaustion, of ascorbic acid, 
and  there  is  NO  mediated  stress  in  the  healthy  acid  and  ascorbic  acid  secreting 
stomach.  These studies have allowed us to determine where there are the different 
types of stresses, as the ratio of nitrite to nitrosamine allows us to determine whether 
the stress is from NO, where there is both nitrite and NMOR formed, or from acid-
catalysed nitrosation from nitrous acid, where there is accumulation of nitrite in the 
tubing but there is not the nitrosating potential of this to generate nitrosamine within 
the tubing.  It has previously been established that NO has mutagenic potential to a 
cell through DNA base deamination, inactivating DNA repair enzymes, inactivating 
DNA repair enzymes and through the generation of N-nitrosocompounds such as 
nitrosamines.  It is also known that within cells there is a range of compounds that 
could be nitrosated to potentially mutagenic products. These compounds that are 
potentially nitrosated include secondary amines, polyamines, amino acids, peptides 
and amides (200,288-290).  With particular relevance to the upper gastrointestinal 
tract  are  conjugated  bile  salts  glycocholic  acid  and  taurocholic  acid.    These  are 
amides that are potentially present within the refluxate of bile.  It is known that bile 
and acid reflux are irritants to the lower oesophagus causing oesophagitis.  With 216 
 
oesophagitis as a background, there is then also the potential of nitrosated bile salts 
adding insult to the already exposed and damaged epithelium. 217 
 
Chapter 8  Studies to determine intraepithelial nitrate and nitrite from human 
upper gastrointestinal tract tissue 
 
8.1   Introduction 
 
While in vitro studies suggest a potential mechanism for nitrosative stress from 
dietary nitrate, with the possible implication of this chemistry contributing to the 
increasing  incidence  in  adenocarcinoma  at  and  around  the  gastroesophageal 
junction, there had been no confirmation of this stress from human tissue studies.  
As has been discussed previously within this thesis, an influx of nitrite is a good 
marker of increased nitrosative stress.  Therefore, if increased nitrite and related 
chemistry, such as nitrate, could be measured in the intraepithelial compartment of 
cells from human tissue biopsies, this would be good evidence for nitrosative stress 
at an in vivo cellular level. 
 
The intraepithelial measurement of nitrite and nitrate from biopsies from the 
upper GI tract has not previously been described, therefore new techniques were 
attempted to obtain this information.  This chapter describes the process of obtaining 
human biopsy specimens from specific anatomical regions of the oesophagus and 
stomach,  cleaning  of  these  samples,  lysis  of  the  cells  within  these  samples  and 
specific analysis of nitrite and nitrate from the samples.  The subsequent Chapter, 
Chapter 9, will describe anatomical variation in nitrate and nitrite concentrations 
from biopsies. 218 
 
 
Previous studies within this thesis have analysed nitrite from a simple medium 
in bench-top models.  Human tissue is more complex and therefore analysis of two 
different  methods  of  determining  nitrite  concentration  was  undertaken.    These 
methods are the Greiss Reagent and the release of NO recorded using an NO probe, 
and are described in this chapter. 
 
As well as measuring nitrite from upper gastrointestinal tract biopsies, it is also 
important to measure nitrate in vivo.  This is because human tissue is more complex 
than previously used bench top models.  It has been shown that in biological tissue 
the most important metabolic reaction of NO is with iron in oxyhaemoglobin to 
produce methaemoglobin and nitrate (291), as shown in the following reaction:   
 
[HbFe(II)O2]2 + NO  [HbFe(III)]3
+ + NO3
- 
 
For example, the uptake of NO into the red blood cells with subsequent oxidation is 
the major metabolic pathway for endogenously formed NO (292).  Also, it is known 
that  NO  reacts  with  superoxide  in  aqueous  solution  to  form  peroxynitrite.  
Superoxide ion has been shown to be ubiquitous in mammalian cells (293).  The 
peroxynitrite/peroxynitrous  acid  system  is  known  to  be  very  labile,  and  the 
decomposition products from this are nitrate, nitrite and dioxygen (294), as shown 
by the following reactions: 
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O2
- + NO  OONO 
 
4OONO  2NO3
- + 2NO2
- + O2 
 
It has also previously been shown that in the presence of peroxynitrite, nitrite is 
converted to nitrate.  Therefore, in the following studies nitrate concentration is also 
measured.  
 
Upper gastrointestinal tract biopsies require a cleaning process, as surrounding 
mucus and the haem components of blood would interfere with subsequent analysis 
of intraepithelial nitrite/nitrate.  Within the lumen, oesophageal defences against acid 
include  pre-epithelial  compartments  such  as  mucus  and  bicarbonate  (295,296).  
Mucus itself is  not  an  effective barrier to  hydrogen ions  (297,298) but  provides 
mucosal protection by contributing to an area of low turbulence. Adjacent to the 
mucosa is the unstirred water layer (299).  This layer acts as a sink for bicarbonate 
ions,  creating  an  alkaline  environment  close  to  the  mucosal  surface  (298-300).  
Mucus,  lining  the  epithelial  surfaces,  will  be  the  first  point  of  contact  of  the 
luminally generated NO.  Nitrite is formed from the reaction of NO with water at a 
more neutral pH, so therefore nitrite can be expected to be formed here when NO 
diffuses into the mucus. This would mean that unclean biopsies could record high 
nitrite  concentrations  from  the  mucus,  without  this  being  a  reflection  of 
intraepithelial nitrite content. 
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There are several mucolytic agents that are used in cleaning mucus from biopsy 
samples.  Mucolytic agents that were explored as possible cleaning agents for the 
studies presented in the chapter were N-Acetylcysteine (NAC) (301), pepsin, and 
pronase  E.    Unfortunately,  these  cleaning  agents  are  normally  used  in  a  setting 
where  rupture  or  leak  of  the  cell  membranes  would  not  be  important.    For  the 
proposed  measurement  of  intraepithelial  contents,  it  was  thought  that  the  ideal 
solution would be isotonic and non toxic to the cell membrane.  Pepsin works best at 
lower pH and from pH 6 and above is unstable.  Therefore, this wasn’t suitable for 
use in these studies where there is a neutral pH.  NAC is known to be a mucolytic 
agent  that  has  been  previously  used  to  clean  surrounding  mucus  from 
gastrointestinal biopsy specimens.  Solutions between 3 and 10% NAC have been 
used effectively to clean samples from the upper gastrointestinal tract (302,303).  A 
solution of NAC is acidic and the pH of a solution of 3.1% NAC is 3.  "Pronase E" 
is  the name  given to  a  group of proteolytic enzymes  produced by Streptomyces 
griseus K-1.  At least 10 proteases are in the mixture, five serine-type proteases, two 
zinc  endopeptidases,  two  zinc  leucine  aminopeptidases  and  one  zinc 
carboxypeptidase.  Digestion with the product has been useful when extensive or 
complete degradation of protein is required.  It has previously been used to digest 
mucus from rat stomachs in experimental models (304-307).  In previous studies this 
has always been used as part of a harvesting of cells and has not been used simply to 
clean around biopsy specimens.  It has stable activity across a range of pH from 5.0-
9.0.   Cleaning methods are described in this chapter. 
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After cleaning of the surrounding mucus, lysis of the cell membranes within the 
biopsy  sample  had  to  be  performed  as  the  intracellular  concentrations  are  the 
measurements that are expected to be important.  A suitable method of cell lysis, to 
release intracellular nitrite and nitrate into surrounding PBS, had to be developed 
and is discussed. 
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8.2 Materials and Methods 
 
8.2.1 Obtaining and storing upper gastrointestinal tract samples 
 
Epithelial  biopsies  from  the  oesophagus  and  stomach  were  obtained  from 
volunteers  undergoing  upper  gastrointestinal  endoscopy  in  Gartnavel  General 
Hospital.    Ethical  approval  for  the  studies  was  granted  by  the  West  Glasgow’s 
University NHS Trust Ethical Approval Committee.  All patients were confirmed 
Helicobacter pylori negative by urease CLO testing, and were not receiving antacid 
therapy.  Biopsies were taken using standard endoscopy forceps with large capacity.  
The gastroesophageal junction was identified as the top of the mucosal folds and 
coincided  with  the  squamo-columnar  junction  in  these  healthy  subjects.  
Oesophageal  biopsies  were  taken  5  cm  above  the  gastroesophageal  junction.  
Proximal  stomach  biopsies  were  taken  immediately  below  the  gastroesophageal 
junction.  Distal stomach biopsies were taken from the distal body of the stomach.  
Immediately  after  removing  the  forceps  from  the  scope  portal,  the  sample  was 
transferred  from  the  forceps  using  tweezers,  and  placed  into  a  1  mL  plastic 
Eppendorf test tube after undergoing a cleaning process.  PBS (80 µL) was added to 
the sample, which was placed in liquid nitrogen for transfer to a -70
oC freezer.  All 
samples were analysed within four weeks. 
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8.2.2 Determining the optimal method for cleaning biopsy samples 
 
Cleaning Solutions assessed:  
 
NAC -  In order to prevent osmotic and acidic lysis of our cells during the 
cleaning  stage,  it  was  important  to  clean  samples  at  a  neutral  pH,  with  a 
physiological osmolarity.  Therefore, sodium bicarbonate (200 mM) was added to 
3.1% NAC to give a final pH of 7.2 and osmolarity of 320 mM.  Biopsy samples 
were left in this solution for 30 minutes.  After 30 minutes the sample was taken out 
and placed on benchguard paper, and any obvious surrounding mucus removed. 
 
Pronase E – 1% pronase was added to PBS (pH 7.4).  The biopsy samples were 
placed  in  a  plastic  Eppendorf  test  tube  containing  2  mL  of  this  solution  for  30 
minutes.  Thereafter, the samples were placed on benchguard paper and any obvious 
surrounding mucus was cleaned. 
 
In experiments used to assess the efficacy of cleaning using these solutions, 
twelve  biopsy  samples  were  placed  in  an  Eppendorf  test  tube  containing  2  mL 
KNO3
- (5mM) enriched with 
15N.  These were compared to control samples exposed 
to the same contaminant but which had no cleaning.  
15N content of samples was 
then analysed.  
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8.2.3  Protein concentration as a measure for weight of biopsy samples 
 
Upper  gastrointestinal  tract  biopsy  samples  vary  largely  in  size.    Multiple 
biopsy samples were taken and analysed for wet and dry weight after heating in an 
incubator overnight.  It is particularly important to do this given that oesophageal 
biopsies are more difficult to obtain and generally are smaller.  This revealed that 
wet weight could vary by up to five times between the biopsy sample weights.  The 
dry weight was approximately 10-15% of the wet weight.  The protein content may 
be used as a standard against size for each sample.  This would allow standardisation 
of the nitrite and nitrate content of each sample, according to concentration per unit 
of protein.  
 
8.2.4 Releasing intraepithelial contents by cell membrane lysis 
 
A comparison of four different methods of cell lysis was made by measuring 
total nitrite and protein concentrations from each biopsy sample.  Each method was 
performed on  each sample from  each of  the three areas  of interest  in  the upper 
gastrointestinal  tract.   There  were thirty-six times  samples  taken to obtain  mean 
values (± 1 standard deviation).   
 
Snap freezing:  Immediately after the cleaning process the biopsy sample was 
placed in 80 µL PBS in a 1 mL plastic Eppendorf test tube.   It was then immediately 225 
 
placed  into  liquid  nitrogen  to  snap  freeze  the  sample,  thus  bursting  the  cell 
membranes. 
Homogenisation:  After snap freezing the samples were homogenised in a 
glass, 1 mL, hand held homogeniser for 120 seconds. 
Sonication:  After snap freezing, the samples were defrosted and sonicated at 
6 microns amplitude for three minutes before being centrifuged for three minutes at 
13000 rpm in a microcentaur.  The supernatant was thereafter analysed. 
Homogenisation and Sonication combined: samples were snap frozen then 
homogenised, sonicated and centrifuged as in the above descriptions. 
 
8.2.5  Biopsy nitrite concentration analysis  
 
Within  the  laboratory  we  had  access  to,  and  experience  of  using,  several 
methodologies for nitrite concentration measurement.  Previous assessment of the 
HPLC  method  suggested  it  did  not  provide  any  more  accurate  measurement 
compared to the relatively simple Greiss reagent. For the studies in this chapter the 
Greiss reagent was compared to measurement using a NO probe. 
 
a.  NO probe 
b.  One step Greiss reagent 
 
a.  NO assessment is based on using NO production in an acidic environment 
and measuring NO with a WPI NO probe.  The method used was based on 226 
 
the same principles, and used the same probe, as discussed in Chapter 2.1.1.  
There  was  however several  differences  from  the basic methodology  and 
these will be described here.  These differences arise mainly due to the 
small volumes and small concentrations of nitrite expected to be found.  
 
The  NO  probe  was  calibrated  at  room  temperature  using  known 
standards. As the sample was diluted by surrounding PBS, the expected 
concentration  of  nitrite,  and  therefore  NO  generated  was  low.    The 
standards used to calibrate the probe were therefore, 10 nM, 50 nM, 100 
nM, 500 nM and 1 µM nitrite.  To the standards, an acidic reaction solution 
(Solution A) was added to generate NO.  Solution A was made up of 30mls 
dH2O, 0.55 g of potassium iodide (KI) and 200 µL of concentrated H2SO4.  
This had to be stored in the dark until it is used to prevent the KI reacting 
with light.  80 µL of each standard was added to 80 µL of solution A to 
obtain a graph of standard concentrations against the pA reading of each 
and to provide a y value from which we were able to calculate the NO 
concentration produced from the samples with unknown nitrite content.  As 
with the standards, we added 80 µL of sample to solution A to liberate the 
nitrite  as  NO  and  took  a  pA  reading  which  was  converted  into  a 
concentration of NO released.  In this experiment there was gross excess of 
KI  in  acid  this  reflects  the  nitrite  concentrations  as  all  nitrite  will  be 
converted to NO. 
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Given  that  the  approximate  intracellular  volume  of  the  samples  was 
only 3 µL, the total volume of acidic solution that could be used to initiate 
the  release  of  NO  was  very  small,  and  this  led  to  several  technical 
difficulties.  There has to be sufficient volume to cover the membrane of the 
probe.  Also, due to the fact that the reading was based on a current, when 
the  NO  probe  was  touched  the  baseline  amplitude  of  electrical  current 
changed.  Although the amplitude changes due to this interference were 
only a matter of tens of pA they were still significant because the samples 
being analysed were very dilute and the readings we expected to see were 
very small.   
 
b.   One  step  Greiss  Reagent  –  Nitrate  and  nitrite  have  previously  been 
measured within human biological material by the simple Greiss reaction 
(308-310). This method of measuring is outlined in Chapter 2.1.4. 
 
After deliberately exposing 12 biopsy samples to high concentrations of NO 
generated in the model shown in figure 8.1, nitrite concentrations were measured 
using both of the methods described above.  Of the total 80 µL volume half was used 
for analysis by the NO probe method, and half was used for the one step Greiss 
reagent method.   
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Figure 8.1:  Schematic  diagram  of  the  model  used  to  expose  human  upper 
gastrointestinal tract biopsy samples to NO.  A 20 mL glass vial was 
filled with HCl (pH 1.5), ascorbic cid (1 mM), NaSCN (1 mM) and 
NaNO2 (50 µM) to allow generation of approximately 50 µM of NO.  
The lid of this vial was cut in the middle to establish a small hole.  Into 
this hole were placed three biopsy samples, so that the samples were 
both in contact with, both the lower layer to form a seal, and also the air 
outside the vial.  Concentrations of NO were 45 µM and above in the 
aqueous phase of this model after 30 seconds, and were maintained at 
this high concentration for the 15 minutes that the biopsies remained 
inside.   
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8.3 Results  
 
8.3.1 Cleaning with NAC and pronase E 
 
These experiments revealed that after cleaning with 3.1% NAC only 7% 
15N 
remained  while  25% 
15N  remained  when  Pronase  E  was  used  as  the  cleaning 
solution.  These experiments showed that while cleaning was not 100% effective 
with NAC, it was the best available solution and was more effective than Pronase E. 
 
8.3.2 Protein as standardisation for the weight of a sample 
 
There was a linear relationship between the weight of a biopsy and protein 
content (figure 8.2).  When these results were charted there was a direct correlation 
between protein content and sample weight, with the slope of best fit a linear line r
2 
= 0.954: 
 
y (µg) = 3.7(mg) x X        (where y is the protein content in mg and X is the 
unknown weight of a sample in mg) 
 
This allowed use of the protein concentration as a standardising unit for nitrite 
and nitrate concentrations.  The units for nitrate and nitrite are then given against the 
protein concentration of a sample (µg).   230 
 
 
 
Figure 8.2:  This  shows  the  linear  relationship  between  the  weight  of  a  biopsy 
sample and the protein measurement between the weight and the protein 
measurement of a sample from the human upper gastrointestinal tract.  
Samples  from  the  oesophagus  are  labelled  ,  samples  from  the 
proximal  stomach  ,  and  samples  from  the  distal  stomach  .  The 
protein concentration of a biopsy sample added to an Eppendorf test 
tube containing 80 µL PBS was plotted against the wet weight of the 
same sample.  The number of samples evaluated was twenty-one and 
these were taken in equal number from oesophagus, proximal stomach 
and distal stomach. 
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8.3.3 Releasing intraepithelial contents 
 
Perhaps  not  surprisingly,  the  combined  method  involving  all  three 
approaches gave results with the highest concentrations of protein and nitrite per 
biopsy specimen (figure 8.3).  The mean nitrite concentration of samples for each 
method was 12 (± 4.7) µM for snap freezing alone, 40 (± 7.3) µM for snap freezing 
and sonication, 46 (± 8.1) µM for snap freezing and homogenization and 66 (± 11.7) 
µM for a combination of all three methods.  The difference between a combination 
approach and each individual method was statistically significant (p = 0.0001)   The 
mean protein content for each method was 49 (± 10.2) µg for snap freezing alone, 87 
(± 16.0) µg for snap freezing and sonication, 92 (± 16.4) µg for snap freezing and 
homogenization and 110 (± 20.1) µg for a combination of all three methods (p = 
0.001).  Performing all three of these actions on the biopsy samples represented the 
most effective method, and was therefore employed for all subsequent analysis. 
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Figure 8.3:  Mean  nitrite  (µM)  (blue  column)  and  protein  (µg)  (red  column) 
concentrations in each sample when analysed by the different methods.  
Methods were snap freezing only, snap freezing and sonication, snap 
freezing and homogenization or a combination of all procedures.  Data 
labels show mean values.  Error bars represent 1 standard deviation.  
Statistical significance is shown. 
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8.3.4 Nitrite analysis 
 
8.3.4.1 Results to determine the better method of nitrite analysis in human  
studies 
 
The results for each sample when analysed by both the Greiss reagent method 
and NO probe method, are shown in figure 8.4. The average nitrite concentration 
from the NO probe method was 12.9 (± 2.1) µM, while the average from the greiss 
reagent  was  18.0  (±  4.3)  µM.    There  was  a  statistically  significant  difference 
between  the two methods  (p=0.00004).   On all but  two samples, the amount of 
nitrite detected was greater with the Greiss reagent.   
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Figure 8.4:  This graph compares the µM nitrite concentration measured using both 
NO probe recording and Greiss reaction in human biopsy samples.  For 
each biopsy sample, both methods were performed and compared.  The 
line between points in the NO probe column and Greiss column is to 
display  the  measurements  for  one  sample  assessed  by  the  different 
methods. 
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8.3.4.2 Assessment of interference with the Greiss reaction 
 
It has been established above that the one step Greiss reaction was the better of 
the  methods  for  nitrite  analysis  from  biopsy  samples.    However,  a  previously 
published paper by Tsikas et al (308) had suggested that, in the presence of the thiol 
groups  on  glutathione  and  NAC,  there  would  be  interference  with  the  Greiss 
reaction, since the reaction works on the basis of acidifying the solution to allow the 
reaction to  occur.   It  was  suggested that this  would  result in  nitrosothiols  being 
formed from nitrite.  In an attempt to clarify this further, a series of experiments was 
set up using standard concentrations of nitrite, and subjecting them to the Greiss 
reagent in the presence of varying concentrations of glutathione and NAC.  Ascorbic 
acid  was  also  assessed  during  these  experiments,  for  any  interference.    The 
concentration  of  nitrite  standards  used  was  25  µM,  50  µM  and  100  µM.    The 
percentage nitrite recorded after addition of ascorbic acid, glutathione and NAC was 
then measured by the one step Greiss reagent method.   
 
Across  a  range  of  concentrations  from  10  µM  to  500  µM  there  was  no 
interference from glutathione, NAC or ascorbic acid (Table 8.1).  At glutathione and 
ascorbic acid concentrations of 1 mM and above there was interference with the 
Greiss reaction.  Only at NAC concentrations of 5 mM and 10 mM was there a 
recorded  reduction  in  nitrite  concentration  and  the  reduction  was  only  2-3%.  
Assessment for synergy between glutathione and ascorbic was also made, at the 
concentrations shown to significantly interfere with the reaction (10 mM).  There did 236 
 
not appear to be any synergy.  Instead the combined effect of these two antioxidants 
led to an 18% reduction in nitrite concentration.   
 
Within the samples that were being assessed the concentrations of the solutions 
would be considerably smaller than the concentrations required to interfere with the 
Greiss  reaction.    The  studies  performed  by  Tsikas  et  al  suggested  that  smaller 
concentrations of these antioxidants would lead to interference (308).  However, in 
their studies they did not use a one step Greiss reaction, but rather, they left the 
solution acidified for two hours prior to adding the dye component.  This could have 
allowed time for the thiol groups to cause more interference by forming nitrosothiols 
from acidified nitrite.   
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Table 8.1:  Percentage of nitrite measured using the one step Greiss reaction, after a 
known  concentration  of  nitrite  standard  was  added  to  one  of  three 
antioxidants,  ascorbic  acid,  NAC  and  glutathione,  to  assess  for  any 
interference with the Greiss reaction by these antioxidants. 
 
% of standard nitrite concentration  
measured by greiss reagent 
Antioxidant 
concentration 
Glutathione  Ascorbic acid  NAC 
10 µM  100  100  100 
50 µM  100  100  100 
75 µM  100  100  100 
100 µM  100  100  100 
250 µM  100  100  100 
500 µM  100  100  100 
1 mM  98  99  100 
5 mM  95  96  98 
10 mM  88  77  97 
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8.3.4.3 Comparison of nitrite to nitrosothiol content of biopsy samples  
 
It has previously been suggested that, in the acidic environment generated by 
the Greiss reaction, all the nitrite would react with intracellular thiol groups to form 
nitrosothiols  (308).    Nitrosothiols  will  also  be  formed  from  nitrosation  of  thiol 
groups in vivo, although the percentage of the total nitrite ending up as nitrosothiols 
would  be  expected  to  be  small.  To  assess  this  further,  we  measured  both 
nitrosothiols and nitrite from twelve biopsies obtained from an equal mix of the 
oesophagus, proximal stomach and distal stomach.  We measured the nitrosothiols in 
the presence of an excess of glutathione, to both donate thiol groups, and act as a 
reducing agent.  Therefore, when we measured nitrosothiols the total intracellular 
nitrite would be measured.  Nitrosothiol measurement was through the NO probe 
method described in Chapter 8.2.5 and Chapter 2.1.7. 
 
The results show that there is no significant difference between the nitrosothiol 
concentration measured and the nitrite concentration measured by the Greiss reagent 
(p=0.60) (Figure 8.4).  The mean total nitrosothiol concentration was 12.1 (± 5.7) 
µM while the nitrite concentration was 13.8 (± 5.1) µM.  Therefore, the contribution 
of nitrosothiols to total biopsy nitrite was not detectable by the methods adopted in 
this study and therefore were not measured in further studies. 
 
 
   239 
 
 
 
Figure 8.5:  Human upper gastrointestinal tract biopsy specimens were analysed for 
nitrite  concentration  (µM),  using  the  Greiss  reagent  method,  and  for 
nitrosothiol  concentrations  (µM),  using  a  method  whereby  all  nitrite 
would  also  be  converted  to  nitrosothiol.    The  concentration  of 
nitrosothiol (µM) is therefore a reflection of sample nitrite + nitrosothiol 
concentrations.  Comparison is made between the sample concentration 
of nitrite, measured using the different methods, to assess any additional 
concentration recorded in the nitrosothiol samples which would reflect 
true nitrosothiol concentration. 
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8.4  Discussion 
 
The  intention,  in  performing  the  studies  in  this  chapter,  was  to  develop  a 
method  of  assessing  human  upper  gastrointestinal  tract  intracellular  nitrate  and 
nitrite concentrations, to enable assessment of nitrosative stress.  Previous studies 
using  silastic  tubing  as  an  epithelial  compartment  had  shown  that  nitrite  was  a 
marker of nitrosative stress.   
 
It was possible to standardise sample nitrite and nitrate concentrations relative 
to the protein content of each biopsy sample.  This allowed for the varied sizes of 
biopsy that are taken from the upper gastrointestinal tract.  Although the biopsy 
samples would have protein contained within the mucus layer the cleaning effect, of 
over  90%,  was  consistent  between  samples  from  the  three  anatomical  regions 
sampled and between samples from the same anatomical region.  This means that if 
the  protein  content  was  being  overestimated  it  would  be  so  constantly.    Protein 
content, therefore, is a useful standardising measurement for nitrite and nitrate.   
 
Processing of samples was effective in terms of releasing intracellular content 
into  PBS  by  a  combination  of  snap  freezing,  sonication  and  homogenisation.  
Although a combination of these techniques yielded the highest concentrations of 
nitrite  and  protein  the  actual  degree  of  cell  membrane  destruction  was  not 
determined.  This could mean that the concentrations recorded are an underestimate 
of the true intracellular concentrations.   An independent control, such as electron 241 
 
microscopy,  could  be  employed  to  assess  the  degree  of  cell  membrane  lysis.  
Measurement of nitrite by the one step Greiss reaction was validated in our studies, 
which also show that the contribution of nitrosothiols from the samples was not 
relevant.    
 
To enable accurate assessment of intracellular contents it was apparent that the 
mucus barrier present in the upper gastrointestinal tract would have to be removed.  
Unfortunately, mucus in the upper gastrointestinal tract is relatively adherent to the 
epithelium.    This  is  particularly  the  case  in  the  stomach.    The  best  mucolytic 
cleaning solution was found to be NAC.  This has been used previously to clean the 
upper  gastrointestinal  tract  from  mucus,  but  not  in  the  context  of  measuring 
intracellular  content  concentrations.    In  our  studies,  the  cleaning  achieved  was 
removal of over 90% of the surrounding mucus from biopsy samples.   
 
NAC appeared to be the best cleaning solution.  However, acetylcysteine is the 
N-acetyl derivative of the amino acid  L-cysteine and exhibits direct and indirect 
antioxidant  properties.  Its  free  thiol  group  is  capable  of  interacting  with  the 
electrophilic  groups  of  ROS  (310,311).  This  interaction  with  ROS  leads  to 
intermediate formation of NAC thiol, with NAC disulphide as a major end product 
(312). In addition, NAC can exert an indirect antioxidant effect related to its role as 
a GSH precursor in vivo. It has been shown that thiols enhance NO generation from 
NO  releasing  agents  (313,314).  This  could,  theoretically,  result  in  the  cleaning 
solution used in our experiments releasing NO from nitrite within the mucus layer.  242 
 
NO would then be free to pass into the epithelial compartment and form nitrite and 
nitrosating species.  However, the reaction of nitrite with NAC will take place in the 
neutral environment of the mucus lining of the oesophagus.  The NAC produced for 
the studies was also made up in 200 mM sodium bicarbonate to neutralise the pH of 
the solution and to make it more isotonic.  This means that although NO would be 
produced from this reaction in an acidic environment its production in a neutral 
environment would be minimal.   
 
Overall, measurement of upper gastrointestinal tract biopsy nitrate and nitrite is 
possible using the methods described.  The major problem with these methods is 
cleaning of adherent mucus from the biopsy sample prior to subsequent analysis for 
nitrite and nitrate.  The mucus is likely to have a high concentration of nitrate and 
nitrite.    The  cleaning  methods  do  appear  to  be  able  to  clean  over  90%  of  the 
surrounding mucus and although it may not be possible to extrapolate data relevant 
to intraepithelial concentrations of nitrate and nitrite, the nitrosative stress within the 
biopsy sample of an anatomical region can be determined. 
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Chapter  9:  Upper  gastrointestinal  tract  biopsy  sample  nitrite  and  nitrate 
concentrations  
 
9.1 Introduction 
 
The  hypothesis,  that  intraepithelial  nitrite  and  nitrate  reflect  where  NO 
generation is maximal, would mean that on analysis of samples from three areas of 
the upper gastrointestinal tract, oesophagus, proximal stomach and distal stomach, 
we would expect samples from the proximal stomach of healthy subjects to have the 
highest concentrations of nitrite and nitrate.  In previous studies it was not possible 
to remove all adherent mucus from biopsy samples.  This means that measuring 
intraepithelial  nitrate  and  nitrite  is  not  possible  with  the  methods  described.   
However,  studies  were  performed  to  look  for  biopsy  sample  nitrite  and  nitrate 
concentrations.    While  it  is  not  possible  to  extrapolate  from  this  series  of 
experiments  whether  this  increase  is  related  to  intracellular  nitrate  and  nitrite,  it 
could  still  provide  information  regarding  nitrosative  chemistry  within  the  upper 
gastrointestinal tract. The working hypothesis was that biopsy sample nitrite and 
nirrate concentrations would be higher in proximal stomach biopsies, as compared to 
oesophageal and distal stomach biopsies, due to generation of NO from salivary 
nitrite meeting acidic gastric juice.  To show that the higher concentrations were 
related to ingested nitrate, the studies were performed before and after the ingestion 
of a nitrate drink. 
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9.2 Methods 
 
9.2.1 Healthy volunteers 
 
A total of 17 healthy volunteers were enrolled, 9 of whom were male.  The 
median age was  52  years.  All  volunteers were  Helicobacter pylori negative,  as 
detected by urease CLO testing, and had no history of antacid ingestion.  Endoscopy 
with biopsy was performed on two separate days.  On day one, the volunteer had 60 
mL of control drink which was dH2O.  On the second day the volunteer was given a 
60 mL drink containing 2 mmole KNO3.  Endoscopy with biopsy sampling was 
performed 2 hours after either the control or nitrate drink was given. On each day six 
biopsies were taken from each of, the oesophagus (5cm above the GO junction), 
proximal stomach (just below the gastroesophageal junction) and the distal stomach.  
A 1 mL salivary sample was collected at times 0 and 120 minutes for nitrite analysis.  
At the same time intervals as salivary samples were taken, the volunteers had blood 
samples  taken  for  analysis  of  serum  nitrate  from  an  i.v  cannula,  placed  in  the 
antecubital fossa prior to the start of the experiment. 
 
9.2.2 Processing of biopsy samples 
 
Biopsy samples were immediately placed in a 2 mL solution of 3.1% NAC in 
NaOH  (pH  7.4)  and  left  for  30  minutes  before  being  subjected  to  the  cleaning 
process and cell lysis described in sections 8.2.2 and 8.2.4.  Of the cleaned sample, 245 
 
snap frozen, homogenised and sonicated in 80 µL PBS, 20 µL was then analysed for 
each  of  protein,  nitrite  and  nitrate  concentrations.      Biopsy  nitrate  and  nitrite 
concentrations were recorded as concentration per µg protein. 
 
9.2.3 Serum nitrate analysis 
 
Blood samples (10 mL) were taken at times 0 and 120 minutes.  The first 5 mL 
of this sample was discarded to allow for dead space within the i.v cannula.  2 mL of 
serum sample was stored at –20°C until it was analysed. On thawing, 400 µL of 
sample  was  centrifuged  through  a  10-kilodalton  ultrafilter  to  remove  high-
molecular-weight  proteins.  Samples  were  then  mixed  with  nitrate  reductase  in 
reaction buffer and analysed as described in Chapter 2.1.5.  
 
9.2.4 Salivary nitrite analysis 
 
Salivary samples (1 mL) were obtained at times 0 and 120 minutes.  This was 
mixed  with  10  µL  of  5.0  M  NaOH.    This  rendered  the  samples  alkaline  and 
prevented loss of nitrite. Samples were stored at 4°C, then centrifuged and analyzed 
the same day on 96-well microplates using the modified Griess reaction as described 
in Chapter 2.1.4. 
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9.3 Results 
 
9.3.1 Salivary nitrite 
 
For volunteers on the day they consumed the control drink, the median salivary 
nitrite concentration prior to the administration of the control was 42.5 (interquartile 
range, 28.5 – 97.3) µM.  120 minutes after the administration of the control drink, 
the salivary nitrite concentration did not significantly change (p=0.09) from the basal 
reading, with a median concentration of 52.0 (interquartile range, 35.8 – 86.2) µM.  
However, on the day the volunteers were given a 2 mmole potassium nitrate drink, 
there  was  a  significant  increase  (p=0.0000003)  in  the  median  salivary  nitrite 
concentration from 39.7 (interquartile range, 29.6 – 65.8) µM on sampling prior to 
administration of the drink to a concentration 264.8 (interquartile range, 160.1 – 
358.6) µM 120 minutes after the drink was given. 
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9.3.2 Serum nitrate  
 
On the day the volunteers consumed the control drink, the median serum nitrate 
concentration prior to the administration of the control was 11.6 (interquartile range, 
4.3 - 17.3) µM.  At 120 minutes after the administration of the control drink, the 
serum nitrate concentration  did  not  significantly change (p=0.19)  from  the basal 
reading,  with  a  median  concentration  of  12.2  (interquartile  range,  7.2-15.7)  µM.  
However, in those who were given a 2 mmole potassium nitrate drink, there was a 
significant increase (p=0.00004) in the median serum nitrate concentration from 13.5 
(interquartile range, 5.6-18.3) µM on sampling prior to administration of the drink to 
54.7 (interquartile range, 31.2-69.8) µM 120 minutes after the drink was given. 
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9.3.3 Nitrate and nitrite concentrations at different anatomical sites 
 
Samples  from  the proximal  stomach  had  the highest  concentrations  of  both 
nitrite and nitrate.  The median nitrite concentration from the proximal stomach was 
36.7 (interquartile range 19.5 – 48.2) µM per µg protein, which was a significantly 
higher  concentration  than  the  concentrations  from  the  oesophagus  (14.5  µM) 
(p=0.00001) and distal stomach (24.0 µM) (p=0.0003) (figure 9.1).  For all three 
regions  of  the  upper  GI  tract  from  which  biopsies  were  taken,  there  was  a 
significantly  higher  nitrate  than  nitrite  concentration.    The  median  nitrate 
concentration in the proximal stomach was 114.1 (interquartile range 64.5 - 222.1) 
µM  per  µg  protein,  which  is  significantly  higher  than  the  concentration  in  the 
oesophagus (65.2 µM) (p = 0.00004) and distal stomach (65.7 µM) (p=0.00002). 
 
After ingestion of a 2 mmole KNO3 drink, there was a significant increase in 
the  median  nitrite  and  nitrate  concentrations  for  all  anatomical  sites  sampled, 
compared to control drink ingestion samples.  The greatest percentage increase in 
concentrations was seen in the proximal stomach samples, where there was a three 
fold  increase  in  nitrite  concentration  with  a  median  nitrite  concentration  of  124 
(interquartile range 86.2 – 176.2) µM per 100 µg protein (p=0.000002), and 2.5 fold 
increase  in  nitrate  concentrations  with  a  median  nitrate  concentration  of  285 
(interquartile range 167.2 – 341.9) µM per 100 µg protein (p=0.00007) (Figure 9.2). 
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 Figure 9.1: Median nitrite concentrations expressed as µM per µg protein are shown 
for three regions of the human upper gastrointestinal tract (oesophagus, 
proximal  stomach  and  distal  stomach)  after  a  control  drink  (blue 
columns) and after a drink containing 2 mmole nitrate (red columns).  
Data labels show the median value.  The error bars represent the 1
st and 
3
rd interquartile range. 
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Figure 9.2:  Median  nitrate  concentrations  expressed  as  µM  per  µg  protein  are 
shown  for  three  regions  of  the  human  upper  gastrointestinal  tract 
(oesophagus, proximal stomach and distal stomach) after a control drink 
(blue  columns)  and  after  a  drink  containing  2  mmole  nitrate  (red 
columns).   Data labels show the median value.  The error bars represent 
the 1
st and 3
rd interquartile range. 
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9.4 Discussion 
 
This study suggests that, in vivo, there is an increase in nitrosative stress within 
the  human  upper  gastrointestinal  tract  after  nitrate  ingestion.    The  mechanism 
proposed  for  the  increase  in  this  stress  is  through  the  generation  of  NO  where 
salivary  nitrite,  produced  in  greater  concentrations  after  a  nitrate  meal  due  to 
bacterial  conversion  and  enterosalivary  recirculation,  meets  acidic  gastric  juice 
containing ascorbic acid.  NO can then rapidly cross the lipid cell membrane into the 
neutral epithelial compartment forming nitrosating species and nitrite.   
 
After the control drink was given, the proximal stomach was the site of the 
highest concentrations of nitrite and nitrate.   This is likely due to this region being 
the first point of contact of salivary nitrite with acidic gastric juice in the presence of 
ascorbic acid.  Even in the control group there will be carriage of nitrite in saliva as 
shown  by  the  concentration  of  salivary  nitrite  being  40  –  50  µM  (221).    It  has 
previously  been  shown  that  the  concentrations  of  nitrite  along  the  length  of  the 
oesophagus are similar to the concentrations in saliva (221).  NO will therefore be 
generated in the proximal stomach, as nitrite meets ascorbic acid in acidic gastric 
juice.   
 
After ingestion of a nitrate drink the nitrite concentration of biopsy samples 
from all three regions of upper gastrointestinal tract was higher than concentrations 
found in the control samples.  The greatest increase in nitrite concentrations was 252 
 
observed in samples from the proximal stomach where this was three fold.  There 
are two potential mechanisms for this.  There is the generation of NO as discussed 
for the control group.  The maximal point of NO production will be the proximal 
stomach, where salivary nitrite meets gastric juice containing ascorbic acid.  The 
second mechanism is  through  acid-catalysed nitrosation, where the ascorbic acid 
within the proximal stomach is exhausted after reaction with nitrite (221).  Nitrite 
will then form nitrous acid in the proximal stomach and this may diffuse into the 
neighbouring intraepithelial cellular compartments.   
 
In our study, the biopsy concentration of nitrate was higher than nitrite in the 
control  samples  and  increased  after  a  nitrate  drink.    There  are  two  possible 
mechanisms to explain the increase in nitrate from NO generation.  The first of these 
is  the  well  recognised  reaction  of  NO  with  the  iron  contained  within 
oxyhaemoglobin to produce methaemoglobin and nitrate (117).  NO can also be 
expected, within a cell, to react with the superoxide to form peroxynitrite.   Nitrate is 
a  decomposition  product  of  peroxynitrite.    These  chemical  reactions  are  shown 
below: 
 
O-O- + N=O  OONO
-    the reaction of superoxide with NO 
 
4OONO
-  NO3
- + 2NO2
- + O2   the decomposition of peroxynitrite to 
nitrate, nitrite and oxygen 
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There are a few potential problems in concluding that the increases in biopsy 
sample nitrite and nitrate are all due to generation of NO.  The main problem relates 
to the cleaning of the biopsy specimens.  It had been the intention in this study that 
measurement  of  nitrite  and  nitrate  concentrations  would  have  been  from  the 
intracellular  compartment.    Enrichment  studies  using 
15N  suggested  that  93%  of 
adherent mucus was cleaned from the biopsies using NAC.  While this suggests 
reasonable cleaning, it is not enough to provide confidence that the increases in 
biopsy  sample  nitrite  and  nitrate  are  all  due  to  an  increase  in  intracellular 
compartment concentrations of these compounds.  It is possible that the increases 
observed were mainly due to an increase in the adherent mucus concentrations of 
these compounds. The mucus overlying the epithelium of the upper gastrointestinal 
tract has a neutral pH and when NO meets this environment the NO can be expected 
to form nitrite.  Whether there is enough of a mucus barrier to prevent any of the 
very high concentrations of NO seen to be produced at the gastroesophageal junction 
and proximal stomach (43,45,280)
  is unknown.   
 
As  well  as  nitrosative  stress  from  NO,  there  is  also  the  potential  for  acid-
catalysed  nitrosation  to  be  having  an  effect  in  these  studies.    Previous  work  by 
Suzuki et al has shown that after a nitrate rich meal there is a change in the nitrite to 
ascorbic acid ratio such that acid-catalysed nitrosation is favoured (221).  This could 
be due to exhaustion of available gastric juice ascorbic acid such that nitrous acid is 
formed in acid from nitrite.  This can then pass into the epithelial compartment and 254 
 
here be converted to nitrite.  Acid-catalysed nitrosation within the stomach is well 
recognised and discussed in the literature.   
 
This is, therefore, an interesting study in mapping potential nitrosative stress in 
the upper gastrointestinal tract.  The proximal stomach is the site of maximal nitrite 
and nitrate concentrations.  The study also shows that after a nitrate meal there is an 
increase  in  nitrosative  stress,  and  this  is  most  marked  in  the  proximal  stomach.  
While it is possible that some of the increased stress is not NO mediated, the fact 
that,  in  these  healthy  volunteers,  the  proximal  stomach  is  the  site  of  maximal 
concentration of nitrite and of the increase in nitrite after a nitrate meal, makes it 
likely that NO has a significant role to play in nitrosative stress after a nitrate meal.   
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Chapter 10:  Rat model: Nitrite as a marker of nitrosative stress 
 
10.1 Introduction 
 
It has previously been found that nitrite is a marker of nitrosative stress in an 
in vitro model simulating the chemistry occurring at the gastroesophageal junction 
(44).  Nitrite is, therefore, an attractive candidate as a marker of nitrosative stress in 
biological tissue of the upper gastrointestinal tract.  Studies performed using rat 
stomach tissue were devised to evaluate the efficacy of the cleaning of biological 
tissue required prior to quantification of intracellular nitrite and nitrate, and later, to 
assess  the  effect  of  NO  on  epithelial  samples  to  determine  if  nitrite  was  a 
measurable marker of NO in biological tissue. 
 
The availability of human tissue is dependent on biopsies taken at time of 
endoscopy.    Rat  tissue  is  more  freely  available  and  can  be  obtained  in  large 
quantities, as the entire stomach can be removed for tissue analysis.  Although the 
rat stomach is not anatomically or physiologically identical to the human stomach, 
as  it is  more easily obtained, it allows multiple experiments  to  be perfomed to 
assess  whether the measurement of  biopsy  nitrite and nitrate,  related to NO, is 
possible.  There is a difference in the thickness of the mucus in the rat stomach 
compared to the human.  The mucus layer between the acidic gastric lumen and the 
epithelial surface is thicker in human samples than in rat (315).  As the whole rat 256 
 
stomach can be dissected out, an appropriate sized piece of tissue can be placed in 
specifically designed experimental models.   
 
The rat stomach is divided into two parts, the forestomach and corpus (figure 
10.1 and 10.2):  Forestomach: thin-walled, non-glandular section that receives the 
oesophagus and serves as a holding chamber for food. Its walls are similar to those 
of  the  oesophagus.  Corpus:  thick-walled,  glandular  section.  Its  walls  have 
secretory glands that produce digestive enzymes and mucus. Digestion begins in the 
corpus. The pyloric sphincter controls the movement of food from the corpus to the 
intestines and specifically the duodenum. 
 
         The forestomach and the corpus are separated by a low fold of tissue called 
the limiting ridge (margo plicatus). The limiting ridge extends circumferentially 
from  the  large  curvature  of  the  stomach  to  the  small  curvature,  just  below  the 
oesophagus. At the oesophagus, the course of the limiting ridge bends into a U-
shape and almost surrounds the oesophageal opening (316).  
 
In  the  following  studies  in  this  chapter,  the  rat  forestomach  was  used  to 
represent the human oesophageal tissue, while the rat stomach corpus tissue was 
used to represent the human stomach tissue. 
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Figure 10.1: A  schematic  diagram  of  the  rat  stomach,  showing  the  forestomach, 
limiting ridge (margo plicatus) and corpus regions of the stomach.  The 
oesophagus empties into the forestomach.  The corpus empties into the 
duodenum through the pyloric sphincter.  The limiting ridge separates 
the forestomach from the corpus. 
 
                                            
Figure 10.2:  The rat stomach can be seen to be divided into the forestomach and the 
corpus, by the limiting ridge which extends circumferentially from the 
large curvature of the stomach to the small curvature, just below the 
oesophagus. 
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10.2 Methods and materials 
 
10.2.1 Rats 
 
All rats used were female Wistar rats greater than 250g in weight.  The large 
weight  was  used  to  ensure  that  the  size  of  the  stomach  was  adequate  for  our 
experiments.  The rats were fasted for 24 hours prior to dissection. 
 
Dissection of the rats took place in the animal house after being sacrificed 
using 50% CO2 and O2 causing asphyxiation.  The dissection consisted of making a 
vertical incision the length of the rat, from vagina to sternum.  The incision went 
through to the abdominal cavity where the stomach was located underneath the 
liver.    The  stomach  was  separated  from  the  peritoneum  and  remainder  of  the 
gastrointestinal tract, by several small incisions.  
 
10.2.2 Storage and preparation of tissue 
 
The stomach was immediately placed in chilled Krebs solution and kept on ice 
after dissection.  The stomachs were then transferred to the laboratory, where the 
experiments were performed within 2 hours of the dissection. 
 
Once in the laboratory, the stomach was cut along the greater curvature to 
enable visualisation of the margo plicatus.  The whole stomach was then briefly 259 
 
rinsed in dH2O to remove remaining food residue.  Tissue from both the corpus and 
forestomach was used in the experimental models.  It was technically difficult to 
obtain, solely, the epithelial layer.  In these experiments the mucosa was removed 
by  injecting  1  mL  saline  solution  to  create  a  bleb  into  the  submucosa,  thereby 
lifting  the  mucosa  from  the  underlying  layers.    This  area  of  mucosa  was  then 
carefully dissected from the rest of the tissue, using a 0.5mm scalpel blade.  Once 
tissue for analysis was obtained, it was cleaned anplaced in PBS (80 µL) before 
being snap frozen in liquid nitrogen before storage at -70
oC. 
 
10.2.3 Processing of tissue  
 
After thawing the samples required a cleaning process to remove surrounding 
mucus from the rat tissue.  As discussed in Chapter 8.2.2, 3.1% NAC at neutral pH 
in PBS is a mucolytic agent with the capability of cleaning surrounding mucus from 
human tissue.  Where rat tissue has been cleaned, in the following experiments, 
3.1% NAC has been used. 
 
Samples  were  then  snap  frozen,  homogenised  and  sonicated  to  release 
intracellular compartment constituents, as discussed in Chapter 8.2.4.  Initially there 
was  difficulty  homogenising  rat  stomach  samples,  both  in  a  glass  hand  held 
homogenizer, and also in a larger steel shafted serrated head mortar and pestle.  
Therefore,  softening  of  the  samples  by  alkalisation  was  performed  to  aid  the 
homogenisation process.  Alkalisation was achieved using sodium hydroxide, by 260 
 
adding 50 μL of 5 M NaOH to 420 μL of PBS.  After this alkalisation the samples 
were  homogenised  using  a  glass  hand  held  homogenizer  (Anachem  Ltd, 
Bedforshire, UK), with subsequent centrifugation of the sample at 13000g.   
 
10.2.4 Chemical analysis 
 
Measurement of NO and O2 was performed using WPI probes and sensors as 
described in Chapter 2.1.1 and 2.1.2.  Methods for protein, nitrite and 
15N analysis 
were as for human samples and are described in Chapter 2.1.3, 2.1.4 and 2.1.6.   
 
The analysis of nitrate was performed with some adjustments from previous 
methods.   Nitrate reductase which converts nitrate to nitrite is a pH dependent 
enzyme  working  best  at  pH  7.5.    Samples  in  these  experiments  were  strongly 
alkaline after a softening process prior to homogenisation.  Although the samples 
were placed in PBS, the volume of PBS used was small and did not cause the pH of 
the sample to reach neutrality.  It was found that, when the pH was not corrected to 
a neutral pH, we did not record any nitrate from our samples.  This problem was 
overcome by using a ‘super’ acidic buffer which was constituted as 0.1 M NaOH 
and half volume 0.3 M HCl.  When plating the samples, 30µL of sample was taken 
and 30 µL of the ‘super’ buffer was added to make the final pH neutral.  Samples 
were then analysed for nitrate concentrations as described in Chapter 2.1.5. 
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10.2.5 Contamination studies to assess cleaning of sample 
 
10.2.5.1 Immersion in 5 mM nitrate 
 
Dissected  rat  stomach  mucosa  from  both  the  forestomach  and  corpus  was 
removed,  and  subjected  to  one  of  the  following  conditions  in  a  1  mL  plastic 
Eppendorf  test  tube:  exposed  to  dH2O  and  left  unclean,  exposed  to  dH2O  but 
cleaned in 3.1% NAC for 30 minutes, exposed to 5 mM KNO3 for 30 minutes then 
left unclean or exposed to 5 mM KNO3 for 30 minutes then cleaned in 3.1% NAC 
for a further 30 minutes. 
 
The stomach from six different rats was used for these experiments and six 
different samples from each rat were used for each condition to which the mucosa 
was exposed.  Samples were then analysed for protein, nitrate and nitrite. 
 
10.2.5.2 Three layer Delrin model contamination studies with 5 mM nitrite 
and nitrate 
 
A specially designed Delrin model was constructed as shown in Figure 10.3.   
The lower chamber in this model was filled with a solution of 5 mM KNO3 or 5 
mM KNO2 to contaminate the sample.  Contamination studies were performed in 
this model as it is similar to the model used to perform the studies subjecting rat 
tissue to NO.  Tissue from six rats, from both the corpus and forestomach, were 
placed between the upper and lower layers of this model.  In this experiment there 262 
 
was a control sample, which was placed within the Delrin model containing only 
dH2O only before being either cleaned in 3.1% NAC or left unclean.  Of the tissue 
placed within the KNO3 Delrin model, half of the samples were left unclean, while 
the other half of the samples were subjected to the cleaning process in 3.1% NAC.  
For  each  experimental  condition  there  were  six  samples  in  each  arm  of  the 
experiment per rat stomach. 
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Figure 10.3: Three-phase Delrin model used to subject the epithelial surface of rat 
stomach mucosa to high concentrations of contaminant KNO 3  or 
KNO2.  In this three-phase model the rat tissue formed the middle 
layer.    The  rat  tissue  was  supported  by  a  hydrophobic  altesil 
membrane (thickness 0.8mm) through which NO and O2 are known 
to pass.  The tissue was placed between two layers of the membrane.  
The membrane had a hole cut, in the centre of where the tissue lay, to 
allow the  rat  tissue to  be the only  contact  between the upper  and 
lower layers of the model.  The lower chamber consisted of 5 mM 
KNO3
 or KNO2.  The upper chamber was formed by 400 μL PBS at a 
neutral pH.   
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10.2.5.3  Three  layer  Delrin  model  contamination  with 
15N  nitrite  and 
nitrate 
 
To  assess  the  extent  of  contamination  after  cleaning  more  closely,   
experiments  were  perfomed  involving  a  labeled 
15N  preparation  of  nitrite  and 
nitrate.    This  allowed  determination  of  whether  nitrogen  measured  was 
contamination from the nitrate and nitrite used to spike the samples or whether it 
was nitrogen already present in the sample.  If 
15N concentrations were high, then 
the cleaning was not as efficient as we required for assessing intraepithelial nitrite 
and nitrate. 
 
  The 
15N nitrite and nitrate was used in the same Delrin experimental model as 
shown in figure 10.3.  The concentrations used as contaminant solutions were 5 
mM K
15NO2 and 5 mM K
15NO3.   After processing in the standard way described in 
10.2.3,  samples  were analysed for protein, nitrite, nitrate and 
15N content.   Six 
samples, from each of six different rats, were taken and subjected to experimental 
conditions.  
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10.2.6 Model used to assess the effect of NO on rat epithelial cells 
 
Experiments were performed, within a three layer model, with rat stomach 
tissue  being  exposed  to  NO  produced  from  the  acidification  of  nitrite  in  the 
presence of ascorbic acid (figure 10.4). 
 
Rat mucosal tissue was obtained as described in 10.2.1.  Both the glandular 
corpus of the rat stomach and the forestomach were used.  Once the appropriate 
tissue was obtained, it was placed between two layers of altesil membrane which 
had been specially prepared.  The membrane was cut with a hole in the middle, this 
was to allow the rat tissue to be the only layer between the upper chamber and the 
lower chamber.  The tissue was then clamped in place in the Delrin model.  HCl 
(pH 1.5) with ascorbic acid (1 mM) to a volume of 17.9 mL was added to the lower 
chamber.  The experiments were initiated by adding 120 µM nitrite to the lower 
chamber, except in control experiments where nitrite was replaced with dH2O. 
 
Experiments were performed to ensure that this system was allowing rat tissue 
to be exposed to appropriate concentrations of NO.  NO levels were measured, 
using a WPI NO probe, from the upper chamber surface of the rat tissue to ensure 
that NO was passing through the tissue.  We found that it took between 60 and 90 
seconds for the NO to diffuse through the tissue, after the addition of the nitrite to 
the  lower  layer.  After  that  time  there  was  a  steady  rise  in  the  NO  level  to  a 
maximum of between 60 and 70 µM at the end of the twenty minute experiments 266 
 
(figure 10.5).  At no point during the experiment was the upper layer deficient in O2 
as measured with a WPI O2 probe placed in the upper chamber on the rat surface.  
At the end of the 20 minute experiment the pH in the upper chamber was still 
neutral,  showing  the  integrity  of  the  rat  stomach  tissue  to  form  a  middle  layer 
during the experiment.   
 
Thereafter,  experiments  were  performed  to  determine  if  we  could  measure 
intracellular  nitrite/nitrate  in  the  rat  stomach  tissue  by  exposing  the  tissue  to 
generated  NO.    The  experiments  were  set  up  as  described  above.    In  addition, 
control experiments, with tissue from the same rat, were set up exactly as above, 
but on these occasions no nitrite was added to the lower chamber.  Instead, in these 
control  experiments  there  was  no  generation  of  NO,  as  was  confirmed  by  the 
absence of a rise when the NO level was measured using the NO probe and meter. 
 
A series of experiments to assess the effect of nitrous acid on the samples was 
also  set  up,  by  having  the  same  experimental  conditions  as  in  the  experiments 
generating NO except that the lower chamber had no ascorbic acid present.  In 
these experiments there was no recordable NO generation in the upper chamber.  
All samples were cleaned using 3.1% NAC as described in Chapter 8.2.2.  
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Figure 10.4: Three layer Delrin model to expose rat stomach mucosa to NO  
generated from acidified nitrite in the presence of ascorbic acid.  Rat 
stomach tissue was placed between two layers  of silicone altesil 
membrane (thickness 0.8mm), with a hole in the membranes so that 
there was an area of tissue that was not covered by the membrane.  
This was then clamped between the top of the D elrin lower base unit 
and the upper Delrin unit.  Into the lower unit was added HCl (pH 1.5) 
and ascorbic acid (1mM).  This is to represent the acidic environment 
of the stomach.  The upper layer had 400 µL PBS added to it (pH 7.4).  
The rat tissue used  was the mucosa obtained after a submucosal bleb 
had lifted the mucosa from underlying tissue .  After the addition of  268 
 
nitrite (120 µM) to the lower layer NO is generated in this layer and the 
rat tissue that is above is exposed to this NO.   
 
 
 
 
 
Figure 10.5: NO and O2 concentrations on the upper surface of rat stomach tissue 
after the addition of nitrite (120 µM) to an acid environment containing 
ascorbic  acid  in  the  lower  chamber  of  a  three-phase  Delrin  model.  
Data labels show the mean NO concentration at 15 minutes. n=12 
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10.3 Results 
 
10.3.1 Contamination studies  
 
10.3.1.1 Immersion studies in 5 mM KNO3 
 
 
The immersion form of contamination with 5 mM KNO3
 led to a significant 
rise in mean nitrate concentration compared to samples which were not subjected to 
any nitrate (figure 10.6) (p<0.0001).  In forestomach samples, there was effective 
cleaning  of  samples  with  only  8%  more  nitrate  present  after  contamination  and 
cleaning as compared to samples that had not been exposed to contaminant.  The 
mean  nitrate  concentration  of  samples  exposed  to  nitrate  and  cleaned  was  24.8 
(±3.7) µM per µg protein compared to 22.9 (±2.0) µM per µg protein for samples 
which were not subjected to contaminant nitrate and cleaned (figure 10.6) (p=0.18).  
This  represented  cleaning  of  around  96%  when  compared  to  the  contaminated 
unclean sample.  The rat stomach corpus samples appeared to be more difficult to 
clean, as the mean nitrate concentration  of samples subjected to nitrate and cleaned 
is 28.6 (±3.2) µM per µg protein compared to 24.5 (±4.1) µM per µg protein when 
samples were not subjected to nitrate and cleaned (p=0.03).  This means there was 
16%  more  nitrate  on  the  contaminated  samples  than  the  control  samples.    The 
cleaning  efficiency  when  contaminated  unclean  samples  were  compared  to 
contaminated clean samples was 92%.  There was no significant difference in mean 270 
 
nitrite concentrations for samples subjected to contamination with nitrate (p=0.64).  
There  was,  however,  a  trend  for  the  mean  nitrite  concentration  to  be  lower  in 
samples  that  were  cleaned  over  those  that  were  not  cleaned,  but  this  was  not 
statistically significant (p=0.29).  
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Figure 10.6: The mean nitrate and nitrite concentrations (µM per µg protein) are 
shown for rat tissue contamination studies.  The tissue from either the 
forestomach (blue bars) or corpus (red bars) were either left unaltered 
or  left  immersed  in  a  plastic  Eppendorf  test  tube  containing  5  mM 
KNO3
-  for  30  minutes.    Samples  were  then  either  analysed  without 
cleaning  or  subjected  to  cleaning  in  3.1%  NAC.    The  mean 
concentrations are given to the left for nitrate concentrations and to the 
right for nitrite concentrations.  Data labels show mean values. Error 
bars represent 1 standard deviation.  n=36 
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10.3.1.2 Delrin model contamination with nitrate and nitrite to assess cleaning 
 
In  studies  with  nitrate  as  the  contaminant:    The  mean  nitrate  and  nitrite 
concentrations in the Delrin model contamination studies showed that the cleaning 
process was effective in cleaning what appeared to be 100% of contaminant KNO3
 
from  the  forestomach  samples  (figure  10.7).    As  in  the  immersion  studies,  the 
cleaning process was not as efficient for the corpus samples, although the mean 
nitrate  concentration  from  contaminated  clean  samples  was  only  8%  more  than 
uncontaminated cleaned samples (p=0.28).   
 
In studies with nitrite as the contaminant: The mean nitrate concentrations, 
when  the  contaminant  was  KNO2,  did  not  significantly  increase  compared  to 
control samples exposed to deionised water only (p=0.08).  There was however a 
trend for the nitrate concentration to be slightly increased after exposure to KNO2 
with subsequent cleaning, with a mean concentration of 28.0 (±2.7) µM per µg 
protein for forestomach samples (figure 10.8).  The highest concentration of nitrate, 
in any of the samples, from all four conditions, was found in the corpus samples 
exposed to KNO2 and subsequently cleaned, although the difference between this 
and the cleaned uncontaminated sample was not statistically significant (p=0.11).  
The mean nitrite concentrations were appropriately elevated after exposure and no 
cleaning.    There  was  however  20%  and  27%  more  nitrite,  in  forestomach  and 
corpus  samples  respectively,  after  contamination  and  cleaning  compared  to  no 
contamination and cleaning (figure 10.8). 
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Figure 10.7: Mean  nitrate  and  nitrite  concentrations  from  KNO3  Delrin  model 
contamination  studies.    Rat  tissue  biopsies  were  either  placed  in  a 
Delrin model as shown in figure 10.3 and exposed to 5 mM KNO3
 for 
30 minutes or were left uncontaminated by placing them in a model 
containing deionised water only (H2O).  The mean nitrate and nitrite 
concentrations  are  shown  after  either  being  left  unclean  or  cleaned 
using 3.1% NAC.  The blue columns represent the mean concentrations 
for tissue from the forestomach while the red column represents the 
corpus.  Mean nitrate concentrations are shown on the left hand side of 
the  chart  and  mean  nitrite  concentrations  on  the  right.    Data  labels 
show mean values.  Error bars show 1 standard deviation. (n=18) 
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Figure 10.8: Mean  nitrate  and  nitrite  concentrations  from  KNO2  delrin  model 
contamination rat studies.  Rat tissue biopsies were either placed in a 
Delrin model as shown in Figure 10.3 and exposed to 5 mM KNO2
 for 
30 minutes or were left uncontaminated by placing them in a model 
containing deionised water only (H2O).  The mean nitrate and nitrite 
concentrations are shown after either being left unclean or cleaned using 
3.1% NAC.  The blue columns represent the mean concentrations for 
tissue from the forestomach while the red column represents the corpus.  
Mean nitrate concentrationsare shown on the left hand side of the chart 
and mean nitrite concentrations on the right.  Data labels show mean 
values.  Error bars represent 1 standard deviation. (n=18) 
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10.3.1.3  Delrin model with 
15N 
 
With 
15N Nitrate
 
 
The 
15N measured after forestomach rat  mucosal  samples  were exposed to 
contaminant  K
15NO3
  in  a  Delrin  model  with  subsequent  NAC  cleaning  was  no 
higher than the background 
15N measured from samples not exposed to K
15NO3 
(0.07 ng versus 0.08 ng) (p=0.7).  There was a slight increase of approximately 
20% in the corpus samples 
15N content (p=0.05), although there appeared to be 
cleaning effectiveness of over 97% using 3.1% NAC (Figure 10.9). 
 
With 
15N Nitrite
 
 
The 
15N  measured  in  forestomach  and  corpus  cleaned  samples  exposed  to 
K
15NO2  was  slightly  elevated  compared  to  samples  exposed  to  dH2O  (Figure 
10.10).  For forestomach samples this difference was not statistically significant 
(p=0.23).  However, the difference was statistically different for the more glandular 
rat corpus samples (p=0.004).  For both forestomach and corpus samples there was 
over 98% effective cleaning when the cleaned samples exposed to K
15NO2
 were 
compared to unclean K
15NO2 against the control samples.   
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Figure 10.9: The mean 
15N content (ng 
15N per µg protein) from forestomach (blue 
column) and corpus (red column) rat stomach tissue samples exposed 
to either dH2O or 5mM K
15NO3 in a delrin model.  The samples were 
then either cleaned in 3.1% NAC or left unclean.  Data labels show 
mean values.  Error bars represent 1 standard deviation. (n=18) 
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Figure 10.10: The mean 
15N content (ng 
15N per µg protein) from forestomach (blue 
column) and corpus (red column) rat stomach tissue samples exposed 
to either dH2O or 5mM K
15NO2 in a delrin model.  The samples were 
then either cleaned in 3.1% NAC or left unclean.  Data labels show 
mean values.  Error bars represent 1 standard deviation. (n=18) 
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10.3.2 Studies in three-phase Delrin model to assess the effect of NO and nitrous 
acid on rat epithelial cell nitrate and nitrite  
 
There  were  significant  differences  in  the  mean  nitrate  and  nitrite 
concentrations of both corpus and forestomach rat samples, when comparing tissue 
exposed  to  NO  against  tissue  exposed  to  deionised  water  only.    There  were 
increases  of  50%  (corpus)  (p=0.0003)  and  67%  (forestomach)  (p=0.00009)  in 
measurable nitrite and approximately 30% (both corpus and forestomach) increase 
in mean nitrate concentrations after NO exposure for both forestomach (p=0.002) 
and corpus samples (p=0.001) (Figure 10.11).   
 
There was no statistical difference in mean nitrate and nitrite concentrations 
when samples exposed to nitrous acid were compared to samples exposed to water 
only  for  both  forestomach  (nitrite  p=0.91,  nitrate  p=0.86)  and  corpus  (nitrite 
p=0.96, nitrate p=0.79)) samples (Figure 10.11).  
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Figure  10.11:  Mean  concentrations  of  nitrite  and  nitrate  for  both  corpus  (red 
column) and forestomach (blue column) rat mucosal samples after 
exposure  to  NO  or  nitrous  acid  in  a  three-phase  Delrin  model.  
There  were  three  different  conditions  within  the  Delrin  model 
shown in figure 10.4 that the samples were exposed to: deionised 
water  and  cleaned, exposed to  NO and then cleaned, exposed to 
nitrous  acid  and  then  cleaned.      Mean  nitrate  concentrations  are 
shown  on  the  right  hand  side  of  the  chart  and  mean  nitrite 
concentrations on the left.  Data labels show mean values.  Error 
bars represent 1 standard deviation. (n=18) 
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10.4 Discussion 
 
The  studies  described  in  this  chapter  had  the  primary  aims  of  effectively 
cleaning  rat  stomach  biopsy  samples  of  adherent  mucus,  and  to  determine  if 
changes in intracellular nitrite and nitrate were recordable after exposure of this 
tissue  to  high  concentrations  of  NO.    Both  of  these  primary  aims  have  been 
achieved.   The ability to measure changes in intracellular nitrite and nitrate is 
important as we move towards determining a marker of nitrosative stress in human 
subjects.   
 
The  samples  from  the  upper  gastrointestinal  tract  are  known  to  have  an 
adherent mucus lining on the surface (317).  The rat stomach is divided in two by 
the margo plicatus, into the more glandular corpus in the more distal portion of 
stomach, and the more proximal forestomach which in cell type more resembles the 
human oesophagus.  The glandular part of the stomach can be expected to have 
more adherent mucus and this is consistent with the findings in this study, that the 
corpus tissue was more difficult to clean when tissue samples were subjected to 
nitrate and nitrite contaminants.  Although the corpus was more difficult to clean, 
more  than  97%  of  contaminant  nitrate  and  nitrite  was  effectively  washed  from 
samples after being subjected to a cleaning process in NAC, as evidenced in 
15N 
studies.  It is not surprising to find that rat mucosa is easier to clean with NAC than 
human tissue as it has been shown that the mucus layer is more adherent in human 
stomach tissue compared to rat tissue.  This, therefore, allows further work with rat 
stomach  samples  to  determine  intramucosal  nitrite  and  nitrate  concentrations. 281 
 
However, it should be noted that there is no independent marker of cleaning of 
these  biopsy  samples  and  the  effectiveness  of  the  cleaning  process  cannot  be 
considered perfect.  This is important as the concentrations of nitrite and nitrate 
measured were small and any contamination from the mucus could be significant 
when measuring intracellular concentrations.  An independent marker of cleaning is 
also important as nitrogen containing compounds may have been generated during 
the cleaning process, thus underestimating the effectiveness of the cleaning.  It may 
be possible in the future to use a protein marker from within the mucus layer as a 
means of determining the effectiveness of the cleaning process, although this was 
not performed within these studies. 
 
It was interesting to note that there was considerably more nitrate than nitrite 
within the biopsy sample.  It is likely that this was due to the conversion of nitrite to 
nitrate.  This occurs due to oxidation of nitrate in the presence of haemoglobin, as 
NO can react with oxyhaemoglobin to form methaemoglobin and nitrate directly 
(117).  This is the likely mechanism through which the nitrate concentrations were 
found to be increased in our studies where rat tissue was subjected to NO.  Nitrate 
concentrations  were increased in  samples  that  had been deliberately  exposed to 
contaminant nitrite in very high concentrations.  The concentrations of nitrate found 
in  these  experiments  with  nitrite  were  higher  than  those  found  when  the 
contaminant had been the same concentration of nitrate.  This may be explained by 
the generation of low concentrations of NO during the cleaning process with NAC.  
NAC  is  itself  an  antioxidant,  similar  to  glutathione  (310,311),  and  therefore  in 282 
 
reaction with nitrite NAC can be expected to form NO (313,314).  NO could then 
cross over into the cells and react with either oxyhaemoglobin (117) or superoxide, 
forming nitrate.  The reaction of NO with superoxide generates peroxynitrite which 
decomposes to nitrate, nitrite and O2 (294).  The reaction of nitrite with NAC is 
more likely to occur in an acidic environment, therefore in the neutral environment 
of the mucus layer (317) this reaction if likely to liberate only a small concentration 
of NO.  In contamination studies the concentrations of nitrate and nitrite used were 
deliberately  excessive  to  ensure  the  subsequent  cleaning  process  was  adequate.  
This would explain why small concentrations could be found.  The effect of NAC 
on uncontaminated samples is unlikely to be having a significant artefactual effect 
on  nitrite  and  nitrate  concentrations,  as  evidenced  by  the  fact  that  samples  not 
contaminated but rather just cleaned in NAC showed no recordable difference in 
nitrate and nitrite concentrations.  Unfortunately, in our experiments we did not 
examine for the reaction of NAC with nitrite. 
 
It would appear that we are able to measure intramucosal nitrate and nitrite 
concentrations, and the change in these concentrations after exposure to NO.  In 
studies where rat tissue was exposed to nitrite in the absence of ascorbic acid, so 
that only nitrous acid rather than NO would be present, there was no increase in 
nitrate and nitrite concentrations.  This shows that it is the presence of acidified 
nitrite with ascorbic acid present generating NO that is important for the increased 
intramucosal concentrations of nitrite and nitrate.  This not only shows that a flux in 
intraepithelial nitrite and nitrate concentrations is measurable, but also that the NO 283 
 
generated does have direct effects on the tissue in terms of nitrosative stress.  In 
these  studies  we  have  used  nitrite  as  a  marker  of  nitrosative  stress.    The 
concentration of nitrite used in these experiments was not excessive, being 120µM, 
while the concentrations found in vivo have been 5-200µM after a nitrate rich meal 
(45,143).  This means that the concentrations found in vivo are significant enough 
to cause a measurable flux in tissue nitrate and nitrite concentrations, albeit in rat 
tissue.  This  would,  therefore,  allow  for  damage  to  occur  either  through  the 
generation  of  N-nitrosocompounds  or  by  NO  directly  affecting  the  cell.    The 
carcinogenic  effects  of  N-nitrosocompounds  and  NO  are  well  established,  as 
discussed in the introduction to this thesis 
 
A recent study by Asanuma et al looked at a different marker of nitrosative 
stress due to NO in human upper gastrointestinal tract tissue.  This study made use 
of the high affinity of NO for Fe-S cluster proteins, and the fact that measurable 
DNIC  (dinitrosyl  dithiolato  iron  complex)  is  a  biomarker  for  the  interaction 
between Fe-S proteins and NO.  After the ingestion of nitrate drink, the appearance 
of DNIC was found in biopsies from the gastroesophageal junction in a significant 
number of human volunteers.  This, therefore, provides complimentary evidence of 
NO generated within the lumen of the upper gastrointestinal tract having a direct 
effect within the cells in the mucosa (285).  In another recent study by Clemons et 
al, acidification of salivary nitrite, resulting in the generation of NO, was shown to 
produce  double  strand  DNA  breaks  in  transformed  and  primary  Barrett’s 
oesophageal cells, as well as adenocarcinoma cells (238).  These studies show that 284 
 
cells  of  the  upper  gastrointestinal  tract  have  determinable,  detrimental  changes 
related to NO generated from salivary nitrite, albeit in the setting of in vitro studies. 
 
This chapter adds to the current research on nitrosative stress in the upper 
gastrointestinal tract by showing that rat tissue can be adequately cleaned of mucus, 
and that NO flux into the cells is measurable as intramucosal nitrite and nitrate.  It 
would also appear that luminal nitrite requires the conversion to NO to be able to 
have  significant  effects,  as  without  ascorbic  acid  there  was  no  measurable 
difference in nitrite and nitrate concentrations in experiments where rat stomach 
tissue was exposed to nitrous acid in three layer model.  As well as nitrite being a 
marker for this nitrosative stress, we have shown that nitrate is also important to 
measure in the in vivo setting. 
 285 
 
Chapter 11 Concluding discussion 
 
The studies described within this thesis add to the growing body of evidence in 
support of a novel mechanism of nitrosation within the upper gastrointestinal tract 
(43,45,144,221,222,280,285).  Nitrosation within the stomach is well described in 
the literature.  This is known to occur both from acid-catalysed nitrosation through 
decreased  ascorbic  acid  production,  and  also  from  colonisation  by  denitrifying 
bacteria in those who are achlorhydric.  The potential for a third mechanism, but in 
this case occurring in the healthy acid secreting stomach, in the presence of ascorbic 
acid, has been explored within the work presented in the preceding chapters.  Bench 
top experiments have been performed and then transferred into in vivo conditions to 
show the importance of this mechanism of nitrosative stress in human subjects. 
 
  The major source of this nitrosative stress is dietary nitrate.  Through bacterial 
conversion  of  nitrate  to  nitrite,  after  enterosalivary  recirculation  of  nitrate, 
swallowed  saliva  contains  high  concentrations  of  nitrite  (45).    When  this  saliva 
meets acidic gastric juice, in the presence of ascorbic acid, NO is produced (44).  
Ascorbic acid is therefore acting as a luminal antioxidant and, in this compartment, 
is preventing nitrosative stress by limiting the production of nitrosating species such 
as NOSCN and N2O3 (240,267,318,319). 
 
  However, within the upper gastrointestinal tract there is not only a luminal but 
also a lipid compartment.  Lipid is found in two main forms in this region.   There is 
fat  provided  in  the  diet  which  floats  within  the  more  proximal  stomach,  and  in 286 
 
particular  in  the  fundus,  post  prandially  (244).    Perhaps  providing  the  greatest 
surface area of lipid is the epithelial cell bilayer membranes.  The lipid bilayer forms 
a barrier between the luminal and epithelial compartments.  Within cells of intestinal 
metaplasia type there is particularly high lipid content (243).  Work presented in 
chapter  3  showed  that  when  lipid  is  added  to  an  aqueous  phase  the  aqueous 
antioxidant (ascorbic acid) can change from being antioxidant to pro-oxidant.  This 
occurs due to the reaction product of nitrite with ascorbic being the highly lipophilic 
molecule NO.  NO then diffuses into the lipid, where it can rapidly react with O2 to 
form nitrosating species such as N2O3 (251).   In support of ascorbic acid being pro 
carcinogenic in certain situations, a previous study has shown that it can potentiate 
the  growth  inhibitory  effects  of  NO  in  SK-N-MC  human  neuroblastoma  (320).  
Ascorbic acid was not the first antioxidant to have been shown to have carcinogenic 
potential.    The  synthetic  antioxidant  BHA  was  demonstrated,  in  rat  forestomach 
epithelium, to be carcinogenic as early as 1983 (262).  One of the limitations of the 
studies in Chapter 3 was the measurement of lipid nitrosamine concentrations.  A 
robust lipid nitrosamine analysis has subsequently been developed, and results from 
these  experiments  confirm  the  results  presented  in  this  thesis,  showing  that 
nitrosamines are present within the lipid phase in high concentrations within our 
model (255). 
 
  The importance of lipid antioxidants has been recognised for many years.  Α-
tocopherol is the most abundant lipid antioxidant in living organisms.  Our studies 
have shown that this has an important inhibitory effect on nitrosation, in models of 287 
 
the  gastroesophageal  junction.    The  effect  of  ʱ-tocopherol  was  greater  than  β-
carotene, which was in turn greater than the synthetic antioxidant BHT.  This is in 
keeping with in vitro experiments assessing the effectiveness of lipid chain breaking 
antioxidants (270), and also their biological activities in vivo (256).  Other studies 
have  shown  that  β-carotene  has  the  greatest  inhibitory  effect  on  bacterial 
mutagenicity  from  NO  (125).    Nonetheless,  all  three  antioxidants  inhibited 
nitrosation within our model.  The surprising result from this set of experiments was 
the low concentration of ʱ-tocopherol required to prevent nitrosation.  This is due to 
the in vitro recycling of ʱ-tocopherol by ascorbic acid as shown by experiments in 
chapter 5.  Whether this process occurs in vivo is an area of controversy with some 
experiments  suggesting  such  a  process  (162,321),  while  others  have  shown  no 
recycling (174).   There have also been studies to show synergy between β-carotene 
and  ascorbic  acid  (266).    Further  experiments  using  different  combinations  of 
antioxidants could be undertaken in our models of the upper gastrointestinal tract.  
Within the studies presented in this thesis it would also have been worthwhile to 
determine the reaction products of the reaction between ʱ-tocopherol and nitrite, NO 
and nitrosating species.  This may include measurement of reaction products such as 
ʱ-tocopheroxyl radical and ʱ-tocopherolquinone. 
 
  In order to transfer our understanding of gastroesophageal junction chemistry in 
vitro to the in vivo setting, a compartmentalised silastic tubing capable of measuring 
nitrosative stress was produced.  In subsequent studies using this tubing, in healthy 
volunteers,  we  showed  nitrosative  stress  extending  from  the  gastroesophageal 288 
 
junction into the proximal stomach.  This was increased after a nitrate rich drink was 
ingested.  The proposed mechanism for this is that the increased nitrite swallowed in 
saliva, after a nitrate rich meal, causes both the generation of NO while ascorbic acid 
is  present,  and  acid-catalysed  nitrosation  once  gastric  ascorbic  acid  has  been 
overwhelmed in  its  initial  reaction with  nitrite with  subsequent  recycling of this 
nitrite through NO.  The tubing was further developed, in vitro, to include lipid 
antioxidant  smeared  either  inside  or  outside.      Importantly,  this  showed  the 
generation  of  NO  from  the  reaction  between  nitrite  and  ʱ-tocopherol,  whether 
outside or inside the tube.  This modified tubing could be used in vivo in due course, 
although it would be best to standardise the concentrations of ʱ-tocopherol inside the 
tubing before this is undertaken.   
 
  Our in vivo studies have not clearly shown whether nitrite is a good biomarker 
of nitrosative stress in human tissue.  This is mainly due to difficulties in cleaning 
adherent mucus from biopsy specimens.  Perhaps a more useful assessment of NO 
within the cells from the upper gastrointestinal tract would have come from analysis 
using diaminofluorescence  and its  diacetate (322).   Different markers  have been 
assessed by other groups.  In a study by Asanuma et al, Fe-S cluster proteins affinity 
with NO has been used to assess for NO generation in the upper gastrointestinal tract 
after a nitrate rich meal.  A biomarker of the reaction between Fe-S cluster protein 
and NO was found in biopsies from the gastroesophageal junction in a significant 
number  of  subjects.    This,  therefore,  provides  complementary  evidence  of  NO 289 
 
generated within the lumen of the upper gastrointestinal tract having a direct effect 
within the cells in the mucosa (285). 
 
It had been hoped that data regarding the measurement the DNA adduct O
6-
carboxymethyl-2’-deoxyguanosine and O
6-methyl deoxyguanosine as biomarkers of 
nitrosative stress would have been presented within this thesis.  DNA adducts can be 
useful markers of stress as they are more frequent abnormalities than cancer itself, 
they can be recognised early and they predict the onset of disease independently of 
exposure  levels  (323).    Previous  work  had  shown  the  DNA  adduct  O
6-
carboxymethyl-2’-deoxyguanosine present in human gastric biopsy tissue which had 
been  exposed to  endogenously nitrosated  glycine (324).   In our studies,  we had 
hoped  to  measure  the  DNA  adduct  O
6-methyl  deoxyguanosine  and  O
6-
carboxymethyl-2’-deoxyguanosine before and after a nitrate meal.  These studies 
were performed on healthy volunteers.  Unfortunately, however, while waiting for 
refinement of the assay by collaborative colleagues in Greece, the samples were 
destroyed by a freezer failure within our department.  This is an area of research that 
could be explored again in the future.   
 
  Epidemiological studies do not provide a strong association when assessing the 
influence of nitrosamine, and related food intake, on oesophageal and gastric cancer 
(325).  However, recent studies carried out in humans have shown that endogenous 
N-nitrosocompounds  could  be  up  to  30  fold  higher  than  exposure  from  dietary 290 
 
sources,  suggesting  that  only  a  small  part  of  the  human  exposure  to  N-
nitrosocompounds has been measured (326-328). 
 
  The epidemiological evidence for an association between dietary nitrate intake 
and adenocarcinoma of the upper gastrointestinal tract is admittedly weak.  The only 
study to suggest a positive association was a large Swedish based one in 2001 (25),
 
while many others suggest a negative association with a high fruit and vegetable 
intake, likely to be due to the antioxidants present within these foodstuffs.  The 
reason for the lack of a positive association may be due to difficulty elucidating the 
finer details of a subgroup of people who are at risk from this nitrosative stress.   
 
  There are a few important considerations to take into account in interpreting the 
role  of  dietary  nitrate  in  overall  health.    It  is  clear  throughout  many  aspects  of 
biological systems that, while a compound may be protective in some contexts, it 
can be harmful in others.  It would be unreasonable to suggest that nitrate is entirely 
a harmful substance and should be eliminated from our diet.  There is evidence that 
dietary nitrate may indeed by protective.  There has been a recent hypothesis article 
suggesting a cardioprotective effect  from  NO derived from  dietary nitrate (329).  
This stems from epidemiological studies suggesting the strongest protection against 
coronary heart disease was seen in individuals with a high intake of green leafy 
vegetables which are rich in nitrate (330,331).  There is also evidence that dietary 
vegetables reduce blood pressure (332).  As regards the upper gastrointestinal tract, 
there  is  some  evidence  that  dietary  nitrate  has  a  protective  effect.    This  can  be 291 
 
through  increased  gastric  blood  flow,  increased  mucus  thickness  and 
decontamination of the human stomach (333-338).   
 
However, there does appear to be the potential for harmful effects of nitrate in 
the upper gastrointestinal tract.  The specific role has yet to be fully elucidated.  It is 
well  recognised  that  there  will  be  more  than  one  insult  required  to  promote 
carcinogenesis in the lower oesophagus and proximal stomach (339).  Nitrosative 
stress from dietary nitrate may be most harmful in subjects with acid and bile reflux.  
It has  been shown that nitrosative stress  is  shifted into the lower oesophagus  in 
subjects with Barrett’s oesophagus (286).  It is known that acidity has a deleterious 
effect on the mucosal protective barrier leading to caustic injury of the mucosa, as 
well  as  causing  DNA  damage  within  oesophageal  cells  (238).    Bile  refluxate 
provides three conditions which would potentiate nitrosative stress within the lower 
oesophagus.  It contains bile acids such as glycocholic and taurocholic acid that are 
nitrosatable amides.  Spermidine, a nitrosatable polyamine, which is carcinogenic, is 
also present (340).  Bile also contains lecithin which is known to promote nitrosation 
reactions (341).  N-nitrosamides and related compounds are chemically active under 
physiological pH conditions and decompose to form the same alkyldiazohydroxide 
as nitrosamines.  Nitrosamides have been shown to produce both local as well as 
systemic tumours.  Conditions within the lower oesophagus, in those individuals 
with acid and bile reflux, are therefore such that nitrosative stress from nitrate may 
have an important role in adenocarcinoma development. 
 292 
 
  The  work  presented  within  this  thesis  shows  that  dietary  nitrate  has  the 
potential to generate nitrosative stress within the upper GI tract where salivary nitrite 
meets  acidic  gastric  juice.    This  may  have  relevance  to  the  observed  increased 
incidence  of  adenocarcinoma  in  the  cardia  region  of  the  stomach  and  the 
gastroesophageal junction.  The combination of molecular tools with biochemistry is 
likely  to  provide  useful  information  regarding  nitrosative  stress  in  the  upper 
gastrointestinal tract, and in particular the role of dietary nitrate in carcinogenesis of 
the lower esophagus and proximal stomach, as we search for a mutagen responsible 
for the increased incidence of adenocarcinoma in this anatomical region.   
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